gene_id,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,PSC.0228,PSC.0187,PSC.0188,PSC.0174,PSC.0190,PSC.0231,PSC.0230,PSC.0219,PSC.0177,PSC.0186,PSC.0209,PSC.0203,V2,uniprot_accession,gene_name,V5,V6,V7,V8,V9,V10,V11,V12,V13,V14,Entry,Reviewed,Entry.Name,Protein.names,Gene.Names,Organism,Length,Gene.Ontology.biological.process,Gene.Ontology.IDs
g1377,1525.639235,1.270317323,0.30292967,4.193439759,2.75E-05,0.000218245,3221,1352,2123,1314,1512,1541,1723,1302,1334,967,479,863,sp,P54725,RD23A_HUMAN,41.912,408,172,8,1,1176,3,361,8.94E-76,242,P54725,reviewed,RD23A_HUMAN,UV excision repair protein RAD23 homolog A (HR23A) (hHR23A),RAD23A,Homo sapiens (Human),363,nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],GO:0000502; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006289; GO:0019900; GO:0031593; GO:0031648; GO:0032434; GO:0032436; GO:0032991; GO:0043130; GO:0043161; GO:0043231; GO:0045070; GO:0045787; GO:0070628; GO:1990381
g19475,786.8160768,2.190568155,0.328872658,6.660839994,2.72E-11,9.31E-10,1558,1176,670,1012,1250,622,381,302,415,293,310,332,sp,Q9H3F6,BACD3_HUMAN,71.483,263,68,4,88,873,28,284,2.79E-134,386,Q9H3F6,reviewed,BACD3_HUMAN,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10),KCTD10 ULR061 MSTP028,Homo sapiens (Human),313,negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260
g9945,1114.189249,1.461550369,0.272165648,5.370076569,7.87E-08,1.27E-06,1762,992,1091,1913,1151,1202,804,716,808,610,737,594,sp,O73817,PSB3_ONCMY,72.683,205,37,1,1,558,1,205,5.98E-105,302,O73817,reviewed,PSB3_ONCMY,Proteasome subunit beta type-3 (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain),psmb3,Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri),205,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0043161
g13662,222.3821892,-0.806377827,0.231679048,-3.480581583,0.000500326,0.002643264,238,181,141,128,88,81,424,372,308,375,366,219,sp,Q5ZKD9,KLH20_CHICK,28.788,198,122,4,52,624,58,243,2.63E-10,63.2,Q5ZKD9,reviewed,KLH20_CHICK,Kelch-like protein 20,KLHL20 RCJMB04_11i2,Gallus gallus (Chicken),610,Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390
g14478,60.73188569,-2.478275998,0.32038314,-7.735350866,1.03E-14,6.60E-13,21,17,11,21,10,15,102,125,144,120,137,100,sp,P0C2W1,FBSP1_HUMAN,72.727,220,59,1,25,681,39,258,3.93E-115,334,P0C2W1,reviewed,FBSP1_HUMAN,F-box/SPRY domain-containing protein 1 (F-box only protein 45) (hFbxo45),FBXO45 FBX45,Homo sapiens (Human),286,anterior commissure morphogenesis [GO:0021960]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; DNA damage response [GO:0006974]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of synaptic vesicle exocytosis [GO:2000300]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001764; GO:0005576; GO:0005634; GO:0005737; GO:0006511; GO:0006974; GO:0014069; GO:0016567; GO:0019005; GO:0021799; GO:0021800; GO:0021957; GO:0021960; GO:0042734; GO:0042995; GO:0043161; GO:0045202; GO:0045211; GO:0060386; GO:0070936; GO:0098978; GO:0099523; GO:0099524; GO:1990756; GO:2000300
g14472,356.6106183,-0.90343508,0.245093605,-3.686081819,0.000227733,0.001361796,289,199,213,319,129,137,625,514,595,576,619,421,sp,Q5REY7,UBXN7_PONAB,54.088,318,133,6,1,954,1,305,6.50E-99,311,Q5REY7,reviewed,UBXN7_PONAB,UBX domain-containing protein 7,UBXN7 UBXD7,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),489,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005654; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629
g11179,1166.977391,0.537171481,0.19378574,2.771986638,0.005571532,0.019914725,1829,1109,1248,1419,708,904,1357,979,1251,1205,1218,884,sp,Q9R1P4,PSA1_MOUSE,75.949,237,57,0,1,711,1,237,1.23E-133,382,Q9R1P4,reviewed,PSA1_MOUSE,Proteasome subunit alpha type-1 (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain) (Proteasome subunit alpha-6) (alpha-6),Psma1,Mus musculus (Mouse),263,immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000502; GO:0001530; GO:0002376; GO:0002862; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005839; GO:0019773; GO:0043161
g6607,573.3589323,1.026715435,0.300049242,3.421823127,0.000622028,0.003177394,1142,525,636,499,498,650,527,365,689,530,230,405,sp,Q5ZK10,NSF1C_CHICK,42.298,409,188,8,13,1221,2,368,7.08E-85,266,Q5ZK10,reviewed,NSF1C_CHICK,NSFL1 cofactor p47 (p97 cofactor p47),NSFL1C RCJMB04_13o20,Gallus gallus (Chicken),369,autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000045; GO:0000132; GO:0005634; GO:0005795; GO:0005813; GO:0005829; GO:0007030; GO:0008289; GO:0031468; GO:0043130; GO:0043161; GO:0046604; GO:0061025; GO:1904780; GO:1990730
g18476,1034.804131,1.0517391,0.193311914,5.440632591,5.31E-08,8.95E-07,1462,1387,1214,1135,910,1010,987,858,821,927,451,883,sp,Q8QG64,RBX1_SALSA,100,87,0,0,70,330,21,107,3.46E-61,185,Q8QG64,reviewed,RBX1_SALSA,E3 ubiquitin-protein ligase RBX1 (EC 2.3.2.27) (EC 2.3.2.32) (Hyperosmotic protein 21) (sHOP21) (RING-box protein 1) (Rbx1),rbx1 hop21,Salmo salar (Atlantic salmon),108,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0005634; GO:0005737; GO:0006513; GO:0008270; GO:0016567; GO:0019005; GO:0031146; GO:0031463; GO:0031464; GO:0031465; GO:0031467; GO:0043161; GO:0045116; GO:0061630; GO:0061663; GO:0097602
g21244,1004.499074,1.600848527,0.313427924,5.107549153,3.26E-07,4.47E-06,3010,977,1061,1168,857,916,848,533,847,490,415,515,sp,Q9Z2U1,PSA5_MOUSE,79.253,241,50,0,1,723,1,241,3.60E-147,413,Q9Z2U1,reviewed,PSA5_MOUSE,Proteasome subunit alpha type-5 (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome subunit alpha-5) (alpha-5) (Proteasome zeta chain),Psma5,Mus musculus (Mouse),241,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0019773; GO:0043161
g14871,780.7714899,1.118435913,0.293641488,3.808848403,0.000139616,0.000900515,1710,665,889,982,620,695,731,564,610,392,812,429,sp,P25787,PSA2_HUMAN,82.203,236,39,2,1,705,1,234,2.20E-144,405,P25787,reviewed,PSA2_HUMAN,Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3) (Proteasome subunit alpha-2) (alpha-2),PSMA2 HC3 PSC3,Homo sapiens (Human),234,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615],GO:0000502; GO:0000932; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0009615; GO:0019773; GO:0034774; GO:0043161; GO:0070062; GO:1904813
g11585,1621.458056,1.354470952,0.279696219,4.84265021,1.28E-06,1.50E-05,3160,1467,1626,1707,1849,1807,1248,991,1339,870,1174,921,sp,P46471,PRS7_MOUSE,90.553,434,40,1,1,1302,1,433,0,763,P46471,reviewed,PRS7_MOUSE,26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2),Psmc2 Mss1,Mus musculus (Mouse),433,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000932; GO:0005524; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0043161; GO:0043197; GO:0140296
g17328,162.3532508,1.42792885,0.365713512,3.904501214,9.44E-05,0.000643503,220,159,155,155,224,219,125,84,111,97,52,168,sp,Q9HAU4,SMUF2_HUMAN,70.5,200,50,2,1,600,1,191,5.31E-96,300,Q9HAU4,reviewed,SMUF2_HUMAN,E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2),SMURF2,Homo sapiens (Human),748,"negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0000122; GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016607; GO:0017015; GO:0030512; GO:0030514; GO:0042802; GO:0043161; GO:0045121; GO:0045892; GO:0046332; GO:0060071; GO:0061630; GO:0090263; GO:1901165
g17329,411.2786026,1.987134134,0.391268888,5.078691904,3.80E-07,5.11E-06,713,362,416,372,683,565,284,130,173,200,108,324,sp,A9JRZ0,SMUF2_DANRE,67.614,528,105,6,1,1398,242,765,0,733,A9JRZ0,reviewed,SMUF2_DANRE,E3 ubiquitin-protein ligase SMURF2 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2),smurf2,Danio rerio (Zebrafish) (Brachydanio rerio),765,negative regulation of BMP signaling pathway [GO:0030514]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005634; GO:0005737; GO:0005886; GO:0016567; GO:0030514; GO:0043161; GO:0045121; GO:0046332; GO:0061630
g13964,979.0957353,-1.627383103,0.271217765,-6.0002821,1.97E-09,4.64E-08,572,784,467,246,206,316,2959,2135,1251,2140,1019,1643,sp,P49407,ARRB1_HUMAN,57.045,440,145,12,187,1488,4,405,3.35E-151,441,P49407,reviewed,ARRB1_HUMAN,Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2),ARRB1 ARR1,Homo sapiens (Human),418,G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],GO:0000139; GO:0000785; GO:0001664; GO:0001934; GO:0002031; GO:0002092; GO:0003713; GO:0004857; GO:0005096; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0006357; GO:0006511; GO:0007165; GO:0007601; GO:0015031; GO:0016567; GO:0016604; GO:0030659; GO:0031143; GO:0031397; GO:0031410; GO:0031625; GO:0031701; GO:0032088; GO:0032715; GO:0032717; GO:0035025; GO:0043149; GO:0043161; GO:0045746; GO:0045944; GO:0070374; GO:1990763
g12733,731.5553764,0.64748658,0.219892412,2.944560818,0.003234134,0.012677327,744,1135,701,686,625,623,822,629,643,638,816,569,sp,Q8BK63,KC1A_MOUSE,81.373,306,56,1,25,942,5,309,0,510,Q8BK63,reviewed,KC1A_MOUSE,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),Csnk1a1,Mus musculus (Mouse),337,cell division [GO:0051301]; cell morphogenesis [GO:0000902]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],GO:0000287; GO:0000776; GO:0000902; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005813; GO:0005819; GO:0005829; GO:0005929; GO:0006468; GO:0007030; GO:0007165; GO:0016055; GO:0016607; GO:0018105; GO:0030877; GO:0032436; GO:0036064; GO:0042277; GO:0043161; GO:0045104; GO:0051219; GO:0051301; GO:0090090; GO:0106310; GO:1900226; GO:1990904
g14363,1106.996185,0.546852485,0.176437182,3.099417475,0.001939016,0.008284427,1327,1043,974,1163,874,1207,1594,1015,1020,1070,866,1071,sp,Q6GPF3,CUL3B_XENLA,78.609,762,150,3,10,2256,7,768,0,1233,Q6GPF3,reviewed,CUL3B_XENLA,Cullin-3-B (CUL-3-B),cul3b,Xenopus laevis (African clawed frog),768,cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149],GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005827; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0016477; GO:0016567; GO:0017145; GO:0031463; GO:0031625; GO:0035024; GO:0040016; GO:0043149; GO:0043161; GO:0045842; GO:0048208; GO:0072686; GO:1901992
g5001,538.059899,1.142401174,0.25306969,4.514176207,6.36E-06,6.19E-05,1213,534,574,601,369,606,484,473,512,312,328,319,sp,Q5RE15,PSMD8_PONAB,67.293,266,85,1,4,795,24,289,2.27E-120,348,Q5RE15,reviewed,PSMD8_PONAB,26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12),PSMD8,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),289,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005634; GO:0005829; GO:0008541; GO:0022624; GO:0043161
g5002,1134.452049,1.589344875,0.296470533,5.360886499,8.28E-08,1.33E-06,2674,928,1107,1488,1310,1061,822,612,790,599,606,665,sp,P62334,PRS10_MOUSE,89.717,389,40,0,1,1167,1,389,0,723,P62334,reviewed,PRS10_MOUSE,26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42),Psmc6 Sug2,Mus musculus (Mouse),389,ERAD pathway [GO:0036503]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005524; GO:0005634; GO:0008540; GO:0016234; GO:0016887; GO:0022624; GO:0031597; GO:0036402; GO:0036503; GO:0042802; GO:0043161; GO:0045899; GO:0090261
g208,390.7642792,2.08689625,0.673383665,3.099119209,0.001940969,0.008290809,457,126,122,184,1077,619,130,273,265,144,122,117,sp,D3ZQG6,TRIM2_RAT,28.906,256,140,8,1,732,8,233,1.92E-16,86.7,D3ZQG6,reviewed,TRIM2_RAT,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),Trim2,Rattus norvegicus (Rat),744,cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630; GO:1990830
g5709,429.9058296,1.322084954,0.271311075,4.872948715,1.10E-06,1.31E-05,636,557,406,373,486,580,371,246,260,381,179,365,sp,Q93034,CUL5_HUMAN,75.456,493,87,3,1,1401,296,780,0,749,Q93034,reviewed,CUL5_HUMAN,Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1),CUL5 VACM1,Homo sapiens (Human),780,ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; reelin-mediated signaling pathway [GO:0038026]; regulation of neuron migration [GO:2001222]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0000082; GO:0004842; GO:0005262; GO:0005634; GO:0005829; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031466; GO:0031625; GO:0038023; GO:0038026; GO:0038128; GO:0043161; GO:0070979; GO:0090734; GO:0097193; GO:0160072; GO:2001222
g15362,1318.780669,1.136812388,0.2622506,4.334832358,1.46E-05,0.000126443,2367,1293,1359,1304,1413,1341,1389,717,1011,885,1244,761,sp,O43242,PSMD3_HUMAN,65.868,501,163,2,22,1503,34,533,0,587,O43242,reviewed,PSMD3_HUMAN,26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58),PSMD3,Homo sapiens (Human),534,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813
g3209,1423.27628,0.712001026,0.203356337,3.501248277,0.000463084,0.002474765,2147,1319,1220,1265,1190,1758,1924,1285,1228,1299,1123,1107,sp,A9JTG5,HOIL1_DANRE,37.931,609,336,10,262,2007,121,714,3.27E-135,416,A9JTG5,reviewed,HOIL1_DANRE,RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog),rbck1 zgc:175152,Danio rerio (Zebrafish) (Brachydanio rerio),714,defense response to bacterium [GO:0042742]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039],GO:0004842; GO:0042742; GO:0043123; GO:0043130; GO:0043161; GO:0046872; GO:0048701; GO:0071600; GO:0071797; GO:0097039
g23285,739.5888172,1.060411792,0.256758251,4.130000845,3.63E-05,0.000278112,1432,696,751,802,660,764,608,508,752,459,587,510,sp,Q9V3H2,PSDE_DROME,86.495,311,39,1,1,933,1,308,0,566,Q9V3H2,reviewed,PSDE_DROME,26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory complex subunit p37B) (26S proteasome regulatory subunit rpn11) (Yippee-interacting protein 5),Rpn11 yip5 CG18174,Drosophila melanogaster (Fruit fly),308,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0016579; GO:0043161; GO:0046872; GO:0070628; GO:0140492
g23854,60.92048869,-2.187878565,0.582619182,-3.755246367,0.000173171,0.001079523,0,35,21,23,7,27,181,91,105,135,132,94,sp,Q9R1A8,COP1_MOUSE,52.924,342,132,9,100,1092,123,446,6.47E-111,343,Q9R1A8,reviewed,COP1_MOUSE,E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2),Cop1 Rfwd2 RNF200,Mus musculus (Mouse),733,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212],GO:0000139; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0046872; GO:0061630
g23853,54.23902331,-2.155465952,0.383718717,-5.617307308,1.94E-08,3.67E-07,25,17,7,31,8,15,187,76,79,97,130,91,sp,Q9R1A8,COP1_MOUSE,76.981,265,57,1,1,783,469,733,6.45E-148,434,Q9R1A8,reviewed,COP1_MOUSE,E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2),Cop1 Rfwd2 RNF200,Mus musculus (Mouse),733,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212],GO:0000139; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0046872; GO:0061630
g20953,871.1657972,0.808152002,0.259560491,3.113540125,0.001848574,0.007956406,1779,858,967,978,673,544,890,800,936,639,726,579,sp,Q9V3G7,PSMD6_DROME,71.722,389,110,0,1,1167,1,389,0,586,Q9V3G7,reviewed,PSMD6_DROME,26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit S10) (Protein Rpn7),Rpn7 CG5378,Drosophila melanogaster (Fruit fly),389,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0043161
g19889,473.7226721,1.539740668,0.390108195,3.946958019,7.92E-05,0.000551304,702,421,424,350,784,613,328,185,303,428,184,340,sp,A5HK05,APBP2_RAT,67.826,575,183,1,10,1734,3,575,0,808,A5HK05,reviewed,APBP2_RAT,Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2),Appbp2,Rattus norvegicus (Rat),585,intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005654; GO:0005874; GO:0006886; GO:0016567; GO:0030659; GO:0031462; GO:0043161; GO:0046907; GO:1990756
g133,50.07800856,4.753232026,1.168068461,4.06930945,4.72E-05,0.000349903,12,212,142,4,0,168,5,8,10,2,0,1,sp,Q9R1R2,TRIM3_MOUSE,30,180,122,2,16,549,7,184,9.52E-21,97.4,Q9R1R2,reviewed,TRIM3_MOUSE,Tripartite motif-containing protein 3 (EC 2.3.2.27) (RING finger protein 22) (RING finger protein HAC1),Trim3 Hac1 Rnf22,Mus musculus (Mouse),744,negative regulation of translation [GO:0017148]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252],GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252
g11649,1218.598221,1.375924638,0.341829125,4.025182576,5.69E-05,0.000412791,2198,1249,1323,1492,1523,922,2253,595,612,699,530,677,sp,Q9ES00,UBE4B_MOUSE,49.164,1076,493,9,337,3435,106,1170,0,1051,Q9ES00,reviewed,UBE4B_MOUSE,Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2),Ube4b Ufd2 Ufd2a,Mus musculus (Mouse),1173,ERAD pathway [GO:0036503]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030163; GO:0031175; GO:0034450; GO:0034976; GO:0036503; GO:0043161; GO:0051082; GO:0051117; GO:0051865; GO:0061630
g12645,344.3604404,0.499874898,0.190384092,2.625612738,0.008649316,0.028479148,436,326,306,322,283,352,498,379,319,312,254,338,sp,Q9P0J7,KCMF1_HUMAN,60.641,343,116,5,1,1017,1,328,8.36E-130,380,Q9P0J7,reviewed,KCMF1_HUMAN,E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (ZZ-type zinc finger-containing protein 1),KCMF1 FIGC ZZZ1,Homo sapiens (Human),381,negative regulation of HRI-mediated signaling [GO:0141191]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to oxidative stress [GO:0006979]; synaptic signaling [GO:0099536]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0005829; GO:0005886; GO:0006511; GO:0006979; GO:0008270; GO:0043161; GO:0045202; GO:0061630; GO:0070534; GO:0070936; GO:0099536; GO:0141191; GO:1904813
g14607,372.7141995,1.393825395,0.351405735,3.966427567,7.30E-05,0.000514821,533,324,417,252,592,429,376,260,220,331,180,166,sp,Q5NVK7,SPOP_PONAB,81.163,361,67,1,4,1086,15,374,0,596,Q5NVK7,reviewed,SPOP_PONAB,Speckle-type POZ protein,SPOP,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),374,localization [GO:0051179]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of proteolysis [GO:0030162],GO:0000209; GO:0005634; GO:0005737; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161; GO:0051179
g4190,865.9911937,1.015922234,0.231926204,4.380368486,1.18E-05,0.000106325,1730,811,988,1297,604,636,790,703,660,685,642,667,sp,P60901,PSA6_RAT,79.268,246,51,0,1,738,1,246,3.25E-151,424,P60901,reviewed,PSA6_RAT,Proteasome subunit alpha type-6 (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) (Proteasome subunit alpha-1) (alpha-1),Psma6,Rattus norvegicus (Rat),246,positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in protein catabolic process [GO:0051603],GO:0000502; GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0005839; GO:0005840; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0043161; GO:0051059; GO:0051092; GO:0051603
g2521,1874.745592,0.831911535,0.269402338,3.087989287,0.002015157,0.008530975,2230,1845,1690,1610,2162,2077,2685,1333,1276,2219,1181,1446,sp,Q8BZZ3,WWP1_MOUSE,66.667,582,176,5,1060,2763,341,918,0,786,Q8BZZ3,reviewed,WWP1_MOUSE,NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase WWP1) (WW domain-containing protein 1),Wwp1,Mus musculus (Mouse),918,lung development [GO:0030324]; negative regulation of DNA-templated transcription [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217],GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016567; GO:0030217; GO:0030324; GO:0043161; GO:0045892; GO:0061630
g2520,1378.59344,0.949555244,0.306093306,3.102175792,0.001921038,0.008221243,2483,1052,1468,1878,1259,1063,1437,1258,1479,1014,543,1138,sp,Q32KL2,PSB5_BOVIN,62.637,273,85,4,1,810,1,259,6.65E-116,336,Q32KL2,reviewed,PSB5_BOVIN,Proteasome subunit beta type-5 (EC 3.4.25.1),PSMB5,Bos taurus (Bovine),263,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to oxidative stress [GO:0006979],GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005839; GO:0006979; GO:0019774; GO:0043161
g16729,199.7291642,1.262087244,0.313762796,4.022424778,5.76E-05,0.00041732,431,210,141,227,230,172,199,135,146,101,131,145,sp,Q9VBP9,NPL4_DROME,51.266,316,143,1,1,915,337,652,4.29E-112,341,Q9VBP9,reviewed,NPL4_DROME,Nuclear protein localization protein 4 homolog,Npl4 CG4673,Drosophila melanogaster (Fruit fly),652,cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0031625; GO:0043130; GO:0043161; GO:0045879; GO:0046872; GO:0071795; GO:0098586
g16728,131.6924371,1.739631347,0.324588333,5.359500548,8.35E-08,1.34E-06,215,128,115,262,141,143,125,76,89,60,52,50,sp,P60670,NPL4_MOUSE,45.148,237,94,3,1,606,1,236,6.48E-67,196,P60670,reviewed,NPL4_MOUSE,Nuclear protein localization protein 4 homolog (Protein NPL4),Nploc4 Kiaa1499 Npl4,Mus musculus (Mouse),608,"ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0051117
g3771,821.2952088,0.758735642,0.295214214,2.570118939,0.01016636,0.032559415,951,1341,1085,461,545,1011,1144,740,687,931,285,786,sp,Q7TPD1,FBX11_MOUSE,71.357,803,219,5,310,2709,136,930,0,1198,Q7TPD1,reviewed,FBX11_MOUSE,F-box only protein 11,Fbxo11,Mus musculus (Mouse),930,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756
g17771,341.6857397,1.036329503,0.258825525,4.003969486,6.23E-05,0.0004475,502,350,404,218,378,425,410,269,242,225,255,248,sp,Q969H0,FBXW7_HUMAN,64.236,288,88,5,847,1707,195,468,9.88E-119,370,Q969H0,reviewed,FBXW7_HUMAN,F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4),FBXW7 FBW7 FBX30 SEL10,Homo sapiens (Human),707,cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570],GO:0001570; GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045741; GO:0045746; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0051443; GO:0055088; GO:0070374; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1902806; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2000346; GO:2000639; GO:2001205
g17770,148.0885597,1.184910478,0.346417941,3.420465105,0.000625142,0.003192397,246,166,120,119,186,169,152,72,87,146,144,63,sp,Q969H0,FBXW7_HUMAN,89.048,210,23,0,1,630,498,707,9.52E-126,374,Q969H0,reviewed,FBXW7_HUMAN,F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4),FBXW7 FBW7 FBX30 SEL10,Homo sapiens (Human),707,cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570],GO:0001570; GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045741; GO:0045746; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0051443; GO:0055088; GO:0070374; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1902806; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2000346; GO:2000639; GO:2001205
g12053,1438.858587,1.259398058,0.228737872,5.505857192,3.67E-08,6.45E-07,2795,1451,1578,1840,1336,1365,1214,1187,1169,1047,676,882,sp,Q60692,PSB6_MOUSE,62.174,230,87,0,1,690,1,230,2.85E-95,281,Q60692,reviewed,PSB6_MOUSE,Proteasome subunit beta type-6 (EC 3.4.25.1) (Low molecular mass protein 19) (Macropain delta chain) (Multicatalytic endopeptidase complex delta chain) (Proteasome delta chain) (Proteasome subunit Y) (Proteasome subunit beta-1) (beta-1),Psmb6 Lmp19,Mus musculus (Mouse),238,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005839; GO:0019774; GO:0043161
g15858,966.6397039,1.296128463,0.217306589,5.964515232,2.45E-09,5.71E-08,2012,990,1175,1080,867,964,1086,723,737,649,428,546,sp,Q4R7L3,PRS6B_MACFA,85.442,419,60,1,1,1257,1,418,0,680,Q4R7L3,reviewed,PRS6B_MACFA,26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (Proteasome 26S subunit ATPase 4),PSMC4 QtsA-14940,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),418,blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0001824; GO:0005524; GO:0005654; GO:0005829; GO:0008540; GO:0016887; GO:0022624; GO:0036402; GO:0043161
g1447,15111.59746,1.640544969,0.324675797,5.052871148,4.35E-07,5.78E-06,23115,14364,14613,18800,20762,18543,9586,6852,9186,7080,12576,7029,sp,P23787,TERA_XENLA,87.223,767,96,2,2155,4455,10,774,0,1330,P23787,reviewed,TERA_XENLA,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (p97) (Valosin-containing protein) (VCP),vcp,Xenopus laevis (African clawed frog),805,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985],GO:0000785; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0042802; GO:0043161; GO:0044877; GO:0061857; GO:0097352; GO:1903843; GO:1905634
g4233,1971.977593,1.302894447,0.297296573,4.38247382,1.17E-05,0.000105564,4116,1772,1712,1988,2281,2115,1683,1501,1517,969,1387,1157,sp,P48601,PRS4_DROME,89.342,441,45,1,1,1323,1,439,0,771,P48601,reviewed,PRS4_DROME,26S proteasome regulatory subunit 4 (P26s4),Rpt2 P26s4 Pros26.4 CG5289,Drosophila melanogaster (Fruit fly),439,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005524; GO:0005654; GO:0005829; GO:0005838; GO:0008540; GO:0016887; GO:0036402; GO:0043161
g15882,158.4770846,3.846256325,0.782095257,4.917887292,8.75E-07,1.07E-05,313,751,213,23,70,292,47,27,0,15,40,25,sp,Q9C040,TRIM2_HUMAN,34.969,163,96,3,4,489,3,156,3.63E-26,108,Q9C040,reviewed,TRIM2_HUMAN,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2),TRIM2 KIAA0517 RNF86,Homo sapiens (Human),744,negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630
g8525,456.0475538,1.449739993,0.390030089,3.716995259,0.000201606,0.0012296,621,348,935,243,273,1047,341,375,362,242,224,225,sp,P17439,GBA1_MOUSE,53.871,310,140,3,1,927,204,511,1.60E-114,343,P17439,reviewed,GBA1_MOUSE,Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase),Gba1 Gba,Mus musculus (Mouse),515,antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin epidermis development [GO:0098773]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021],GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0035307; GO:0042391; GO:0043161; GO:0043202; GO:0043243; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:0098773; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037
g12673,1259.460511,2.525007812,0.315373339,8.006408603,1.18E-15,8.70E-14,1297,1731,1745,1625,1963,1889,695,407,489,513,209,466,sp,Q3ULA2,FBW1A_MOUSE,74.409,508,103,2,7,1449,98,605,0,787,Q3ULA2,reviewed,FBW1A_MOUSE,F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit),Btrc Fbw1 Fbxw1 Fwd1 Kiaa4123,Mus musculus (Mouse),605,branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-templated transcription [GO:0045892]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006508; GO:0006511; GO:0008013; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0033598; GO:0038061; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:0071407; GO:1990756; GO:1990757
g6489,1428.557322,1.153813976,0.272972302,4.226853676,2.37E-05,0.000192043,2814,1110,1412,1629,1562,1322,1477,952,1250,1163,795,878,sp,O88685,PRS6A_MOUSE,83.953,430,59,3,31,1317,22,442,0,713,O88685,reviewed,PRS6A_MOUSE,26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Tat-binding protein 1) (TBP-1),Psmc3 Tbp1,Mus musculus (Mouse),442,blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000932; GO:0001824; GO:0005524; GO:0005634; GO:0008540; GO:0016887; GO:0022624; GO:0036402; GO:0043161; GO:0048471
g3645,409.4904026,-1.090988862,0.309299475,-3.527289726,0.000419837,0.002276683,164,182,342,160,168,296,855,881,376,631,740,582,sp,Q4R834,SIR2_MACFA,53.102,403,168,6,1,1206,1,383,5.67E-134,392,Q4R834,reviewed,SIR2_MACFA,NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2),SIRT2 QtsA-13614,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),389,cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; epigenetic regulation of gene expression [GO:0040029]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; regulation of myelination [GO:0031641]; tubulin deacetylation [GO:0090042],GO:0000122; GO:0000792; GO:0003682; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006476; GO:0010507; GO:0010801; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0040029; GO:0042177; GO:0042903; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0044224; GO:0044242; GO:0045599; GO:0045836; GO:0045944; GO:0046872; GO:0046970; GO:0048471; GO:0051301; GO:0051726; GO:0051781; GO:0051987; GO:0061433; GO:0070403; GO:0070446; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0140773; GO:0140774; GO:1900119; GO:1900195; GO:2000378
g17977,527.4091925,2.251359197,0.314443931,7.159811269,8.08E-13,3.67E-11,805,565,556,807,842,582,292,221,212,151,203,250,sp,Q9Z255,UBE2A_MOUSE,92.617,149,11,0,1,447,1,149,2.80E-102,292,Q9Z255,reviewed,UBE2A_MOUSE,Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (mHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A),Ube2a Rad6a,Mus musculus (Mouse),152,blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of mitophagy [GO:1901526]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567],GO:0000209; GO:0000785; GO:0001701; GO:0001741; GO:0001835; GO:0004842; GO:0005524; GO:0005764; GO:0005770; GO:0006281; GO:0016567; GO:0031625; GO:0033503; GO:0043161; GO:0060135; GO:0061631; GO:0070936; GO:0070979; GO:1901526
g11907,4101.285315,3.132260595,0.542801542,5.770544757,7.90E-09,1.64E-07,6456,6323,5642,2199,6260,8969,465,360,996,538,2171,1128,sp,A1Z6E0,GUS_DROME,65.108,278,89,4,19,834,1,276,5.92E-135,385,A1Z6E0,reviewed,GUS_DROME,Protein gustavus,gus CG2944,Drosophila melanogaster (Fruit fly),279,cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; wing disc morphogenesis [GO:0007472],GO:0005634; GO:0005737; GO:0005938; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0008354; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449
g10578,304.0559061,1.002962658,0.208636024,4.807236259,1.53E-06,1.75E-05,638,401,417,291,191,240,314,280,253,278,167,196,sp,Q5E9K0,PSB2_BOVIN,55.446,101,27,1,1,249,1,101,5.72E-32,113,Q5E9K0,reviewed,PSB2_BOVIN,Proteasome subunit beta type-2,PSMB2,Bos taurus (Bovine),201,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0019774; GO:0043161
g10579,259.7702746,1.14397682,0.308218682,3.711575213,0.000205973,0.001252427,584,284,363,250,178,246,282,235,204,233,62,190,sp,P40307,PSB2_RAT,58.442,77,32,0,1,231,118,194,4.22E-23,90.5,P40307,reviewed,PSB2_RAT,Proteasome subunit beta type-2 (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I) (Proteasome subunit beta-4) (beta-4),Psmb2,Rattus norvegicus (Rat),201,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070],GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0014070; GO:0019774; GO:0043161
g17254,411.9475031,1.402972138,0.262892229,5.336681667,9.47E-08,1.48E-06,657,706,491,310,433,448,569,225,230,188,242,260,sp,Q80U30,CL16A_MOUSE,54,800,285,17,1,2238,1,771,0,768,Q80U30,reviewed,CL16A_MOUSE,Protein CLEC16A,Clec16a Kiaa0350,Mus musculus (Mouse),1036,autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of autophagosome maturation [GO:1901096],GO:0006914; GO:0008333; GO:0016197; GO:0032435; GO:0036020; GO:0043161; GO:1901096; GO:1901098; GO:1901525
g17258,2817.806859,5.028664242,0.628440791,8.001810692,1.23E-15,8.96E-14,4311,4274,3136,1312,6449,5682,221,172,258,31,421,67,sp,O35717,SOCS2_MOUSE,40.741,189,85,3,166,732,35,196,3.29E-35,127,O35717,reviewed,SOCS2_MOUSE,Suppressor of cytokine signaling 2 (SOCS-2),Socs2,Mus musculus (Mouse),198,cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of multicellular organism growth [GO:0040014]; response to estradiol [GO:0032355],GO:0005131; GO:0005159; GO:0005737; GO:0005942; GO:0007259; GO:0007595; GO:0016567; GO:0031466; GO:0032355; GO:0035556; GO:0040014; GO:0040015; GO:0043161; GO:0045666; GO:0046426; GO:0046854; GO:0046935; GO:0060396; GO:0060400; GO:0060749; GO:0140031; GO:1990756
g14231,1517.820971,2.002393637,0.40588317,4.93342367,8.08E-07,1.00E-05,2152,1228,1274,1382,2750,2379,777,617,956,549,832,591,sp,Q9UBF6,RBX2_HUMAN,91.86,86,7,0,103,360,28,113,8.51E-55,169,Q9UBF6,reviewed,RBX2_HUMAN,RING-box protein 2 (Rbx2) (EC 2.3.2.27) (EC 2.3.2.32) (CKII beta-binding protein 1) (CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein),RNF7 RBX2 ROC2 SAG,Homo sapiens (Human),113,endoplasmic reticulum unfolded protein response [GO:0030968]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; reelin-mediated signaling pathway [GO:0038026]; regulation of neuron migration [GO:2001222]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0019788; GO:0030968; GO:0031466; GO:0038026; GO:0043161; GO:0043687; GO:0045116; GO:0051775; GO:0061630; GO:0061663; GO:0070979; GO:0097602; GO:2001222
g642,50.51774048,1.897391909,0.714021884,2.657330189,0.007876226,0.02633727,113,180,93,11,9,57,32,23,15,32,2,54,sp,Q28DT9,SPSB3_XENTR,38.462,208,120,5,49,663,105,307,5.04E-36,134,Q28DT9,reviewed,SPSB3_XENTR,SPRY domain-containing SOCS box protein 3 (SSB-3),spsb3 TGas007f05.1,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),360,negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],GO:0005634; GO:0010719; GO:0031466; GO:0043161; GO:0070936; GO:0160049; GO:1990756
g17367,978.3217671,3.10839621,0.579142878,5.367235488,8.00E-08,1.29E-06,3782,2279,2843,128,556,562,239,214,370,212,252,160,sp,Q6PJ21,SPSB3_HUMAN,53.409,176,79,2,532,1059,145,317,8.43E-57,193,Q6PJ21,reviewed,SPSB3_HUMAN,SPRY domain-containing SOCS box protein 3 (SSB-3),SPSB3 C16orf31 SSB3,Homo sapiens (Human),355,negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],GO:0005634; GO:0005829; GO:0010719; GO:0019005; GO:0031466; GO:0043161; GO:0070936; GO:0160049; GO:1990756
g6268,35.01084523,-2.118305457,0.797786904,-2.655227161,0.007925502,0.026457923,14,0,16,27,0,13,62,76,69,72,101,25,sp,Q9WVS6,PRKN_MOUSE,49.415,427,188,11,118,1371,57,464,9.12E-135,399,Q9WVS6,reviewed,PRKN_MOUSE,E3 ubiquitin-protein ligase parkin (EC 2.3.2.31) (Parkin RBR E3 ubiquitin-protein ligase),Prkn Park2,Mus musculus (Mouse),464,"adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to L-glutamate [GO:1905232]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; mitophagy [GO:0000423]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitophagy [GO:1901526]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein metabolic process [GO:0019538]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation protein catabolic process at presynapse [GO:0140251]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0000122; GO:0000139; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0001664; GO:0001933; GO:0001963; GO:0001964; GO:0003714; GO:0003779; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007612; GO:0007626; GO:0008013; GO:0008021; GO:0008270; GO:0008344; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010918; GO:0010994; GO:0014069; GO:0015631; GO:0016235; GO:0016567; GO:0016607; GO:0019538; GO:0019900; GO:0019901; GO:0030163; GO:0030165; GO:0030424; GO:0030544; GO:0030672; GO:0031624; GO:0031625; GO:0031648; GO:0032232; GO:0032436; GO:0032991; GO:0034599; GO:0034976; GO:0035249; GO:0035774; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043025; GO:0043065; GO:0043123; GO:0043130; GO:0043161; GO:0043195; GO:0043274; GO:0043524; GO:0043653; GO:0044828; GO:0044877; GO:0045202; GO:0045944; GO:0046329; GO:0046676; GO:0046928; GO:0048471; GO:0050804; GO:0050821; GO:0051582; GO:0051583; GO:0051646; GO:0051865; GO:0051881; GO:0051967; GO:0061630; GO:0061734; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0090258; GO:0090394; GO:0097237; GO:0097602; GO:0097708; GO:0098691; GO:0098793; GO:0098794; GO:0098978; GO:0099072; GO:0099073; GO:0099074; GO:0140251; GO:1900242; GO:1900407; GO:1901526; GO:1902236; GO:1902254; GO:1902530; GO:1903265; GO:1903377; GO:1903382; GO:1903427; GO:1903542; GO:1903861; GO:1904049; GO:1904881; GO:1905232; GO:1905366; GO:1905477; GO:1990381; GO:1990444; GO:1990452; GO:2001171
g12914,582.4528528,1.149359093,0.259959943,4.421293067,9.81E-06,9.01E-05,1191,581,612,656,482,623,517,525,384,419,233,560,sp,P55036,PSMD4_HUMAN,74.719,178,44,1,1,531,1,178,6.24E-86,260,P55036,reviewed,PSMD4_HUMAN,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein),PSMD4 MCB1,Homo sapiens (Human),377,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161; GO:0060090
g12913,497.4443149,1.023552904,0.186727168,5.481542481,4.22E-08,7.29E-07,922,459,599,548,423,476,515,339,365,432,372,374,sp,P55035,PSMD4_DROME,45.038,131,49,4,103,486,271,381,8.72E-22,94.4,P55035,reviewed,PSMD4_DROME,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (54 kDa subunit of mu particle) (Multiubiquitin chain-binding protein) (p54),Rpn10 PROS-54 Pros54 CG7619,Drosophila melanogaster (Fruit fly),396,mitotic sister chromatid segregation [GO:0000070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000070; GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0008270; GO:0008540; GO:0031593; GO:0031624; GO:0043161
g10308,124.961291,-2.228161792,0.298814077,-7.456682823,8.87E-14,4.85E-12,23,65,52,33,15,44,359,215,187,251,300,202,sp,D2GXS7,TRIM2_AILME,22.025,790,507,19,46,2319,14,726,4.22E-41,165,D2GXS7,reviewed,TRIM2_AILME,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,Ailuropoda melanoleuca (Giant panda),744,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0030371; GO:0043161; GO:0043523; GO:0061630
g19544,265.7980313,4.462181808,0.797543731,5.594905499,2.21E-08,4.10E-07,397,2043,404,30,44,113,70,34,8,17,20,31,sp,Q61382,TRAF4_MOUSE,50.647,464,220,4,1,1368,1,463,3.85E-180,515,Q61382,reviewed,TRAF4_MOUSE,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1),Traf4 Cart1,Mus musculus (Mouse),470,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165],GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007165; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699
g6193,672.9773614,1.30838148,0.280100235,4.671118815,3.00E-06,3.20E-05,1049,939,559,641,868,643,684,409,402,560,494,311,sp,O08759,UBE3A_MOUSE,43.541,418,213,6,2155,3396,471,869,1.91E-92,319,O08759,reviewed,UBE3A_MOUSE,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (HECT-type ubiquitin transferase E3A) (Oncogenic protein-associated protein E6-AP),Ube3a,Mus musculus (Mouse),870,androgen receptor signaling pathway [GO:0030521]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008021; GO:0016567; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0043161; GO:0045944; GO:0046872; GO:0048167; GO:0048511; GO:0050804; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:1990416; GO:2000058
g20470,437.4401187,0.881542978,0.210354265,4.190754001,2.78E-05,0.000220456,517,563,464,440,464,365,568,346,329,394,354,286,sp,O95376,ARI2_HUMAN,57.639,432,180,2,130,1425,62,490,0,541,O95376,reviewed,ARI2_HUMAN,E3 ubiquitin-protein ligase ARIH2 (ARI-2) (Protein ariadne-2 homolog) (EC 2.3.2.31) (Triad1 protein),ARIH2 ARI2 TRIAD1 HT005,Homo sapiens (Human),493,developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; positive regulation of protein targeting to mitochondrion [GO:1903955]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0043161; GO:0048588; GO:0061630; GO:0070534; GO:0070936; GO:0071425; GO:1903955
g10811,1074.994566,2.296574905,0.462717324,4.963235191,6.93E-07,8.70E-06,916,906,976,742,2474,1764,711,370,335,473,437,380,sp,Q8VHQ2,SOCS7_MOUSE,59.88,167,66,1,2410,2907,386,552,3.15E-51,194,Q8VHQ2,reviewed,SOCS7_MOUSE,Suppressor of cytokine signaling 7 (SOCS-7),Socs7 Cish7 Nap4,Mus musculus (Mouse),579,cerebral cortex radially oriented cell migration [GO:0021799]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; layer formation in cerebral cortex [GO:0021819]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942],GO:0005634; GO:0005737; GO:0005886; GO:0005942; GO:0008286; GO:0009968; GO:0016567; GO:0021799; GO:0021819; GO:0021942; GO:0031466; GO:0035556; GO:0043161; GO:0045444; GO:0046854; GO:0046935; GO:0140031; GO:1990756
g19466,367.9968301,1.128147726,0.37002103,3.04887462,0.002297003,0.009534043,771,232,367,435,358,388,605,382,167,290,117,229,sp,Q92890,UFD1_HUMAN,62.662,308,107,4,4,909,1,306,5.32E-130,375,Q92890,reviewed,UFD1_HUMAN,Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1),UFD1 UFD1L,Homo sapiens (Human),307,"cellular response to misfolded protein [GO:0071218]; ERAD pathway [GO:0036503]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0043161; GO:0071218
g9089,101.7952018,-1.118040918,0.422267473,-2.647707885,0.008103952,0.026943997,73,83,87,66,29,9,195,152,136,229,209,94,sp,Q5ZM55,FEM1B_CHICK,49.44,625,289,2,64,1860,4,627,0,625,Q5ZM55,reviewed,FEM1B_CHICK,Protein fem-1 homolog B (FEM1b) (FEM1-beta),FEM1B RCJMB04_3b14,Gallus gallus (Chicken),627,apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001
g20821,57.02825727,-2.570201958,0.752022221,-3.417720763,0.000631479,0.003217474,14,30,35,0,0,16,174,183,83,136,75,79,sp,Q91ZT8,ASB9_MOUSE,37.594,266,154,7,52,837,30,287,3.29E-46,160,Q91ZT8,reviewed,ASB9_MOUSE,Ankyrin repeat and SOCS box protein 9 (ASB-9),Asb9,Mus musculus (Mouse),290,intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005739; GO:0016567; GO:0031466; GO:0035556; GO:0043161; GO:0045732; GO:1990756
g23546,1468.152257,0.767187682,0.155663208,4.928510044,8.29E-07,1.02E-05,2140,1608,1839,1617,1118,1215,1620,1341,1454,1304,948,1252,sp,P70195,PSB7_MOUSE,61.786,280,80,4,1,768,1,277,4.19E-117,339,P70195,reviewed,PSB7_MOUSE,Proteasome subunit beta type-7 (EC 3.4.25.1) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z) (Proteasome subunit beta-2) (beta-2),Psmb7 Mmc14,Mus musculus (Mouse),277,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0016604; GO:0019774; GO:0043161
g22030,631.6245495,2.536249037,0.447212423,5.671240129,1.42E-08,2.79E-07,1552,582,813,174,920,1285,353,174,174,276,233,172,sp,A0A0G2JZ79,SIR1_RAT,65.549,328,106,4,25,1005,1,322,4.33E-153,450,A0A0G2JZ79,reviewed,SIR1_RAT,NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-),Sirt1,Rattus norvegicus (Rat),555,"angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to amyloid-beta [GO:1904646]; cellular response to antibiotic [GO:0071236]; cellular response to curcumin [GO:1904644]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to resveratrol [GO:1904639]; cellular response to rotenone [GO:1904648]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin B3 [GO:0071303]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin formation [GO:0031507]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron apoptotic process [GO:0051402]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of centrosome duplication [GO:0010824]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to fluoride [GO:1902617]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to kainic acid [GO:1904373]; response to leptin [GO:0044321]; response to mycotoxin [GO:0010046]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to resveratrol [GO:1904638]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; vasodilation [GO:0042311]; white fat cell differentiation [GO:0050872]",GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006325; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007623; GO:0008284; GO:0008630; GO:0009267; GO:0010046; GO:0010460; GO:0010629; GO:0010659; GO:0010667; GO:0010824; GO:0010868; GO:0010875; GO:0010883; GO:0010906; GO:0010976; GO:0014858; GO:0016239; GO:0016567; GO:0016605; GO:0016922; GO:0017136; GO:0019213; GO:0019899; GO:0019904; GO:0030225; GO:0030424; GO:0030426; GO:0030512; GO:0031393; GO:0031507; GO:0031648; GO:0031667; GO:0032007; GO:0032041; GO:0032720; GO:0032868; GO:0032922; GO:0032991; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0035098; GO:0035356; GO:0035358; GO:0035774; GO:0042127; GO:0042149; GO:0042220; GO:0042311; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043398; GO:0043422; GO:0043425; GO:0043518; GO:0043524; GO:0043536; GO:0044321; GO:0045348; GO:0045471; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0046970; GO:0050872; GO:0051019; GO:0051152; GO:0051402; GO:0051658; GO:0051897; GO:0051898; GO:0055089; GO:0060125; GO:0060766; GO:0060907; GO:0061051; GO:0061773; GO:0070301; GO:0070403; GO:0070577; GO:0070857; GO:0070914; GO:0071236; GO:0071303; GO:0071356; GO:0071407; GO:0071456; GO:0071479; GO:0090312; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140297; GO:0140861; GO:0140937; GO:0141050; GO:0160012; GO:1900181; GO:1901797; GO:1901984; GO:1902166; GO:1902176; GO:1902237; GO:1902617; GO:1903427; GO:1904179; GO:1904373; GO:1904638; GO:1904639; GO:1904644; GO:1904646; GO:1904648; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000270; GO:2000614; GO:2000655; GO:2000757; GO:2000773; GO:2000774; GO:2000781
g8908,741.1436865,0.958355174,0.314975327,3.042635696,0.002345161,0.009708121,1634,701,1152,771,500,478,821,621,778,648,236,608,sp,P25789,PSA4_HUMAN,83.772,228,37,0,1,684,1,228,1.96E-145,410,P25789,reviewed,PSA4_HUMAN,Proteasome subunit alpha type-4 (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L) (Proteasome subunit alpha-3) (alpha-3),PSMA4 HC9 PSC9,Homo sapiens (Human),261,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000502; GO:0000932; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0019773; GO:0043161; GO:0043231; GO:0070062
g22031,354.2268636,2.609019336,0.422119126,6.18076551,6.38E-10,1.68E-08,982,371,380,142,582,540,160,116,147,108,82,116,sp,A0A0G2JZ79,SIR1_RAT,39.744,78,39,1,172,405,396,465,2.92E-07,54.3,A0A0G2JZ79,reviewed,SIR1_RAT,NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-),Sirt1,Rattus norvegicus (Rat),555,"angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to amyloid-beta [GO:1904646]; cellular response to antibiotic [GO:0071236]; cellular response to curcumin [GO:1904644]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to resveratrol [GO:1904639]; cellular response to rotenone [GO:1904648]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin B3 [GO:0071303]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin formation [GO:0031507]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron apoptotic process [GO:0051402]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of centrosome duplication [GO:0010824]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to fluoride [GO:1902617]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to kainic acid [GO:1904373]; response to leptin [GO:0044321]; response to mycotoxin [GO:0010046]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to resveratrol [GO:1904638]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; vasodilation [GO:0042311]; white fat cell differentiation [GO:0050872]",GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006325; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007623; GO:0008284; GO:0008630; GO:0009267; GO:0010046; GO:0010460; GO:0010629; GO:0010659; GO:0010667; GO:0010824; GO:0010868; GO:0010875; GO:0010883; GO:0010906; GO:0010976; GO:0014858; GO:0016239; GO:0016567; GO:0016605; GO:0016922; GO:0017136; GO:0019213; GO:0019899; GO:0019904; GO:0030225; GO:0030424; GO:0030426; GO:0030512; GO:0031393; GO:0031507; GO:0031648; GO:0031667; GO:0032007; GO:0032041; GO:0032720; GO:0032868; GO:0032922; GO:0032991; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0035098; GO:0035356; GO:0035358; GO:0035774; GO:0042127; GO:0042149; GO:0042220; GO:0042311; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043398; GO:0043422; GO:0043425; GO:0043518; GO:0043524; GO:0043536; GO:0044321; GO:0045348; GO:0045471; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0046970; GO:0050872; GO:0051019; GO:0051152; GO:0051402; GO:0051658; GO:0051897; GO:0051898; GO:0055089; GO:0060125; GO:0060766; GO:0060907; GO:0061051; GO:0061773; GO:0070301; GO:0070403; GO:0070577; GO:0070857; GO:0070914; GO:0071236; GO:0071303; GO:0071356; GO:0071407; GO:0071456; GO:0071479; GO:0090312; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140297; GO:0140861; GO:0140937; GO:0141050; GO:0160012; GO:1900181; GO:1901797; GO:1901984; GO:1902166; GO:1902176; GO:1902237; GO:1902617; GO:1903427; GO:1904179; GO:1904373; GO:1904638; GO:1904639; GO:1904644; GO:1904646; GO:1904648; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000270; GO:2000614; GO:2000655; GO:2000757; GO:2000773; GO:2000774; GO:2000781
g5983,5418.909686,3.510431061,0.430808573,8.148470767,3.69E-16,3.00E-14,12393,8691,4064,3005,11900,6823,1531,833,736,1026,1241,1050,sp,Q13490,BIRC2_HUMAN,27.511,229,128,6,208,783,391,618,2.51E-17,84.7,Q13490,reviewed,BIRC2_HUMAN,Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2),BIRC2 API1 MIHB RNF48,Homo sapiens (Human),618,"apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; non-canonical NF-kappaB signal transduction [GO:0038061]; placenta development [GO:0001890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]",GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0045088; GO:0045471; GO:0045595; GO:0050727; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:2000116; GO:2000377
g703,536.0704618,0.859886031,0.290520241,2.95981453,0.003078243,0.012206779,678,607,506,548,599,454,508,398,406,754,258,470,sp,Q03601,NHL1_CAEEL,32.367,207,138,2,1897,2514,715,920,9.13E-37,127,Q03601,reviewed,NHL1_CAEEL,RING finger protein nhl-1,nhl-1 F54G8.4,Caenorhabditis elegans,974,negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567],GO:0000209; GO:0004842; GO:0016567; GO:0017148; GO:0030371; GO:0043161; GO:0046872; GO:0061630
g15513,63.05421072,-2.700905727,0.457723197,-5.900740331,3.62E-09,8.04E-08,33,20,18,15,1,8,155,109,86,117,218,102,sp,Q8VBV4,FBXW7_MOUSE,36.095,169,103,3,22,516,477,644,1.58E-25,105,Q8VBV4,reviewed,FBXW7_MOUSE,F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (F-box protein FBW7) (F-box protein Fbxw6) (F-box-WD40 repeat protein 6) (SEL-10),Fbxw7 Fbw7 Fbwd6 Fbxw6,Mus musculus (Mouse),710,cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570],GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016020; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045741; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0051443; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205
g15512,57.64867688,-1.38034577,0.336468113,-4.102456413,4.09E-05,0.000307391,40,23,17,31,28,20,201,85,65,124,86,73,sp,D3Z902,FBXW7_RAT,40.449,89,52,1,259,522,357,445,2.72E-14,69.3,D3Z902,reviewed,FBXW7_RAT,F-box/WD repeat-containing protein 7,Fbxw7,Rattus norvegicus (Rat),713,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570],GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205
g23479,309.6371803,1.882700851,0.368000157,5.116032733,3.12E-07,4.30E-06,463,205,275,406,496,434,194,138,198,177,124,130,sp,P46379,BAG6_HUMAN,43.094,181,92,4,4,534,17,190,8.74E-27,112,P46379,reviewed,BAG6_HUMAN,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),BAG6 BAT3 G3,Homo sapiens (Human),1132,apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140677; GO:1904294; GO:1990381
g23478,1715.613008,1.833383052,0.365832506,5.011536757,5.40E-07,7.02E-06,2700,1074,1432,2661,2802,1851,1439,839,898,910,755,744,sp,P46379,BAG6_HUMAN,28.741,421,238,8,1366,2592,756,1126,1.12E-39,162,P46379,reviewed,BAG6_HUMAN,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),BAG6 BAT3 G3,Homo sapiens (Human),1132,apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140677; GO:1904294; GO:1990381
g1435,681.9923671,-1.802081798,0.398630309,-4.520684347,6.16E-06,6.03E-05,370,413,341,56,231,169,1348,1356,1474,1541,722,1249,sp,P54802,ANAG_HUMAN,47.776,697,354,9,160,2232,42,734,0,680,P54802,reviewed,ANAG_HUMAN,Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form],NAGLU UFHSD1,Homo sapiens (Human),743,adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular lipid catabolic process [GO:0044242]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparan sulfate proteoglycan metabolic process [GO:0030201]; heparin metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; sequestering of iron ion [GO:0097577]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022],GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030201; GO:0030202; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0044242; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0071407; GO:0097577; GO:0097696; GO:0099022; GO:1904389; GO:1904390
g22264,686.1715999,1.008013925,0.372725491,2.704440529,0.006841952,0.023595777,948,1568,675,232,483,925,810,580,287,771,491,460,sp,A7E305,ZSWM8_BOVIN,66.942,242,69,2,562,1257,811,1051,4.44E-94,322,A7E305,reviewed,ZSWM8_BOVIN,Zinc finger SWIM domain-containing protein 8,ZSWIM8,Bos taurus (Bovine),1413,positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005829; GO:0008270; GO:0016567; GO:0031462; GO:0031463; GO:0043161; GO:1990756; GO:2000627
g1579,374.0886846,-1.276486418,0.283048916,-4.5097732,6.49E-06,6.30E-05,248,260,258,259,53,116,835,701,512,609,727,482,sp,Q5T447,HECD3_HUMAN,53.371,875,387,10,1,2613,1,858,0,922,Q5T447,reviewed,HECD3_HUMAN,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),HECTD3,Homo sapiens (Human),861,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471
g1920,756.3182129,1.354618882,0.299114832,4.528758643,5.93E-06,5.82E-05,1419,656,726,930,977,625,658,425,627,530,402,459,sp,Q9Y263,PLAP_HUMAN,50.873,802,369,8,28,2400,8,795,0,819,Q9Y263,reviewed,PLAP_HUMAN,Phospholipase A-2-activating protein (PLA2P) (PLAP),PLAA PLAP,Homo sapiens (Human),795,cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; nervous system development [GO:0007399]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],GO:0005634; GO:0005737; GO:0006644; GO:0006693; GO:0006954; GO:0007165; GO:0007399; GO:0010992; GO:0016005; GO:0016236; GO:0032430; GO:0043130; GO:0043161; GO:0043162; GO:0045202; GO:0070062; GO:0071222; GO:1900045; GO:1903423; GO:1903861; GO:2001224
g143,512.2827686,1.294518187,0.438198744,2.954180508,0.003135006,0.012375913,631,379,404,1273,538,315,408,279,473,235,483,237,sp,Q0IIF7,UBP14_BOVIN,62.677,493,170,7,1,1461,1,485,0,613,Q0IIF7,reviewed,UBP14_BOVIN,Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14),USP14,Bos taurus (Bovine),494,innate immune response [GO:0045087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136],GO:0000502; GO:0004843; GO:0005737; GO:0005886; GO:0016579; GO:0043161; GO:0045087; GO:0061136; GO:0070628
g22627,88.05611698,-1.235365344,0.410000759,-3.013080628,0.002586102,0.010554361,40,57,79,54,21,28,149,150,63,121,279,115,sp,Q5XIU5,PSMF1_RAT,33.333,75,50,0,100,324,65,139,2.39E-17,62.4,Q5XIU5,reviewed,PSMF1_RAT,Proteasome inhibitor PI31 subunit,Psmf1,Rattus norvegicus (Rat),271,negative regulation of proteasomal protein catabolic process [GO:1901799]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000502; GO:0004866; GO:0005783; GO:0005829; GO:0006511; GO:0042803; GO:0043161; GO:0046982; GO:0048471; GO:0070628; GO:1901799
g1389,341.7642792,4.625513857,1.364953028,3.388771453,0.000702065,0.003511687,42,186,1103,22,20,2016,0,5,123,7,0,40,sp,P54802,ANAG_HUMAN,44.355,744,357,10,160,2373,42,734,0,635,P54802,reviewed,ANAG_HUMAN,Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form],NAGLU UFHSD1,Homo sapiens (Human),743,adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular lipid catabolic process [GO:0044242]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparan sulfate proteoglycan metabolic process [GO:0030201]; heparin metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; sequestering of iron ion [GO:0097577]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022],GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030201; GO:0030202; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0044242; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0071407; GO:0097577; GO:0097696; GO:0099022; GO:1904389; GO:1904390
g18359,231.3432352,-0.851128002,0.212577429,-4.003849345,6.23E-05,0.000447549,145,201,157,186,68,111,603,262,333,423,258,353,sp,Q8WV99,ZFN2B_HUMAN,48.263,259,118,6,1,771,1,245,3.25E-73,228,Q8WV99,reviewed,ZFN2B_HUMAN,AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein),ZFAND2B AIRAPL,Homo sapiens (Human),257,"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",GO:0000502; GO:0005737; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0016020; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047
g13000,23.72791781,3.007605526,1.048259132,2.869143166,0.004115855,0.015503825,89,106,26,2,13,10,14,0,4,3,0,19,sp,A4IF63,TRIM2_BOVIN,37.818,275,165,5,1273,2091,472,742,3.13E-53,199,A4IF63,reviewed,TRIM2_BOVIN,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,Bos taurus (Bovine),744,negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630
g388,129.0018382,-1.879389403,0.294541038,-6.380738715,1.76E-10,5.20E-09,46,69,61,74,13,33,416,202,217,290,164,238,sp,O70277,TRIM3_RAT,20.455,176,138,1,109,636,115,288,6.23E-07,55.8,O70277,reviewed,TRIM3_RAT,Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22),Trim3 Berp Rnf22,Rattus norvegicus (Rat),744,negative regulation of translation [GO:0017148]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252],GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252
g387,13.12552502,-2.46589306,0.751232447,-3.282463466,0.001029043,0.004878157,2,3,4,1,0,11,55,22,14,36,7,38,sp,Q9ESN6,TRIM2_MOUSE,46.429,56,23,2,93,254,33,83,2.40E-10,54.3,Q9ESN6,reviewed,TRIM2_MOUSE,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (Neural activity-related RING finger protein) (RING-type E3 ubiquitin transferase TRIM2),Trim2 Kiaa0517 Narf,Mus musculus (Mouse),744,cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017022; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630; GO:1990830
g12528,423.0751688,0.734656831,0.250567539,2.931971287,0.003368179,0.013111632,443,442,485,295,442,487,475,297,396,464,318,367,sp,Q7SXR3,MAEA_DANRE,63.281,384,136,3,10,1149,14,396,3.29E-178,504,Q7SXR3,reviewed,MAEA_DANRE,E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Macrophage erythroblast attacher),maea zgc:63708,Danio rerio (Zebrafish) (Brachydanio rerio),396,cell division [GO:0051301]; erythrocyte maturation [GO:0043249]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0016363; GO:0034657; GO:0043161; GO:0043249; GO:0046872; GO:0051301; GO:0061630
g16612,121.5612444,-1.696595168,0.378906506,-4.477608967,7.55E-06,7.15E-05,35,95,81,41,30,22,199,223,124,229,267,281,sp,Q5ZHY5,CHIP_CHICK,59.286,280,112,1,4,837,35,314,2.25E-117,342,Q5ZHY5,reviewed,CHIP_CHICK,E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1),STUB1 RCJMB04_32b21,Gallus gallus (Chicken),314,cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006281; GO:0006511; GO:0006515; GO:0030018; GO:0034450; GO:0042803; GO:0043161; GO:0045862; GO:0051087; GO:0061630; GO:0071218
g6442,2899.800465,1.371365199,0.304850004,4.498491652,6.84E-06,6.58E-05,5435,2351,2625,4451,3090,2879,2311,1532,2415,1469,2148,1738,sp,Q8VDM4,PSMD2_MOUSE,74.552,892,217,4,31,2706,26,907,0,1270,Q8VDM4,reviewed,PSMD2_MOUSE,26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97),Psmd2,Mus musculus (Mouse),908,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],GO:0000502; GO:0005634; GO:0005838; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161
g7741,603.167444,-0.670170084,0.151742163,-4.416505402,1.00E-05,9.19E-05,448,492,502,425,264,284,1314,899,890,975,766,634,sp,Q3U1J4,DDB1_MOUSE,74.781,1142,285,3,1,3423,1,1140,0,1806,Q3U1J4,reviewed,DDB1_MOUSE,DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor),Ddb1,Mus musculus (Mouse),1140,apoptotic process [GO:0006915]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; ectopic germ cell programmed cell death [GO:0035234]; epigenetic programming in the zygotic pronuclei [GO:0044725]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; spindle assembly involved in female meiosis [GO:0007056]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055],GO:0003684; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006281; GO:0006511; GO:0006915; GO:0006974; GO:0007056; GO:0010498; GO:0016055; GO:0016567; GO:0019076; GO:0031464; GO:0031465; GO:0034644; GO:0035234; GO:0035861; GO:0042752; GO:0043066; GO:0043161; GO:0044725; GO:0044877; GO:0045070; GO:0045722; GO:0045732; GO:0046726; GO:0048511; GO:0051093; GO:0051702; GO:0070914; GO:0071987; GO:0080008; GO:0097602; GO:0160072; GO:1901990; GO:2000242
g13779,1237.158283,1.720514191,0.308835344,5.570975676,2.53E-08,4.65E-07,2862,1140,1325,1525,1474,1223,1140,608,920,509,632,450,sp,Q5F418,PSMD1_CHICK,71.394,818,229,3,7,2457,2,815,0,1152,Q5F418,reviewed,PSMD1_CHICK,26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1),PSMD1 RCJMB04_3m24,Gallus gallus (Chicken),955,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161
g13778,328.0438305,1.44736084,0.334068976,4.332520954,1.47E-05,0.000127586,744,319,348,321,431,233,292,223,244,196,113,225,sp,Q5F418,PSMD1_CHICK,57.143,63,26,1,61,249,876,937,1.00E-13,68.9,Q5F418,reviewed,PSMD1_CHICK,26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1),PSMD1 RCJMB04_3m24,Gallus gallus (Chicken),955,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161
g2687,1226.235496,1.583842542,0.355184472,4.45921111,8.23E-06,7.72E-05,2952,847,1294,1489,1264,1489,841,714,1123,490,771,452,sp,P51665,PSMD7_HUMAN,78.521,284,58,1,7,849,1,284,1.08E-148,424,P51665,reviewed,PSMD7_HUMAN,26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40),PSMD7 MOV34L,Homo sapiens (Human),324,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0034774; GO:0042803; GO:0043161; GO:0070062; GO:1904813
g15347,154.1745556,-0.689048739,0.281491457,-2.447849562,0.014371165,0.043061001,78,113,123,161,42,97,284,233,234,222,256,153,sp,Q9QZN1,FXL17_MOUSE,35.194,412,258,5,541,1758,284,692,3.53E-71,245,Q9QZN1,reviewed,FXL17_MOUSE,F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17) (F-box only protein 13),Fbxl17 Fbl17 Fbx13 Fbxo13,Mus musculus (Mouse),701,entrainment of circadian clock by photoperiod [GO:0043153]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006515; GO:0007399; GO:0008589; GO:0014033; GO:0016567; GO:0019005; GO:0031146; GO:0043153; GO:0043161
g1007,174.9504684,0.691970757,0.271305231,2.550524938,0.010756083,0.034049294,249,123,213,175,164,158,275,167,105,174,98,185,sp,Q80Z37,TOPRS_MOUSE,37.38,313,138,7,91,906,104,399,3.64E-53,203,Q80Z37,reviewed,TOPRS_MOUSE,E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3),Topors,Mus musculus (Mouse),1033,DNA damage response [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of DNA-templated transcription [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0000922; GO:0000930; GO:0003677; GO:0003823; GO:0004842; GO:0005634; GO:0005814; GO:0006511; GO:0006513; GO:0006974; GO:0008630; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0032391; GO:0034504; GO:0036064; GO:0042127; GO:0042771; GO:0043161; GO:0044547; GO:0045893; GO:0046872; GO:0051457; GO:0061630; GO:0070936
g5143,952.1652331,1.048812974,0.242611458,4.323015001,1.54E-05,0.000132458,1716,1094,1239,1361,583,791,814,880,1018,685,516,567,sp,P25788,PSA3_HUMAN,74.39,246,57,2,1,735,1,241,1.73E-135,385,P25788,reviewed,PSA3_HUMAN,Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8) (Proteasome subunit alpha-7) (alpha-7),PSMA3 HC8 PSC8,Homo sapiens (Human),255,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548],GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0019773; GO:0031625; GO:0043161; GO:0045202; GO:0052548; GO:0070062
g9857,2163.802778,1.377630491,0.288702165,4.771805196,1.83E-06,2.05E-05,3534,2216,2083,2610,2701,2160,2085,1455,1920,1254,834,1301,sp,P54814,PRS8_MANSE,91.667,408,28,1,1,1224,1,402,0,741,P54814,reviewed,PRS8_MANSE,26S proteasome regulatory subunit 8 (Protein 18-56),,Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm),402,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005524; GO:0005634; GO:0005737; GO:0008540; GO:0016887; GO:0036402; GO:0043161
g16413,2510.901774,3.529283295,0.390110199,9.046888036,1.47E-19,1.94E-17,3925,3477,5170,1236,2848,6648,492,580,243,555,536,482,sp,Q6PJ21,SPSB3_HUMAN,35.545,211,114,3,58,639,104,309,1.03E-35,132,Q6PJ21,reviewed,SPSB3_HUMAN,SPRY domain-containing SOCS box protein 3 (SSB-3),SPSB3 C16orf31 SSB3,Homo sapiens (Human),355,negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],GO:0005634; GO:0005829; GO:0010719; GO:0019005; GO:0031466; GO:0043161; GO:0070936; GO:0160049; GO:1990756
g20093,13383.63629,1.118949068,0.265045938,4.221717471,2.42E-05,0.000195507,14964,15915,11759,15594,14815,16252,9702,8378,10597,11785,8483,11579,sp,Q02543,RL18A_HUMAN,70.455,176,51,1,1,525,1,176,5.35E-86,253,Q02543,reviewed,RL18A_HUMAN,Large ribosomal subunit protein eL20 (60S ribosomal protein L18a),RPL18A,Homo sapiens (Human),176,cytoplasmic translation [GO:0002181]; translation [GO:0006412],GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626
g11895,133.1345151,-1.072363698,0.377782923,-2.838571128,0.004531602,0.016786088,94,101,63,97,19,86,230,213,215,367,77,225,sp,Q8CBC7,TRM7_MOUSE,72.945,292,75,1,1,876,1,288,2.13E-143,410,Q8CBC7,reviewed,TRM7_MOUSE,tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (EC 2.1.1.205) (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1),Ftsj1,Mus musculus (Mouse),324,cytoplasmic translation [GO:0002181]; neurogenesis [GO:0022008]; tRNA methylation [GO:0030488]; wobble position ribose methylation [GO:0002130],GO:0002130; GO:0002181; GO:0005634; GO:0005737; GO:0005829; GO:0008175; GO:0016423; GO:0022008; GO:0030488; GO:0106339; GO:0106340; GO:1904047
g509,7383.706421,1.251010196,0.43228862,2.8939235,0.003804608,0.01449784,9693,9717,6256,8211,8065,9274,6514,4681,5713,7023,800,7485,sp,P63221,RS21_PIG,73.494,83,22,0,1,249,1,83,1.54E-40,131,P63221,reviewed,RS21_PIG,Small ribosomal subunit protein eS21 (40S ribosomal protein S21),RPS21,Sus scrofa (Pig),83,"cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000461]",GO:0000447; GO:0000461; GO:0002181; GO:0003735; GO:0022627; GO:0043022; GO:0098556
g16638,3315.794203,0.645337346,0.205196873,3.144966758,0.001661057,0.007274229,3194,4752,3151,3266,2539,3570,3421,2861,2952,3667,2233,3624,sp,P27659,RL3_MOUSE,87.013,77,10,0,1,231,1,77,3.56E-42,144,P27659,reviewed,RL3_MOUSE,Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (J1 protein),Rpl3,Mus musculus (Mouse),403,cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412],GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0008097; GO:0022625; GO:0045202; GO:0071353
g6297,15824.88504,1.22099346,0.296080176,4.123860903,3.73E-05,0.000284066,19769,21264,12747,17681,18702,17854,13191,10797,11527,14468,5665,13775,sp,Q8JGR4,RL24_DANRE,63.057,157,55,1,1,462,1,157,6.33E-50,160,Q8JGR4,reviewed,RL24_DANRE,Large ribosomal subunit protein eL24 (60S ribosomal protein L24),rpl24,Danio rerio (Zebrafish) (Brachydanio rerio),157,chordate embryonic development [GO:0043009]; cytoplasmic translation [GO:0002181],GO:0002181; GO:0003729; GO:0003735; GO:0022625; GO:0043009
g9064,9806.792982,0.741598022,0.265470894,2.793519132,0.005213794,0.018856383,10128,12246,8126,9337,8506,12626,9033,5685,7757,11551,8291,10603,sp,Q8UW19,RL36_HYDHA,65.278,72,21,1,1,204,1,72,1.90E-14,66.6,Q8UW19,reviewed,RL36_HYDHA,Large ribosomal subunit protein eL36 (60S ribosomal protein L36),RPL36,Hydrophis hardwickii (Hardwick's spine-bellied seasnake) (Lapemis hardwickii),105,cytoplasmic translation [GO:0002181],GO:0002181; GO:0003735; GO:0022625
g13448,7454.48835,0.806941698,0.213424391,3.78092539,0.000156246,0.00099358,8426,9458,6721,7394,6785,8492,7164,5224,5955,6928,6689,7112,sp,G1SQH0,RL26_RABIT,78.014,141,30,1,1,423,1,140,2.49E-43,142,G1SQH0,reviewed,RL26_RABIT,Large ribosomal subunit protein uL24 (60S ribosomal protein L26),RPL26,Oryctolagus cuniculus (Rabbit),145,"cellular response to gamma radiation [GO:0071480]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of translation [GO:0045727]; regulation of translation involved in cellular response to UV [GO:1904803]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]",GO:0002181; GO:0003735; GO:0005654; GO:0005730; GO:0006364; GO:0006977; GO:0022625; GO:0042273; GO:0045202; GO:0045727; GO:0048027; GO:0071480; GO:1902164; GO:1902167; GO:1904803
g4288,8430.540375,0.966822434,0.29661044,3.259569804,0.001115813,0.005222272,9298,9711,5784,10188,9337,9636,7148,4875,6755,7371,7997,6750,sp,P62861,RS30_HUMAN,59.398,133,54,0,1,399,1,133,9.18E-47,150,P62861,reviewed,RS30_HUMAN,Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein (FAU ubiquitin like and ribosomal protein S30 fusion) [Cleaved into: Ubiquitin-like protein FUBI; Small ribosomal subunit protein eS30 (40S ribosomal protein S30)],FAU,Homo sapiens (Human),133,antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; translation [GO:0006412],GO:0002181; GO:0002227; GO:0003723; GO:0003735; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0015935; GO:0019731; GO:0022626; GO:0022627; GO:0050830; GO:0061844
g21139,2696.493872,0.765966921,0.278463675,2.750688833,0.00594701,0.021007183,2724,4061,1986,2862,2420,2862,2348,1689,1946,2819,2415,3098,sp,A0A1D8PF57,RL29_CANAL,71.739,46,13,0,1,138,1,46,6.02E-17,71.6,A0A1D8PF57,reviewed,RL29_CANAL,Large ribosomal subunit protein eL29 (60S ribosomal protein L29),RPL29 orf19.2310.1 CAALFM_C111040WA,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),63,cytoplasmic translation [GO:0002181],GO:0002181; GO:0003735; GO:0022625
g17634,14990.59955,0.865695454,0.232281369,3.726925916,0.000193829,0.001187789,16877,23222,13087,12362,14882,16007,18935,10398,11977,15558,9082,12865,sp,P38983,RSSA_RAT,64.164,293,89,5,1,879,1,277,3.62E-130,375,P38983,reviewed,RSSA_RAT,Small ribosomal subunit protein uS2 (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (40S ribosomal protein SA) (67 kDa laminin receptor) (67LR) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40),Rpsa Lamr1,Rattus norvegicus (Rat),295,antiviral innate immune response [GO:0140374]; cell-cell adhesion [GO:0098609]; cytoplasmic translation [GO:0002181]; epithelial cell differentiation [GO:0030855]; ribosomal small subunit assembly [GO:0000028],GO:0000028; GO:0002181; GO:0003677; GO:0003735; GO:0005055; GO:0005198; GO:0005604; GO:0005634; GO:0005737; GO:0005886; GO:0015935; GO:0022626; GO:0022627; GO:0030855; GO:0043022; GO:0043025; GO:0043236; GO:0045202; GO:0062023; GO:0098609; GO:0098978; GO:0140374
g16170,7227.855664,0.87561058,0.349529635,2.505111136,0.012241292,0.037787609,9271,10386,6794,6817,6195,7951,5492,3995,4557,4635,11999,5008,sp,P47955,RLA1_MOUSE,73.016,63,17,0,1,189,1,63,2.72E-26,97.1,P47955,reviewed,RLA1_MOUSE,Large ribosomal subunit protein P1 (60S acidic ribosomal protein P1),Rplp1,Mus musculus (Mouse),114,cytoplasmic translation [GO:0002181]; regulation of translation [GO:0006417]; translational elongation [GO:0006414],GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006414; GO:0006417; GO:0022625; GO:0030295; GO:0043021; GO:0045202; GO:0098794
g19012,29487.34226,0.85898716,0.246089007,3.490554775,0.000482019,0.00256305,31660,36431,26593,25639,30250,36054,27585,20875,26967,30437,19651,26296,sp,G1SKF7,RL6_RABIT,59.375,256,97,2,10,756,36,291,1.59E-78,241,G1SKF7,reviewed,RL6_RABIT,Large ribosomal subunit protein eL6 (60S ribosomal protein L6),RPL6,Oryctolagus cuniculus (Rabbit),291,cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005791; GO:0022625
g22950,17935.18184,0.85391637,0.234629804,3.639419866,0.000273253,0.001589747,17847,24741,16807,21795,15895,18239,16601,10932,16385,15100,16389,16253,sp,P05388,RLA0_HUMAN,73.091,275,74,0,1,825,1,275,2.37E-141,404,P05388,reviewed,RLA0_HUMAN,Large ribosomal subunit protein uL10 (60S acidic ribosomal protein P0) (60S ribosomal protein L10E),RPLP0,Homo sapiens (Human),317,cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0036464; GO:0070062; GO:0070180; GO:0098794; GO:1990904
g18210,13485.69093,1.033389249,0.280883665,3.679064954,0.000234091,0.001393809,16170,19478,11623,13658,13283,15955,14561,9848,10453,13995,4502,12247,sp,P51410,RL9_MOUSE,67.188,192,61,1,1,570,1,192,2.53E-96,280,P51410,reviewed,RL9_MOUSE,Large ribosomal subunit protein uL6 (60S ribosomal protein L9),Rpl9,Mus musculus (Mouse),192,cytoplasmic translation [GO:0002181]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236],GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0019843; GO:0022625; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242
g16934,21078.48811,0.772898215,0.229970218,3.360862205,0.000776996,0.00383861,26627,24494,15560,20828,19413,25048,23146,14346,16765,22042,17463,19677,sp,O61231,RL10_DROME,80.282,213,42,0,1,639,1,213,4.13E-131,370,O61231,reviewed,RL10_DROME,Large ribosomal subunit protein uL16 (60S ribosomal protein L10) (QM protein homolog) (dQM),RpL10 Qm CG17521,Drosophila melanogaster (Fruit fly),218,cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025
g1094,11298.20244,0.944189637,0.23942453,3.943579372,8.03E-05,0.000558056,12290,16641,10762,10580,10870,12987,9360,7097,8937,12955,8195,9297,sp,Q9VXX8,RL371_DROME,81.818,88,16,0,1,264,1,88,3.61E-40,131,Q9VXX8,reviewed,RL371_DROME,Large ribosomal subunit protein eL37A (Probable 60S ribosomal protein L37-A) (Ribosomal protein L37-1),RpL37-1 RpL37a CG9091,Drosophila melanogaster (Fruit fly),93,cytoplasmic translation [GO:0002181],GO:0002181; GO:0003723; GO:0003735; GO:0019843; GO:0022625; GO:0022626; GO:0046872
g17410,252.367808,-0.706281979,0.29187978,-2.419770151,0.01553032,0.045849123,144,231,284,154,105,90,772,457,328,305,275,249,sp,D2XV59,GTPB1_RAT,72.084,523,143,2,124,1686,102,623,0,692,D2XV59,reviewed,GTPB1_RAT,GTP-binding protein 1,Gtpbp1,Rattus norvegicus (Rat),669,cytoplasmic translation [GO:0002181]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414],GO:0000049; GO:0000177; GO:0002181; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014; GO:1904678
g16116,4512.928363,1.019573035,0.253247886,4.025988338,5.67E-05,0.000411545,5130,6295,4521,5347,4089,4941,4890,3484,3461,4153,1599,4433,sp,P18101,RL40_DROME,97.656,128,3,0,1,384,1,128,1.06E-89,258,P18101,reviewed,RL40_DROME,Ubiquitin-ribosomal protein eL40 fusion protein (CEP52) [Cleaved into: Ubiquitin; Large ribosomal subunit protein eL40 (60S ribosomal protein L40)],RpL40 Ubi-f UBI-F52 CG2960,Drosophila melanogaster (Fruit fly),128,cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; translation [GO:0006412]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0006412; GO:0006511; GO:0016567; GO:0019941; GO:0022625; GO:0022627; GO:0031386; GO:0031625; GO:0036211
g23112,14829.85381,0.984815002,0.255137318,3.859941028,0.000113414,0.000755273,17027,20748,13330,15417,14296,17241,15214,10956,12367,14829,5977,13834,sp,P36241,RL19_DROME,77.157,197,45,0,1,591,1,197,2.79E-86,256,P36241,reviewed,RL19_DROME,Large ribosomal subunit protein eL19 (60S ribosomal protein L19),RpL19 M(2)60E CG2746,Drosophila melanogaster (Fruit fly),203,cytoplasmic translation [GO:0002181],GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626
g6599,11852.52876,0.880039796,0.287725427,3.058609751,0.002223666,0.009268014,12029,14810,8595,11572,13297,13898,11071,7187,9137,11414,10653,10726,sp,P61314,RL15_RAT,81.373,204,38,0,1,612,1,204,1.79E-110,317,P61314,reviewed,RL15_RAT,Large ribosomal subunit protein eL15 (60S ribosomal protein L15),Rpl15,Rattus norvegicus (Rat),204,cytoplasmic translation [GO:0002181]; response to ethanol [GO:0045471],GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0022625; GO:0022626; GO:0031672; GO:0045202; GO:0045471
g10949,13044.80766,0.837495616,0.239214113,3.501029289,0.000463465,0.002476066,13758,18621,10491,13576,12624,13784,12535,9115,9956,12450,12444,11040,sp,P62907,RL10A_RAT,79.07,215,45,0,4,648,3,217,4.18E-111,320,P62907,reviewed,RL10A_RAT,Large ribosomal subunit protein uL1 (60S ribosomal protein L10a),Rpl10a,Rattus norvegicus (Rat),217,cytoplasmic translation [GO:0002181]; response to ethanol [GO:0045471]; translation [GO:0006412],GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0014069; GO:0022625; GO:0022626; GO:0045202; GO:0045471
g9309,10434.28719,0.803944265,0.224092886,3.587549254,0.000333801,0.00188108,11752,17154,9240,8677,8936,11429,10061,7550,7849,10078,9241,10069,sp,P24049,RL17_RAT,80.247,162,32,0,1,486,1,162,2.75E-97,282,P24049,reviewed,RL17_RAT,Large ribosomal subunit protein uL22 (60S ribosomal protein L17) (Amino acid starvation-induced protein) (ASI) (L23),Rpl17,Rattus norvegicus (Rat),184,cellular response to amino acid starvation [GO:0034198]; cytoplasmic translation [GO:0002181]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to amino acid starvation [GO:1990928],GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0031672; GO:0034198; GO:0045202; GO:0070180; GO:1900087; GO:1990928
g20594,973.7628645,1.704597364,0.482347012,3.533964805,0.000409376,0.00222933,1707,633,833,1759,1330,910,610,280,653,305,1082,289,sp,Q6P799,SYSC_RAT,68.116,483,151,3,1,1446,1,481,0,681,Q6P799,reviewed,SYSC_RAT,"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)",Sars1 Sars,Rattus norvegicus (Rat),512,cytoplasmic translation [GO:0002181]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteine incorporation [GO:0001514]; seryl-tRNA aminoacylation [GO:0006434]; tRNA modification [GO:0006400],GO:0000049; GO:0000122; GO:0000978; GO:0001514; GO:0002181; GO:0004828; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006434; GO:0016525; GO:0019899; GO:0042803; GO:0060090; GO:0098619; GO:1904046
g18183,6111.860919,1.043681146,0.239705674,4.354011015,1.34E-05,0.000117331,7004,8036,5561,6574,6164,7353,5366,4138,4676,5886,3239,5710,sp,O09167,RL21_MOUSE,66.667,162,51,1,10,495,2,160,8.34E-67,203,O09167,reviewed,RL21_MOUSE,Large ribosomal subunit protein eL21 (60S ribosomal protein L21),Rpl21,Mus musculus (Mouse),160,cytoplasmic translation [GO:0002181],GO:0002181; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098794
g13994,18666.49357,0.772609946,0.237005042,3.259888229,0.001114561,0.005217766,21755,22144,15444,16365,18086,22458,19256,13855,14483,17551,18969,15509,sp,P41116,RL8_XENLA,84.921,252,38,0,1,756,1,252,2.55E-160,447,P41116,reviewed,RL8_XENLA,Large ribosomal subunit protein uL2 (60S ribosomal protein L8),rpl8,Xenopus laevis (African clawed frog),257,cytoplasmic translation [GO:0002181],GO:0002181; GO:0003735; GO:0019843; GO:0022625
g11209,10090.45142,1.151506309,0.240358943,4.790777893,1.66E-06,1.89E-05,11762,12993,9472,11178,10468,12764,8612,5836,8140,8423,5570,8830,sp,P27085,RS26_OCTVU,84.348,115,17,1,103,444,1,115,1.45E-53,168,P27085,reviewed,RS26_OCTVU,Small ribosomal subunit protein eS26 (40S ribosomal protein S26),RPS26,Octopus vulgaris (Common octopus),127,cytoplasmic translation [GO:0002181],GO:0002181; GO:0003729; GO:0003735; GO:0005840; GO:0022627; GO:0098556
g17311,11841.92593,0.858584841,0.196429451,4.37095781,1.24E-05,0.000110082,13507,14780,10315,13217,10843,13284,12502,9373,9931,10947,8118,10499,sp,Q90YV0,RL18_ICTPU,77.128,188,43,0,1,564,1,188,7.07E-100,289,Q90YV0,reviewed,RL18_ICTPU,Large ribosomal subunit protein eL18 (60S ribosomal protein L18),rpl18,Ictalurus punctatus (Channel catfish) (Silurus punctatus),188,cytoplasmic translation [GO:0002181],GO:0002181; GO:0003735; GO:0005791; GO:0022625
g11942,44.3619048,-2.903941127,0.606502383,-4.788012721,1.68E-06,1.91E-05,10,15,20,0,2,11,156,130,38,152,72,48,sp,Q8CBC7,TRM7_MOUSE,72.945,292,75,1,1,876,1,288,3.29E-139,400,Q8CBC7,reviewed,TRM7_MOUSE,tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (EC 2.1.1.205) (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1),Ftsj1,Mus musculus (Mouse),324,cytoplasmic translation [GO:0002181]; neurogenesis [GO:0022008]; tRNA methylation [GO:0030488]; wobble position ribose methylation [GO:0002130],GO:0002130; GO:0002181; GO:0005634; GO:0005737; GO:0005829; GO:0008175; GO:0016423; GO:0022008; GO:0030488; GO:0106339; GO:0106340; GO:1904047
g4300,5142.349823,5.002046286,1.151888749,4.34247343,1.41E-05,0.000122594,509,4385,32776,39,108,17559,13,228,674,97,457,577,sp,P80146,SEPR_THESR,39.633,381,202,9,52,1119,30,407,5.67E-75,241,P80146,reviewed,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,Thermus sp. (strain Rt41A),410,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508
g4302,43.20475841,-1.527098879,0.552887515,-2.76204262,0.005744098,0.020418453,37,44,15,4,7,17,103,76,18,147,63,74,sp,P10394,POL4_DROME,25.872,344,226,4,157,1143,882,1211,5.33E-36,145,P10394,reviewed,POL4_DROME,Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],POL ORF3,Drosophila melanogaster (Fruit fly),1237,DNA integration [GO:0015074]; proteolysis [GO:0006508],GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006508; GO:0015074; GO:0042575
g15976,2356.405637,1.079802899,0.280809216,3.84532571,0.000120392,0.000794995,3299,2106,1812,3291,2703,2322,2400,1582,2115,1814,1612,1524,sp,Q92542,NICA_HUMAN,36.061,721,368,22,25,2007,14,701,5.74E-132,408,Q92542,reviewed,NICA_HUMAN,Nicastrin,NCSTN KIAA0253 UNQ1874/PRO4317,Homo sapiens (Human),709,adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; epithelial cell proliferation [GO:0050673]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098],GO:0000139; GO:0002262; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007219; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0010950; GO:0016020; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0030674; GO:0031293; GO:0034205; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042500; GO:0042734; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0050673; GO:0051117; GO:0051402; GO:0070062; GO:0070765; GO:0070851; GO:0071277; GO:1900271; GO:1990926
g19177,8263.458769,4.49740212,1.117373247,4.024977447,5.70E-05,0.000412985,601,7678,34428,102,274,40983,57,476,1915,190,1063,901,sp,P48052,CBPA2_HUMAN,37.688,398,232,6,70,1242,22,410,6.70E-92,286,P48052,reviewed,CBPA2_HUMAN,Carboxypeptidase A2 (EC 3.4.17.15),CPA2,Homo sapiens (Human),419,protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508],GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270
g5599,182.4162259,1.773430758,0.652732298,2.716934284,0.006588969,0.022858732,190,441,330,39,240,186,181,200,7,56,112,65,sp,Q8N7X0,ADGB_HUMAN,34.393,535,254,7,2263,3849,629,1072,8.13E-89,321,Q8N7X0,reviewed,ADGB_HUMAN,Androglobin,ADGB C6orf103,Homo sapiens (Human),1667,proteolysis [GO:0006508]; spermatid development [GO:0007286],GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227
g5598,125.3411437,1.905030031,0.616871884,3.08821018,0.00201366,0.008528637,109,361,292,10,88,201,104,104,24,47,76,38,sp,G3UZ78,ADGB_MOUSE,39.322,295,151,6,1,807,1120,1412,4.61E-35,143,G3UZ78,reviewed,ADGB_MOUSE,Androglobin,Adgb,Mus musculus (Mouse),1657,proteolysis [GO:0006508]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283],GO:0004198; GO:0006508; GO:0007283; GO:0007286; GO:0019825; GO:0020037; GO:0036126; GO:0046872; GO:0097225; GO:0097227
g22207,247.1743812,-0.763010272,0.281824076,-2.707399178,0.006781266,0.023408859,201,138,226,244,83,73,437,401,329,465,280,360,sp,Q5ZIM5,MAP1_CHICK,69.231,364,102,3,16,1077,3,366,0,543,Q5ZIM5,reviewed,MAP1_CHICK,Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1),METAP1 RCJMB04_24o19,Gallus gallus (Chicken),385,proteolysis [GO:0006508],GO:0004239; GO:0005829; GO:0006508; GO:0022626; GO:0046872; GO:0070006
g2736,4857.685739,-1.007272741,0.281930817,-3.57276566,0.000353231,0.00197422,2738,3493,4338,2702,1292,2562,9741,10021,7300,4272,10045,5334,sp,Q5I0D7,PEPD_RAT,62.947,475,175,1,10,1434,7,480,0,577,Q5I0D7,reviewed,PEPD_RAT,Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase),Pepd,Rattus norvegicus (Rat),492,collagen catabolic process [GO:0030574]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],GO:0006508; GO:0008233; GO:0030145; GO:0030574; GO:0043069; GO:0070006; GO:0102009
g13145,125.6000211,-2.88080414,0.476748317,-6.042609981,1.52E-09,3.70E-08,21,53,8,21,30,14,307,246,170,287,420,162,sp,P08594,AQL1_THEAQ,45.932,381,176,9,73,1188,37,396,1.44E-78,254,P08594,reviewed,AQL1_THEAQ,Aqualysin-1 (EC 3.4.21.111) (Aqualysin-I),pstI,Thermus aquaticus,513,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508
g11371,416.4978125,3.143722092,0.679513082,4.626433507,3.72E-06,3.87E-05,1494,572,854,719,288,203,190,48,33,42,11,310,sp,Q9QX15,CA3A1_MOUSE,31.737,668,396,20,1,1941,238,866,1.02E-75,267,Q9QX15,reviewed,CA3A1_MOUSE,Calcium-activated chloride channel regulator 3A-1 (EC 3.4.-.-),Clca3a1 Clca1,Mus musculus (Mouse),902,chloride transport [GO:0006821]; proteolysis [GO:0006508],GO:0005229; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0046872
g11370,81.00515206,3.303261186,0.76304771,4.329036238,1.50E-05,0.000129196,287,86,234,121,55,36,55,4,14,9,0,37,sp,Q9D7Z6,CLCA1_MOUSE,38.095,126,78,0,88,465,21,146,3.04E-34,107,Q9D7Z6,reviewed,CLCA1_MOUSE,Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 3) (mCLCA3) (Protein gob-5),Clca1 Clca3 Gob5,Mus musculus (Mouse),913,calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; proteolysis [GO:0006508],GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005902; GO:0006508; GO:0006816; GO:0006821; GO:0008237; GO:0016020; GO:0030141; GO:0042589; GO:0046872; GO:0071456
g21051,182.1531723,-2.075411546,0.37115773,-5.591723898,2.25E-08,4.17E-07,51,97,78,83,12,57,427,402,225,594,195,341,sp,Q96LD8,SENP8_HUMAN,50.962,208,99,3,25,642,5,211,2.12E-62,196,Q96LD8,reviewed,SENP8_HUMAN,"Sentrin-specific protease 8 (EC 3.4.22.-) (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8)",SENP8 DEN1 NEDP1 PRSC2 FKSG8,Homo sapiens (Human),212,post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0000338; GO:0005829; GO:0006508; GO:0008234; GO:0016579; GO:0019784; GO:0043687
g8939,34.55383979,-1.6968664,0.5719918,-2.966592179,0.003011201,0.011972492,12,20,32,7,0,20,68,46,30,102,68,72,sp,P0C872,JMJD7_MOUSE,54.967,302,126,1,58,963,20,311,2.73E-129,374,P0C872,reviewed,JMJD7_MOUSE,Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 (EC 1.14.11.63) (EC 3.4.-.-) (JmjC domain-containing protein 7) (Jumonji domain-containing protein 7) (L-lysine (3S)-hydroxylase Jmjd7),Jmjd7,Mus musculus (Mouse),316,proteolysis [GO:0006508],GO:0004175; GO:0004177; GO:0004497; GO:0005634; GO:0005737; GO:0006508; GO:0016706; GO:0035064; GO:0046872; GO:0106155
g1986,267.7273344,0.983571525,0.310823306,3.164407256,0.001553992,0.00687038,384,225,237,310,318,253,427,253,200,217,134,138,sp,Q96DT6,ATG4C_HUMAN,41.791,268,95,5,886,1521,11,273,2.48E-62,221,Q96DT6,reviewed,ATG4C_HUMAN,Cysteine protease ATG4C (EC 3.4.22.-) (AUT-like 3 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 3) (Autophagin-3) (Autophagy-related protein 4 homolog C) (HsAPG4C),ATG4C APG4C AUTL1 AUTL3,Homo sapiens (Human),458,aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; protein delipidation [GO:0051697]; protein processing [GO:0016485]; protein transport [GO:0015031]; proteolysis [GO:0006508],GO:0000045; GO:0000423; GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0016485; GO:0019786; GO:0034727; GO:0035973; GO:0051697
g17554,641.4833464,1.313471372,0.307483175,4.271685342,1.94E-05,0.000161641,1485,1339,709,375,294,833,558,425,385,379,482,441,sp,Q6ICB0,DESI1_HUMAN,56.604,159,69,0,19,495,9,167,8.69E-57,190,Q6ICB0,reviewed,DESI1_HUMAN,Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2) (Palmitoyl protein thioesterase DESI1) (EC 3.1.2.22) (Polyubiquitinated substrate transporter) (POST) (S-depalmitoylase DESI1),DESI1 FAM152B PPPDE2,Homo sapiens (Human),168,protein desumoylation [GO:0016926]; protein export from nucleus [GO:0006611]; protein modification by small protein removal [GO:0070646]; proteolysis [GO:0006508]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],GO:0005634; GO:0005829; GO:0006508; GO:0006611; GO:0008474; GO:0016926; GO:0016929; GO:0032434; GO:0032991; GO:0042802; GO:0052816; GO:0061676; GO:0070646
g12071,40.96691052,3.710757401,1.207724022,3.072520985,0.002122589,0.008916752,12,94,126,16,0,164,0,5,19,7,8,0,sp,P29787,TRY5_AEDAE,40.329,243,125,8,61,777,34,260,7.77E-49,165,P29787,reviewed,TRY5_AEDAE,Trypsin 5G1 (EC 3.4.21.4),AAEL013712,Aedes aegypti (Yellowfever mosquito) (Culex aegypti),266,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508; GO:0007586
g19004,607.3505702,3.495085882,0.715586199,4.88422763,1.04E-06,1.25E-05,1716,333,983,121,662,1858,132,83,346,20,55,63,sp,Q9Y5R2,MMP24_HUMAN,39.602,553,285,15,229,1785,80,617,1.67E-108,343,Q9Y5R2,reviewed,MMP24_HUMAN,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],MMP24 MT5MMP,Homo sapiens (Human),645,cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508],GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742
g16586,139.9637383,3.784870473,0.891995948,4.243147607,2.20E-05,0.000180721,189,996,92,34,18,189,54,24,16,44,0,13,sp,P58873,RHBL3_MOUSE,38.095,147,87,2,190,630,31,173,1.15E-22,97.8,P58873,reviewed,RHBL3_MOUSE,Rhomboid-related protein 3 (EC 3.4.21.105) (Ventrhoid transmembrane protein),Rhbdl3 Rhbdl4 Vrho,Mus musculus (Mouse),404,proteolysis [GO:0006508],GO:0004252; GO:0005509; GO:0006508; GO:0016020
g18353,254.6534988,-1.135631881,0.255969802,-4.436585373,9.14E-06,8.48E-05,117,150,237,168,61,109,447,410,310,444,464,446,sp,O02467,ASPG_SPOFR,58.805,318,129,2,67,1017,4,320,6.77E-108,321,O02467,reviewed,ASPG_SPOFR,N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain],,Spodoptera frugiperda (Fall armyworm),320,proteolysis [GO:0006508],GO:0003948; GO:0004067; GO:0005764; GO:0006508; GO:0008798
g21154,1474.734777,2.359828243,0.365999864,6.44762054,1.14E-10,3.46E-09,2618,1106,1712,1508,2601,2089,798,370,707,491,597,536,sp,A6QR55,UBP4_BOVIN,67.982,228,70,1,1,675,1,228,5.19E-103,330,A6QR55,reviewed,UBP4_BOVIN,Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4),USP4,Bos taurus (Bovine),963,negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244],GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0016579; GO:0031397; GO:0031647; GO:0034394; GO:0046872; GO:1904263
g21155,1542.828729,2.404028118,0.365141245,6.583830643,4.58E-11,1.51E-09,2805,1163,1756,1495,2763,2235,831,513,698,440,455,645,sp,B2GUZ1,UBP4_RAT,46.121,464,227,7,1,1332,489,949,1.16E-121,381,B2GUZ1,reviewed,UBP4_RAT,Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4),Usp4,Rattus norvegicus (Rat),961,negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244],GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872; GO:1904263
g11915,1902.267162,4.393134738,0.968340879,4.53676472,5.71E-06,5.63E-05,2599,13744,2725,67,21,2357,168,455,170,49,61,322,sp,A0A2S3R7M0,MARTX_VIBVL,19.732,299,240,0,161,1057,815,1113,5.17E-13,74.7,A0A2S3R7M0,reviewed,MARTX_VIBVL,Multifunctional-autoprocessing repeats-in-toxin (MARTX) (EC 3.4.22.-) [Cleaved into: Actin cross-linking toxin F1 (EC 6.3.2.-); N-epsilon-fatty acyltransferase F2 (EC 2.3.1.-) (Rho inactivation domain-containing toxin F2) (RIDvc); ABH effector region toxin F5; Cysteine protease domain-containing toxin F3 (EC 3.4.22.-)],CRN52_02910,Vibrio vulnificus,5206,proteolysis [GO:0006508],GO:0005576; GO:0006508; GO:0008234; GO:0008289; GO:0016020; GO:0016746; GO:0016874; GO:0020002; GO:0044164; GO:0046872; GO:0090729
g5810,176.4861681,-1.381738814,0.28052152,-4.925607183,8.41E-07,1.04E-05,77,140,73,97,61,54,410,360,168,367,321,250,sp,Q9CXT6,KDM8_MOUSE,28.696,230,146,8,148,795,189,414,1.34E-18,90.9,Q9CXT6,reviewed,KDM8_MOUSE,Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.73) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8) (Lysine-specific demethylase 8),Kdm8 Jmjd5,Mus musculus (Mouse),414,circadian regulation of gene expression [GO:0032922]; fibroblast proliferation [GO:0048144]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; regulation of signal transduction by p53 class mediator [GO:1901796],GO:0000086; GO:0001701; GO:0002039; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006508; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0048144; GO:0051864; GO:0106157; GO:1901796
g15068,41.72395828,-2.173631564,0.904139838,-2.404087811,0.016212878,0.047468172,19,23,5,10,8,14,118,22,17,247,0,123,sp,Q15485,FCN2_HUMAN,55.814,215,92,3,421,1065,102,313,9.45E-77,241,Q15485,reviewed,FCN2_HUMAN,Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35),FCN2 FCNL,Homo sapiens (Human),313,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065
g1332,96.71472845,-1.002799404,0.400413171,-2.504411636,0.012265524,0.037838617,93,115,62,61,8,26,185,143,130,172,174,135,sp,P47245,NRDC_RAT,45.028,362,184,8,1,1074,809,1159,1.16E-90,298,P47245,reviewed,NRDC_RAT,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase),Nrdc Nrd1,Rattus norvegicus (Rat),1161,negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of axonogenesis [GO:0050772]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; proteolysis [GO:0006508],GO:0004222; GO:0005739; GO:0006508; GO:0008233; GO:0030425; GO:0031643; GO:0046872; GO:0050772; GO:0051044; GO:0120163
g23743,2254.463507,1.473155752,0.321659297,4.579863738,4.65E-06,4.71E-05,2549,1912,1911,4182,2804,2474,1483,1415,1408,1559,1345,1383,sp,P55866,CASP3_XENLA,38.764,178,89,5,538,1068,122,280,2.35E-27,112,P55866,reviewed,CASP3_XENLA,Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (xCPP32) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12],casp3,Xenopus laevis (African clawed frog),282,proteolysis [GO:0006508],GO:0004175; GO:0005737; GO:0006508; GO:0097200
g9438,6985.562582,2.25781598,0.33388034,6.762350785,1.36E-11,4.94E-10,11852,9398,6462,6437,12090,8725,3191,3026,3246,2646,3190,2066,sp,Q9UDY8,MALT1_HUMAN,32.536,627,333,23,721,2424,120,715,9.98E-68,244,Q9UDY8,reviewed,MALT1_HUMAN,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),MALT1 MLT,Homo sapiens (Human),824,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321
g9439,169.0144779,-1.159475788,0.308937101,-3.753112805,0.000174652,0.001087629,142,92,150,105,18,71,371,280,256,283,312,206,sp,Q1JP61,KDM8_BOVIN,28.358,268,166,11,94,840,145,405,2.79E-13,74.7,Q1JP61,reviewed,KDM8_BOVIN,Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.73) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8),KDM8 JMJD5,Bos taurus (Bovine),406,circadian regulation of gene expression [GO:0032922]; fibroblast proliferation [GO:0048144]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; regulation of signal transduction by p53 class mediator [GO:1901796],GO:0000086; GO:0001701; GO:0002039; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006508; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0048144; GO:0051864; GO:0106157; GO:1901796
g16352,171.2436713,2.501145124,0.97546014,2.56406697,0.010345358,0.03300566,228,747,363,72,11,259,53,19,0,27,37,225,sp,Q8IYS1,P20D2_HUMAN,44.11,399,198,6,115,1236,31,429,1.24E-77,250,Q8IYS1,reviewed,P20D2_HUMAN,Xaa-Arg dipeptidase (EC 3.4.13.4) (Beta-Ala-Lys dipeptidase),PM20D2 ACY1L2,Homo sapiens (Human),436,proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246
g7863,498.5672252,3.133159273,1.195163732,2.621531418,0.008753569,0.028759451,81,633,2188,0,21,1938,12,85,371,29,88,90,sp,O43895,XPP2_HUMAN,41.642,682,355,16,1,2031,28,671,1.98E-173,514,O43895,reviewed,XPP2_HUMAN,Xaa-Pro aminopeptidase 2 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (Membrane-bound AmP) (mAmP) (X-Pro aminopeptidase 2),XPNPEP2,Homo sapiens (Human),674,proteolysis [GO:0006508],GO:0004177; GO:0005576; GO:0005886; GO:0006508; GO:0016020; GO:0046872; GO:0070006; GO:0070062; GO:0098552
g13659,123.9936476,1.393263356,0.38636021,3.606125375,0.000310803,0.001769979,183,122,98,266,134,82,118,102,69,107,74,37,sp,Q5XJY4,PARL_MOUSE,48.901,364,155,9,4,1059,28,372,8.01E-111,331,Q5XJY4,reviewed,PARL_MOUSE,"Presenilin-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]",Parl Psarl,Mus musculus (Mouse),377,membrane protein proteolysis [GO:0033619]; mitochondrial fusion [GO:0008053]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of mitophagy [GO:1901524]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]; signal peptide processing [GO:0006465],GO:0004175; GO:0004252; GO:0005634; GO:0005739; GO:0005743; GO:0006465; GO:0006508; GO:0008053; GO:0016485; GO:0030162; GO:0033619; GO:0090201; GO:1901524; GO:1903214; GO:2000377; GO:2001243
g22278,441.4228191,1.82781508,0.452143737,4.042553135,5.29E-05,0.000387881,657,1563,692,202,106,663,285,315,202,245,164,209,sp,P37892,CBPE_LOPAM,48.984,443,200,9,1,1296,1,428,2.67E-134,397,P37892,reviewed,CBPE_LOPAM,Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase),cpe,Lophius americanus (American angler) (Anglerfish),454,proteolysis [GO:0006508],GO:0004181; GO:0005576; GO:0006508; GO:0008270; GO:0030658
g2743,94.59135317,-2.841360396,0.334900361,-8.484196281,2.17E-17,2.07E-15,17,18,32,33,4,19,309,237,179,234,142,140,sp,Q54P70,Y4757_DICDI,32.847,137,80,6,1624,2016,635,765,2.51E-08,61.6,Q54P70,reviewed,Y4757_DICDI,OTU domain-containing protein DDB_G0284757 (EC 3.1.2.-),DDB_G0284757,Dictyostelium discoideum (Social amoeba),766,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004843; GO:0006508; GO:0016579
g10952,111.4007456,0.681358337,0.277084241,2.459029554,0.013931315,0.042029161,175,171,110,96,83,82,158,65,62,123,85,142,sp,E1C1R4,UBP47_CHICK,60.87,115,44,1,103,447,1253,1366,3.02E-33,127,E1C1R4,reviewed,UBP47_CHICK,Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47),USP47,Gallus gallus (Chicken),1375,base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006284; GO:0006508; GO:0006974; GO:0016579; GO:0035520
g14094,172.6024442,-1.10166876,0.355692744,-3.097248332,0.001953262,0.008333455,105,69,192,47,32,143,355,294,321,259,238,247,sp,Q9CZR2,NALD2_MOUSE,28.879,651,356,19,304,2058,82,691,1.11E-66,237,Q9CZR2,reviewed,NALD2_MOUSE,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),Naalad2,Mus musculus (Mouse),740,carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508],GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008233; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129
g14093,1430.711931,-0.655718576,0.240190974,-2.729988406,0.006333655,0.02214963,1092,945,1173,1218,383,1042,2548,1911,2090,1592,2677,1775,sp,O15484,CAN5_HUMAN,43.029,416,228,4,1,1233,228,639,8.58E-118,360,O15484,reviewed,CAN5_HUMAN,Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3),CAPN5 NCL3,Homo sapiens (Human),640,proteolysis [GO:0006508]; signal transduction [GO:0007165],GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0045202; GO:0070062
g23157,2249.646717,4.702921947,0.657734417,7.150183756,8.67E-13,3.89E-11,4066,13090,2993,155,1185,3017,311,145,122,260,103,303,sp,P80646,CTRB_GADMO,32.468,231,136,9,1570,2229,18,239,1.13E-22,102,P80646,reviewed,CTRB_GADMO,Chymotrypsin B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B],,Gadus morhua (Atlantic cod),245,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586
g588,3188.363266,4.977763388,1.101685204,4.518317365,6.23E-06,6.08E-05,391,1791,10373,44,128,19193,17,150,413,56,315,340,sp,P80146,SEPR_THESR,51.235,324,152,4,160,1119,88,409,7.63E-99,302,P80146,reviewed,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,Thermus sp. (strain Rt41A),410,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508
g21213,2922.097767,4.427050931,0.861014696,5.141667096,2.72E-07,3.83E-06,2413,10420,4700,69,865,11456,41,369,372,99,546,296,sp,Q5G266,NETR_TRAPH,37.445,227,130,6,580,1239,280,501,2.79E-38,150,Q5G266,reviewed,NETR_TRAPH,Neurotrypsin (EC 3.4.21.-) (Serine protease 12),PRSS12,Trachypithecus phayrei (Phayre's leaf monkey),875,exocytosis [GO:0006887]; proteolysis [GO:0006508],GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195
g21210,6536.648633,7.49775008,0.798400403,9.390964798,5.95E-21,9.25E-19,8741,8039,3917,572,19647,14783,97,87,14,21,207,79,sp,G5ECS8,ADT1_CAEEL,44.66,103,50,3,79,369,1263,1364,1.65E-12,67,G5ECS8,reviewed,ADT1_CAEEL,A disintegrin and metalloproteinase with thrombospondin motifs adt-1 (ADAMTS adt-1) (EC 3.4.24.-),adt-1 C02B4.1,Caenorhabditis elegans,1461,extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872
g4026,4567.555525,-2.603997819,0.342174787,-7.61013938,2.74E-14,1.64E-12,837,1274,2321,536,561,1302,12906,12040,6745,6784,11178,7537,sp,Q9VT65,CANB_DROME,46.132,698,342,12,22,2067,246,925,0,604,Q9VT65,reviewed,CANB_DROME,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],CalpB CG8107,Drosophila melanogaster (Fruit fly),925,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540
g13110,626.9234167,3.318793256,1.067060418,3.110220564,0.001869477,0.008031052,1869,3701,265,29,391,308,16,647,25,11,73,18,sp,P17538,CTRB1_HUMAN,39.516,248,127,9,127,858,32,260,1.41E-44,164,P17538,reviewed,CTRB1_HUMAN,Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C],CTRB1 CTRB,Homo sapiens (Human),263,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586
g23741,125.6294874,-0.923382211,0.341657067,-2.702658018,0.006878748,0.023690985,96,102,144,86,18,36,266,166,139,207,192,237,sp,Q9CXY9,GPI8_MOUSE,63.603,272,96,1,1,816,85,353,2.44E-130,379,Q9CXY9,reviewed,GPI8_MOUSE,GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K),Pigk,Mus musculus (Mouse),395,attachment of GPI anchor to protein [GO:0016255]; proteolysis [GO:0006508],GO:0003923; GO:0006508; GO:0016255; GO:0042765
g19522,568.7991699,1.524656695,0.415729939,3.667420969,0.000245009,0.001448307,791,892,897,133,572,1007,594,259,210,430,275,433,sp,Q8NFA0,UBP32_HUMAN,55.593,885,303,15,256,2886,516,1318,0,967,Q8NFA0,reviewed,UBP32_HUMAN,Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32),USP32 USP10,Homo sapiens (Human),1604,positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263
g6550,213.7703264,1.444989068,0.297095687,4.863716078,1.15E-06,1.37E-05,374,292,297,166,265,178,220,137,86,140,87,185,sp,A3KQS4,MINY1_DANRE,53.571,308,138,1,190,1098,149,456,4.11E-111,340,A3KQS4,reviewed,MINY1_DANRE,Ubiquitin carboxyl-terminal hydrolase MINDY-1 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-1) (Protein FAM63A),mindy1 fam63a si:ch211-210h11.5,Danio rerio (Zebrafish) (Brachydanio rerio),520,proteolysis [GO:0006508],GO:0004843; GO:0006508; GO:0036435; GO:1990380
g12005,80.48086137,2.871814427,1.07323074,2.675859273,0.007453794,0.025204911,54,223,255,15,0,243,32,41,45,10,0,14,sp,Q9W436,NEP_DROME,46.056,393,208,2,16,1185,458,849,1.11E-129,396,Q9W436,reviewed,NEP_DROME,Neprilysin-1 (EC 3.4.24.11),Nep1 CG5905,Drosophila melanogaster (Fruit fly),849,proteolysis [GO:0006508],GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872
g3583,91.40387763,-2.381620213,0.419668186,-5.675007762,1.39E-08,2.73E-07,42,12,44,26,7,28,198,205,79,149,227,243,sp,Q7L266,ASGL1_HUMAN,51.325,302,136,5,61,957,12,305,3.02E-83,257,Q7L266,reviewed,ASGL1_HUMAN,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],ASRGL1 ALP CRASH,Homo sapiens (Human),308,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],GO:0001917; GO:0004067; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008798; GO:0033345
g9400,476.3248566,0.52788868,0.162803044,3.242498839,0.001184864,0.005491332,619,579,621,380,240,535,577,499,410,471,357,532,sp,O76031,CLPX_HUMAN,67.093,313,66,5,286,1158,103,400,6.87E-118,347,O76031,reviewed,CLPX_HUMAN,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial",CLPX,Homo sapiens (Human),633,ATP metabolic process [GO:0046034]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006508; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662
g5241,1478.760558,3.184013533,1.112371427,2.862365444,0.004204918,0.015763637,565,1693,6375,11,86,5743,12,217,962,27,423,273,sp,Q95M12,LGMN_BOVIN,48.798,416,207,5,67,1305,17,429,1.12E-138,407,Q95M12,reviewed,LGMN_BOVIN,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)",LGMN PRSC1,Bos taurus (Bovine),433,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624],GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0006624; GO:0019886; GO:0032801; GO:0043202; GO:0051603; GO:1901185
g8177,3582.092509,0.889394593,0.247593589,3.59215518,0.000327954,0.001856412,4780,4250,6166,4374,1542,3804,4456,2418,3188,2221,3839,2207,sp,Q9DEX3,CATD_CLUHA,55.409,379,155,4,58,1164,21,395,3.58E-150,433,Q9DEX3,reviewed,CATD_CLUHA,Cathepsin D (EC 3.4.23.5),ctsd,Clupea harengus (Atlantic herring),396,proteolysis [GO:0006508],GO:0004190; GO:0005764; GO:0006508
g22714,1642.893735,2.412997591,0.934656405,2.581694812,0.009831648,0.031689902,444,1326,6938,73,94,6087,354,374,1189,87,641,885,sp,P07858,CATB_HUMAN,45.223,314,110,9,64,843,26,331,1.56E-70,224,P07858,reviewed,CATB_HUMAN,Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain],CTSB CPSB,Homo sapiens (Human),339,cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590],GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0036021; GO:0042470; GO:0042981; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0062023; GO:0070062; GO:0097067; GO:1904090; GO:1904813
g23904,22775.51883,2.622483342,0.476023226,5.509149977,3.61E-08,6.35E-07,24509,10510,16432,43861,42231,38818,10359,8848,5671,4913,9534,6869,sp,Q3SYW2,CO2_BOVIN,27.284,777,430,31,673,2778,25,741,3.78E-60,223,Q3SYW2,reviewed,CO2_BOVIN,Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment],C2,Bos taurus (Bovine),750,"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]",GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006958; GO:0009617; GO:0045087; GO:0046872
g6127,39.84522166,-2.276808205,0.881670039,-2.582381283,0.009812111,0.031643884,0,9,48,0,9,6,115,66,76,118,74,42,sp,P20825,POL2_DROME,33.846,260,164,3,958,1734,376,628,1.04E-36,150,P20825,reviewed,POL2_DROME,Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],pol,Drosophila melanogaster (Fruit fly),1059,DNA integration [GO:0015074]; proteolysis [GO:0006508],GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006508; GO:0015074; GO:0042575
g12155,7205.490786,4.400418879,1.149298663,3.828786215,0.000128777,0.000838699,391,6215,28873,46,192,37024,68,312,1565,210,1261,854,sp,P32822,TRYB_RAT,33.333,231,136,6,70,738,24,244,1.80E-26,106,P32822,reviewed,TRYB_RAT,Trypsin V-B (EC 3.4.21.4),,Rattus norvegicus (Rat),246,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872
g19768,223.9509691,0.807766032,0.247323204,3.266034152,0.001090651,0.005117779,359,233,225,327,131,213,410,184,162,147,191,143,sp,P87362,BLMH_CHICK,54.725,455,178,4,10,1308,6,454,3.13E-178,508,P87362,reviewed,BLMH_CHICK,Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40) (Aminopeptidase H),BLMH,Gallus gallus (Chicken),455,homocysteine catabolic process [GO:0043418]; proteolysis [GO:0006508]; response to toxic substance [GO:0009636],GO:0004177; GO:0004197; GO:0005737; GO:0006508; GO:0008234; GO:0009636; GO:0043418; GO:0070005
g24087,266.4495201,3.437277346,1.080943811,3.179885312,0.001473334,0.006578241,138,814,701,11,0,1014,14,51,89,9,50,89,sp,P12821,ACE_HUMAN,47.126,609,309,7,70,1875,638,1240,0,600,P12821,reviewed,ACE_HUMAN,"Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]",ACE DCP DCP1,Homo sapiens (Human),1306,amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; animal organ regeneration [GO:0031100]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]; vasoconstriction [GO:0042310],GO:0001666; GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0007565; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009410; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0019229; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031667; GO:0031711; GO:0032496; GO:0032943; GO:0034616; GO:0038166; GO:0042310; GO:0042445; GO:0042447; GO:0042755; GO:0043065; GO:0043171; GO:0045907; GO:0046325; GO:0048167; GO:0048286; GO:0050435; GO:0050482; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0060978; GO:0070062; GO:0070573; GO:0071333; GO:0071548; GO:0071838; GO:0086091; GO:0090281; GO:0097066; GO:0097225; GO:0097746; GO:1901363; GO:1902033; GO:1903597; GO:1904045; GO:2000170
g5949,665.3909613,2.359449398,0.878487527,2.685808648,0.007235451,0.024637394,236,480,3528,49,13,1897,293,222,198,275,152,434,sp,P15684,AMPN_RAT,42.484,805,430,15,4,2376,176,961,0,634,P15684,reviewed,AMPN_RAT,Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13),Anpep,Rattus norvegicus (Rat),965,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; metanephric proximal tubule development [GO:0072237]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485]; proteolysis [GO:0006508],GO:0001525; GO:0004177; GO:0005615; GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0072237
g4204,198.5555175,3.180851194,1.196056187,2.659449638,0.007826843,0.026191551,85,200,796,5,12,828,13,10,170,8,0,63,sp,Q9Y3Q0,NALD2_HUMAN,45,740,390,11,55,2238,6,740,0,660,Q9Y3Q0,reviewed,NALD2_HUMAN,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),NAALAD2,Homo sapiens (Human),740,proteolysis [GO:0006508],GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046872
g623,202.0852987,-2.746931398,0.758351695,-3.622239415,0.000292064,0.001685061,38,10,10,88,45,51,117,243,44,964,635,463,sp,O00602,FCN1_HUMAN,57.343,143,60,1,88,513,184,326,1.64E-51,170,O00602,reviewed,FCN1_HUMAN,Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin),FCN1 FCNM,Homo sapiens (Human),326,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0005886; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:0097367; GO:1903028; GO:1904813; GO:1905370
g19175,432.7627536,4.218553452,1.323321776,3.187851609,0.001433341,0.006437905,85,371,1095,0,41,2613,0,17,62,10,131,65,sp,P15088,CBPA3_HUMAN,39.516,124,61,3,1,351,297,413,2.48E-19,85.1,P15088,reviewed,CBPA3_HUMAN,Mast cell carboxypeptidase A (MC-CPA) (EC 3.4.17.1) (Carboxypeptidase A3),CPA3,Homo sapiens (Human),417,proteolysis [GO:0006508]; regulation of angiotensin levels in blood [GO:0002002],GO:0002002; GO:0004181; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0030133; GO:0030141; GO:0062023
g9657,1134.883493,1.805743508,0.571550433,3.159377376,0.001581066,0.006972996,1308,525,444,1395,2540,1360,588,580,387,468,1137,403,sp,A0A386CAB9,NLRP1_DANRE,23.743,358,208,12,544,1560,252,563,9.24E-11,69.7,A0A386CAB9,reviewed,NLRP1_DANRE,"NACHT, LRR and PYD domains-containing protein 1 homolog (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1, C-terminus (NLRP1-CT); NACHT, LRR and PYD domains-containing protein 1, N-terminus (NLRP1-NT)]",nlrp1 si:ch211-66k16.28,Danio rerio (Zebrafish) (Brachydanio rerio),1355,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981],GO:0002221; GO:0005524; GO:0005737; GO:0006508; GO:0006954; GO:0008233; GO:0012501; GO:0032731; GO:0042981; GO:0045087; GO:0050729; GO:0061702; GO:0072558
g18370,82.27979451,-2.061858143,0.48385891,-4.261279681,2.03E-05,0.000168499,45,28,25,61,7,6,178,150,122,152,233,119,sp,B5DEQ3,XPP3_RAT,55.23,239,105,1,40,756,268,504,3.43E-99,301,B5DEQ3,reviewed,XPP3_RAT,Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3),Xpnpep3,Rattus norvegicus (Rat),506,glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508],GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006
g18371,82.5494687,-1.421889597,0.335952659,-4.232410603,2.31E-05,0.000188033,26,51,35,66,20,32,143,181,115,197,93,144,sp,Q9NQH7,XPP3_HUMAN,54.225,142,64,1,232,654,41,182,5.25E-49,171,Q9NQH7,reviewed,XPP3_HUMAN,Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3),XPNPEP3,Homo sapiens (Human),507,glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508],GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006
g3861,12046.64949,4.90974438,1.137970961,4.314472466,1.60E-05,0.000137031,809,11392,51277,65,346,60116,73,608,2336,317,975,816,sp,P00767,CTRB_BOVIN,37.109,256,113,7,67,723,1,245,1.07E-43,150,P00767,reviewed,CTRB_BOVIN,Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C],,Bos taurus (Bovine),245,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586
g18940,43.07194924,-4.553505461,1.039497585,-4.380486811,1.18E-05,0.00010632,7,4,10,0,0,0,198,3,103,66,29,224,sp,P04323,POL3_DROME,37.755,294,150,4,1,795,334,623,5.63E-59,209,P04323,reviewed,POL3_DROME,Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],pol,Drosophila melanogaster (Fruit fly),1058,DNA integration [GO:0015074]; proteolysis [GO:0006508],GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006508; GO:0015074; GO:0042575
g22159,12573.87022,3.569465279,0.634866909,5.622383568,1.88E-08,3.57E-07,9537,4856,10730,15497,25305,36431,5790,3341,2823,855,524,1856,sp,Q99PW6,MMP24_RAT,35.095,473,239,16,148,1401,83,542,2.27E-77,257,Q99PW6,reviewed,MMP24_RAT,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],Mmp24 Mt5mmp,Rattus norvegicus (Rat),618,cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508],GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008233; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742
g21444,165.7426044,-1.586495931,0.613279335,-2.586905902,0.009684203,0.031298499,33,43,171,6,32,145,487,394,211,169,260,320,sp,Q9P2N4,ATS9_HUMAN,31.041,1018,524,31,4,2787,995,1924,2.60E-127,427,Q9P2N4,reviewed,ATS9_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-),ADAMTS9 KIAA1312,Homo sapiens (Human),1935,aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192],GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671
g17386,1663.568638,1.252876341,0.35769177,3.502670303,0.000460619,0.002464511,2712,976,1247,2188,2265,1763,1460,1252,1323,1010,1185,894,sp,P23004,QCR2_BOVIN,41.084,443,256,4,49,1365,12,453,1.66E-115,349,P23004,reviewed,QCR2_BOVIN,"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)",UQCRC2,Bos taurus (Bovine),453,proteolysis [GO:0006508],GO:0004222; GO:0005739; GO:0005743; GO:0006508; GO:0046872; GO:0070469
g12267,178.3992408,1.995485127,0.649590193,3.071913876,0.002126911,0.008930749,151,525,355,98,21,426,128,95,10,81,68,148,sp,P52948,NUP98_HUMAN,34.615,234,127,8,85,741,62,284,1.49E-19,95.9,P52948,reviewed,NUP98_HUMAN,Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)],NUP98 ADAR2,Homo sapiens (Human),1817,"mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]",GO:0000973; GO:0003713; GO:0003723; GO:0003729; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006508; GO:0006606; GO:0006913; GO:0006999; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034398; GO:0034399; GO:0042405; GO:0044614; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:0140693; GO:1990841; GO:1990904
g8609,436.3546935,3.061280464,0.783862439,3.905379707,9.41E-05,0.000641897,282,267,281,1693,806,176,154,95,66,8,287,50,sp,P59509,ATS19_MOUSE,32,150,80,6,82,480,809,953,1.90E-15,73.9,P59509,reviewed,ATS19_MOUSE,A disintegrin and metalloproteinase with thrombospondin motifs 19 (ADAM-TS 19) (ADAM-TS19) (ADAMTS-19) (EC 3.4.24.-),Adamts19,Mus musculus (Mouse),1210,aortic valve morphogenesis [GO:0003180]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0003180; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0030199; GO:0031012; GO:0046872
g5296,211.0419451,-0.654102552,0.170846215,-3.828604299,0.000128872,0.000839016,160,178,175,120,93,125,359,374,260,385,260,245,sp,Q9UI42,CBPA4_HUMAN,28.371,356,203,16,37,1035,61,387,4.17E-21,98.6,Q9UI42,reviewed,CBPA4_HUMAN,Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3),CPA4 CPA3 UNQ694/PRO1339,Homo sapiens (Human),421,hormone catabolic process [GO:0042447]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0042447; GO:0043171
g619,724.474935,5.110652963,1.386012154,3.687307465,0.000226639,0.001356604,107,844,3751,14,43,2912,0,9,198,12,0,49,sp,P21128,ENDOU_HUMAN,32.353,408,240,10,85,1269,24,408,9.95E-64,213,P21128,reviewed,ENDOU_HUMAN,Uridylate-specific endoribonuclease (EC 4.6.1.-) (Placental protein 11) (PP11) (Protein endoU),ENDOU,Homo sapiens (Human),410,female pregnancy [GO:0007565]; immune response [GO:0006955]; negative regulation of lipid catabolic process [GO:0050995]; post-transcriptional gene silencing [GO:0016441]; proteolysis [GO:0006508],GO:0003723; GO:0004521; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0006955; GO:0007565; GO:0008083; GO:0008236; GO:0016441; GO:0016829; GO:0030145; GO:0030247; GO:0050995
g6237,1063.729383,1.402695815,0.420120479,3.338794196,0.000841429,0.004099694,1088,3108,1723,445,381,1723,894,665,486,566,892,723,sp,Q1JPJ2,XPP1_BOVIN,33.572,697,371,19,175,2238,6,619,6.32E-112,357,Q1JPJ2,reviewed,XPP1_BOVIN,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",XPNPEP1,Bos taurus (Bovine),623,bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0043069; GO:0070006
g6236,624.1844029,2.456886796,0.92314978,2.661417301,0.007781245,0.026058292,172,1070,1610,14,25,2724,175,256,257,63,172,417,sp,Q6P1B1,XPP1_MOUSE,46.988,166,81,3,4,489,457,619,7.44E-48,168,Q6P1B1,reviewed,XPP1_MOUSE,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",Xpnpep1,Mus musculus (Mouse),623,bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0043069; GO:0070006
g6235,1392.247007,2.739573013,0.930133681,2.945354059,0.003225853,0.012647614,374,2813,3731,52,39,5962,413,529,435,92,213,880,sp,Q4WUD3,AMPP1_ASPFU,41.845,466,222,12,184,1551,45,471,8.03E-95,305,Q4WUD3,reviewed,AMPP1_ASPFU,Probable Xaa-Pro aminopeptidase P (AMPP) (Aminopeptidase P) (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Prolidase),ampp AFUA_5G08050,Aspergillus fumigatus (strain ATCC MYA-4609 / CBS 101355 / FGSC A1100 / Af293) (Neosartorya fumigata),654,proteolysis [GO:0006508],GO:0005737; GO:0006508; GO:0046872; GO:0070006
g6234,57.8551162,2.477350422,0.903521071,2.741884503,0.006108782,0.021498671,105,266,70,10,0,116,35,14,7,9,14,51,sp,F1NV61,CASP7_CHICK,46.125,271,134,3,277,1065,43,309,2.64E-78,246,F1NV61,reviewed,CASP7_CHICK,Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7,Gallus gallus (Chicken),309,defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508],GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0042742; GO:0043525; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686
g1564,174.1072762,-2.4275525,0.412616508,-5.883314057,4.02E-09,8.87E-08,46,76,87,65,16,9,551,357,219,430,315,320,sp,P69527,AMPO_RAT,34.762,840,424,14,16,2247,11,822,4.10E-146,451,P69527,reviewed,AMPO_RAT,Aminopeptidase O (AP-O) (EC 3.4.11.-),Aopep Onpep,Rattus norvegicus (Rat),822,proteolysis [GO:0006508],GO:0005730; GO:0006508; GO:0008270; GO:0070006
g21824,2345.75,3.603582844,1.023163529,3.522000876,0.000428303,0.002316326,939,5499,6318,25,95,10422,64,385,685,44,574,606,sp,A8K7I4,CLCA1_HUMAN,35.938,832,465,23,79,2541,23,797,1.50E-137,439,A8K7I4,reviewed,CLCA1_HUMAN,Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (hCLCA1) (Calcium-activated chloride channel protein 1) (CaCC-1) (hCaCC-1),CLCA1 CACC1,Homo sapiens (Human),914,calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; monoatomic ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508],GO:0004222; GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005902; GO:0006508; GO:0006816; GO:0034220; GO:0042589; GO:0046872; GO:0071456
g21827,1184.090109,4.302227424,0.994498212,4.326028314,1.52E-05,0.000130722,619,4722,2634,32,60,4348,20,381,156,14,129,73,sp,Q9D7Z6,CLCA1_MOUSE,31.803,915,524,35,124,2796,25,863,1.71E-108,364,Q9D7Z6,reviewed,CLCA1_MOUSE,Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 3) (mCLCA3) (Protein gob-5),Clca1 Clca3 Gob5,Mus musculus (Mouse),913,calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; proteolysis [GO:0006508],GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005902; GO:0006508; GO:0006816; GO:0006821; GO:0008237; GO:0016020; GO:0030141; GO:0042589; GO:0046872; GO:0071456
g21822,273.6978798,4.316257874,1.416462533,3.047209349,0.002309768,0.009576012,97,322,821,17,0,1485,0,84,44,12,0,38,sp,Q6Q473,CLA4A_MOUSE,31.148,915,543,31,85,2706,20,888,3.64E-111,369,Q6Q473,reviewed,CLA4A_MOUSE,"Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form]",Clca4a Clca6,Mus musculus (Mouse),924,chloride transport [GO:0006821]; proteolysis [GO:0006508],GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0015276; GO:0016324; GO:0046872
g3194,1425.557223,-2.19774758,0.582420646,-3.773471276,0.000160992,0.001017303,125,123,780,501,85,1003,5178,3467,1884,3451,1457,2401,sp,P16444,DPEP1_HUMAN,51.832,382,162,7,130,1272,20,380,4.79E-136,399,P16444,reviewed,DPEP1_HUMAN,Dipeptidase 1 (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP),DPEP1 MDP RDP,Homo sapiens (Human),411,antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; cellular response to xenobiotic stimulus [GO:0071466]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; lactam catabolic process [GO:0072340]; leukotriene D4 catabolic process [GO:1901749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neutrophil chemotaxis [GO:0030593]; proteolysis [GO:0006508],GO:0005615; GO:0005654; GO:0005886; GO:0006508; GO:0006749; GO:0006751; GO:0006954; GO:0008235; GO:0008270; GO:0008800; GO:0016324; GO:0016805; GO:0016999; GO:0030054; GO:0030336; GO:0030593; GO:0031528; GO:0034235; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071466; GO:0071732; GO:0072340; GO:0072341; GO:0098552; GO:1901749
g3207,3666.738113,2.188413792,0.39643184,5.520277559,3.38E-08,5.99E-07,6655,3128,3519,2373,6734,5693,1856,1217,1197,2233,1400,1732,sp,Q9NQC7,CYLD_HUMAN,44.356,505,245,12,2902,4383,470,949,1.87E-121,407,Q9NQC7,reviewed,CYLD_HUMAN,Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD),CYLD CYLD1 KIAA0849 HSPC057,Homo sapiens (Human),956,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein localization [GO:1903829]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; Wnt signaling pathway [GO:0016055]",GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0032088; GO:0032480; GO:0035872; GO:0036064; GO:0043369; GO:0045087; GO:0045577; GO:0045582; GO:0046329; GO:0048471; GO:0048872; GO:0050727; GO:0050728; GO:0050862; GO:0060544; GO:0061578; GO:0061815; GO:0070064; GO:0070266; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901026; GO:1901223; GO:1902017; GO:1903753; GO:1903829; GO:1990108; GO:1990380; GO:2000493; GO:2001238; GO:2001242
g12673,1259.460511,2.525007812,0.315373339,8.006408603,1.18E-15,8.70E-14,1297,1731,1745,1625,1963,1889,695,407,489,513,209,466,sp,Q3ULA2,FBW1A_MOUSE,74.409,508,103,2,7,1449,98,605,0,787,Q3ULA2,reviewed,FBW1A_MOUSE,F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit),Btrc Fbw1 Fbxw1 Fwd1 Kiaa4123,Mus musculus (Mouse),605,branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-templated transcription [GO:0045892]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006508; GO:0006511; GO:0008013; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0033598; GO:0038061; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:0071407; GO:1990756; GO:1990757
g1917,1446.970262,-2.739181288,0.480688031,-5.69845952,1.21E-08,2.42E-07,428,284,438,91,461,108,4358,2333,1483,4341,3303,2843,sp,Q9UKP5,ATS6_HUMAN,51.208,869,403,11,127,2697,258,1117,0,909,Q9UKP5,reviewed,ATS6_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-),ADAMTS6,Homo sapiens (Human),1117,aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508],GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976
g11906,266.3242735,-0.796076043,0.249928748,-3.185211982,0.00144648,0.006485621,176,226,193,96,128,176,521,365,407,308,503,337,sp,Q99497,PARK7_HUMAN,63.388,183,67,0,7,555,6,188,9.90E-76,228,Q99497,reviewed,PARK7_HUMAN,"Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)",PARK7,Homo sapiens (Human),189,"activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of hydrogen peroxide [GO:0061691]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of supramolecular fiber organization [GO:1902903]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]",GO:0000785; GO:0001933; GO:0002866; GO:0003713; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0005912; GO:0006281; GO:0006469; GO:0006508; GO:0006517; GO:0006914; GO:0006954; GO:0006979; GO:0007005; GO:0007265; GO:0007338; GO:0008233; GO:0008344; GO:0009438; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016605; GO:0016684; GO:0019249; GO:0019826; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031334; GO:0031397; GO:0032091; GO:0032148; GO:0032435; GO:0032757; GO:0033138; GO:0033234; GO:0033864; GO:0034599; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0044877; GO:0045121; GO:0045296; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051897; GO:0051899; GO:0051920; GO:0060081; GO:0060765; GO:0061691; GO:0061727; GO:0070062; GO:0070301; GO:0070994; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:0140297; GO:1900182; GO:1901671; GO:1901984; GO:1902176; GO:1902177; GO:1902236; GO:1902903; GO:1902958; GO:1903073; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903376; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1903599; GO:1903751; GO:1905259; GO:1990381; GO:1990422; GO:2000157; GO:2000379; GO:2000679; GO:2000825; GO:2001237; GO:2001268
g9401,191.9693251,0.581928294,0.209456236,2.778281059,0.005464733,0.019618466,206,197,307,189,90,223,208,216,154,192,184,161,sp,O76031,CLPX_HUMAN,64.062,128,46,0,1,384,487,614,1.47E-45,159,O76031,reviewed,CLPX_HUMAN,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial",CLPX,Homo sapiens (Human),633,ATP metabolic process [GO:0046034]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006508; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662
g21415,2767.157152,-1.213283243,0.410422879,-2.956178381,0.003114769,0.012324542,2069,571,794,908,1430,2228,5061,4061,3437,6253,4828,4406,sp,Q9UQC9,CLCA2_HUMAN,34.615,104,63,2,55,366,741,839,7.70E-13,70.1,Q9UQC9,reviewed,CLCA2_HUMAN,"Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]",CLCA2 CACC3,Homo sapiens (Human),943,cell adhesion [GO:0007155]; monoatomic ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508],GO:0004222; GO:0005229; GO:0005254; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006508; GO:0007155; GO:0009925; GO:0030054; GO:0031965; GO:0034220; GO:0046872; GO:0070161
g21414,7515.648886,-1.294471939,0.432013508,-2.99636913,0.002732155,0.011058302,4973,1287,2565,1893,3972,5986,14282,10769,9425,16701,14321,11912,sp,P54281,CLCA1_BOVIN,30.906,618,378,13,124,1941,22,602,8.31E-84,285,P54281,reviewed,CLCA1_BOVIN,Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel) (Epithelial chloride channel protein),,Bos taurus (Bovine),903,calcium ion transport [GO:0006816]; proteolysis [GO:0006508],GO:0005229; GO:0005886; GO:0006508; GO:0006816; GO:0008237; GO:0016324; GO:0046872
g3728,1310.592715,-1.421268369,0.332838751,-4.270140915,1.95E-05,0.000162614,396,731,1120,375,209,952,2777,2214,2065,2493,2230,2102,sp,Q6GQ29,CBPQ_XENLA,58.862,457,188,0,91,1461,13,469,0,567,Q6GQ29,reviewed,CBPQ_XENLA,Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase),cpq pgcp,Xenopus laevis (African clawed frog),469,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0042803; GO:0043171; GO:0046872; GO:0070573
g5188,210.1213384,-2.04467599,0.408926554,-5.00010569,5.73E-07,7.39E-06,70,123,67,102,31,42,522,497,434,110,369,501,sp,Q4R7U8,ASGL1_MACFA,46.602,309,155,3,7,933,1,299,9.44E-86,263,Q4R7U8,reviewed,ASGL1_MACFA,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],ASRGL1 QtsA-14329,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),308,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345
g19533,13.68848852,5.652288353,1.580803298,3.575579809,0.000349453,0.001957425,106,11,30,0,9,4,0,0,0,4,0,0,sp,Q9Y5R2,MMP24_HUMAN,35.34,515,277,20,127,1581,81,569,2.41E-65,228,Q9Y5R2,reviewed,MMP24_HUMAN,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],MMP24 MT5MMP,Homo sapiens (Human),645,cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508],GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742
g8151,80.06974616,-1.14998552,0.404291345,-2.844447538,0.004448851,0.01652316,25,85,68,61,15,15,168,144,118,175,106,102,sp,Q4R684,AMZ2_MACFA,32.273,220,140,4,346,990,98,313,6.33E-25,107,Q4R684,reviewed,AMZ2_MACFA,Archaemetzincin-2 (EC 3.4.-.-) (Archeobacterial metalloproteinase-like protein 2),AMZ2 QtsA-18820,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),360,proteolysis [GO:0006508],GO:0006508; GO:0008237; GO:0046872
g1331,137.6802664,-0.820041821,0.29886509,-2.743852828,0.006072275,0.021386877,89,113,119,122,32,57,197,153,216,295,236,166,sp,Q8BHG1,NRDC_MOUSE,52.89,571,243,3,385,2019,222,792,0,645,Q8BHG1,reviewed,NRDC_MOUSE,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase),Nrdc Nrd1,Mus musculus (Mouse),1161,negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of axonogenesis [GO:0050772]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; proteolysis [GO:0006508],GO:0004222; GO:0005739; GO:0006508; GO:0008233; GO:0030425; GO:0031643; GO:0046872; GO:0050772; GO:0051044; GO:0120163
g16353,269.4491747,-1.273663176,0.288260146,-4.418450463,9.94E-06,9.11E-05,137,157,241,162,46,107,741,529,280,555,269,492,sp,A3KG59,P20D2_MOUSE,42.172,396,183,9,13,1167,26,386,2.43E-79,254,A3KG59,reviewed,P20D2_MOUSE,Xaa-Arg dipeptidase (EC 3.4.13.4),Pm20d2 Acy1l2 Gm424,Mus musculus (Mouse),431,proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246
g20362,74.57773436,-3.18169158,0.893596136,-3.560547603,0.000370082,0.002055671,27,12,6,0,18,9,138,66,53,77,559,23,sp,O57382,TLL2_XENLA,28.475,295,128,5,40,678,595,888,3.20E-34,132,O57382,reviewed,TLL2_XENLA,Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid),tll2 xld,Xenopus laevis (African clawed frog),1019,cell differentiation [GO:0030154]; proteolysis [GO:0006508],GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154
g19379,110.0660659,6.529333683,1.120364297,5.827866615,5.61E-09,1.21E-07,198,164,57,130,357,35,0,5,0,0,0,11,sp,P20918,PLMN_MOUSE,40.206,291,147,7,817,1677,545,812,1.68E-55,203,P20918,reviewed,PLMN_MOUSE,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]",Plg,Mus musculus (Mouse),812,"biological process involved in interaction with symbiont [GO:0051702]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]",GO:0002020; GO:0004175; GO:0004252; GO:0005102; GO:0005576; GO:0005615; GO:0006508; GO:0007596; GO:0009897; GO:0009986; GO:0010812; GO:0016525; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0034185; GO:0042246; GO:0042730; GO:0043536; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051603; GO:0051702; GO:0051918; GO:0051919; GO:0060707; GO:0060716; GO:0062023; GO:0071674; GO:0098685; GO:0098978; GO:0099183; GO:1990405
g9283,574.6866718,3.627772361,0.51284649,7.07379778,1.51E-12,6.45E-11,1363,380,299,589,1502,613,133,100,129,79,87,96,sp,P16519,NEC2_HUMAN,44.586,157,86,1,1,468,447,603,1.23E-40,147,P16519,reviewed,NEC2_HUMAN,Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2) (PC2),PCSK2 NEC2,Homo sapiens (Human),638,enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0005654; GO:0006508; GO:0007399; GO:0016020; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030141; GO:0030425; GO:0034230; GO:0034231; GO:0043005; GO:0043204; GO:0043231
g17596,686.4856293,0.889495749,0.343334886,2.5907526,0.009576631,0.031011925,870,584,554,557,1033,561,721,551,524,611,449,653,sp,B1AQJ2,UBP36_MOUSE,48.156,461,229,6,67,1440,12,465,2.44E-136,451,B1AQJ2,reviewed,UBP36_MOUSE,Ubiquitin carboxyl-terminal hydrolase 36 (EC 2.3.2.-) (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36),Usp36 Kiaa1453,Mus musculus (Mouse),1098,chromatin organization [GO:0006325]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232],GO:0003723; GO:0004843; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006325; GO:0006508; GO:0007000; GO:0016242; GO:0016579; GO:0016607; GO:0016740; GO:0031647; GO:0042981; GO:0050821; GO:0140936; GO:1990380; GO:2000232
g14832,40.86494678,-1.767900016,0.659540408,-2.680502958,0.007351161,0.024923241,20,41,13,16,10,0,58,49,55,141,114,35,sp,Q5G266,NETR_TRAPH,31.173,324,197,7,157,1128,194,491,8.63E-38,149,Q5G266,reviewed,NETR_TRAPH,Neurotrypsin (EC 3.4.21.-) (Serine protease 12),PRSS12,Trachypithecus phayrei (Phayre's leaf monkey),875,exocytosis [GO:0006887]; proteolysis [GO:0006508],GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195
g23767,87.8515845,-1.757450903,0.617314345,-2.846930282,0.004414303,0.016408841,11,41,104,25,7,33,250,249,48,332,54,106,sp,Q2T9J0,TYSD1_HUMAN,32.67,603,331,17,97,1866,26,566,9.54E-81,268,Q2T9J0,reviewed,TYSD1_HUMAN,"Peroxisomal leader peptide-processing protease (EC 3.4.21.-) (Trypsin domain-containing protein 1) [Cleaved into: Peroxisomal leader peptide-processing protease, 15 kDa form; Peroxisomal leader peptide-processing protease, 45 kDa form]",TYSND1,Homo sapiens (Human),566,protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of fatty acid beta-oxidation [GO:0031998],GO:0002020; GO:0004252; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0016020; GO:0016485; GO:0031998; GO:0042802
g11276,48676.39751,8.295643412,0.840461265,9.87034591,5.60E-23,1.10E-20,84772,23520,42462,642,98361,192556,620,338,148,97,507,550,sp,Q8TE57,ATS16_HUMAN,31.452,744,413,25,1,2085,292,987,1.31E-93,318,Q8TE57,reviewed,ATS16_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),ADAMTS16 KIAA2029,Homo sapiens (Human),1224,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017
g11277,15892.98723,8.437602881,0.833975009,10.117333,4.63E-24,1.05E-21,28686,8547,13491,240,31993,61959,155,106,53,24,138,183,sp,P25723,TLD_DROME,26.667,210,134,7,118,711,388,589,1.18E-14,76.6,P25723,reviewed,TLD_DROME,Dorsal-ventral patterning protein tolloid (EC 3.4.24.-),tld CG6868,Drosophila melanogaster (Fruit fly),1067,"amnioserosa formation [GO:0007378]; dorsal/ventral pattern formation [GO:0009953]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485]; proteolysis [GO:0006508]; R8 cell fate specification [GO:0045464]",GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0007313; GO:0007378; GO:0008270; GO:0008586; GO:0009953; GO:0016485; GO:0030513; GO:0032927; GO:0045464
g11275,12727.90389,8.345704818,0.824952303,10.11659072,4.66E-24,1.05E-21,20229,6253,12362,204,23139,54671,175,95,42,25,110,132,sp,Q8TE57,ATS16_HUMAN,36.17,94,57,2,223,495,87,180,1.11E-08,58.2,Q8TE57,reviewed,ATS16_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),ADAMTS16 KIAA2029,Homo sapiens (Human),1224,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017
g16700,1823.125097,-2.767802233,0.548017331,-5.050574274,4.40E-07,5.84E-06,900,101,296,269,544,143,3769,2607,2511,2837,4716,6095,sp,Q9R0S2,MMP24_MOUSE,33.012,518,292,17,124,1599,56,544,9.63E-68,233,Q9R0S2,reviewed,MMP24_MOUSE,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Matrix metalloproteinase-21) (MMP-21) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],Mmp24 Mmp21 Mt5mmp,Mus musculus (Mouse),618,cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508],GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742
g7450,11690.72658,3.792867194,0.783797504,4.839090674,1.30E-06,1.53E-05,45479,4626,2011,12639,6304,42963,2706,5110,1409,1028,1253,159,sp,Q15485,FCN2_HUMAN,57.277,213,89,2,433,1068,102,313,3.09E-79,248,Q15485,reviewed,FCN2_HUMAN,Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35),FCN2 FCNL,Homo sapiens (Human),313,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065
g14701,901.5490025,-1.230814377,0.398042377,-3.092169201,0.001986996,0.008451404,531,642,525,698,200,270,1544,1876,2671,1246,465,1292,sp,P80912,HINT1_RABIT,61.538,130,46,1,1,390,1,126,2.48E-54,169,P80912,reviewed,HINT1_RABIT,Adenosine 5'-monophosphoramidase HINT1 (EC 3.9.1.-) (Desumoylating isopeptidase HINT1) (EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (P13.7),HINT1 HINT,Oryctolagus cuniculus (Rabbit),126,intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508]; purine ribonucleotide catabolic process [GO:0009154]; regulation of DNA-templated transcription [GO:0006355],GO:0000118; GO:0000166; GO:0005634; GO:0005737; GO:0006355; GO:0006508; GO:0009154; GO:0016787; GO:0016926; GO:0016929; GO:0043530; GO:0072332
g9583,860.9489486,1.196239732,0.413628489,2.892063201,0.003827209,0.014566042,994,777,830,2445,591,427,1125,623,486,554,734,391,sp,Q9NVE5,UBP40_HUMAN,52.143,420,186,6,1,1248,1,409,3.57E-110,381,Q9NVE5,reviewed,UBP40_HUMAN,Ubiquitin carboxyl-terminal hydrolase 40 (EC 3.4.19.12) (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40),USP40,Homo sapiens (Human),1235,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016579
g22850,4.223768597,-5.278798175,2.168391203,-2.434430728,0.014915234,0.044345179,0,0,0,0,0,0,3,11,0,42,0,7,sp,P10394,POL4_DROME,30.556,180,122,1,529,1068,1014,1190,2.17E-17,89,P10394,reviewed,POL4_DROME,Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],POL ORF3,Drosophila melanogaster (Fruit fly),1237,DNA integration [GO:0015074]; proteolysis [GO:0006508],GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006508; GO:0015074; GO:0042575
g11751,20951.15958,4.143968084,1.126981563,3.677050468,0.000235946,0.001403006,1560,18770,61533,125,1090,121843,177,1152,5348,870,4565,2580,sp,P49275,DERF3_DERFA,38.258,264,141,9,1,759,4,256,4.07E-43,150,P49275,reviewed,DERF3_DERFA,Mite allergen Der f 3 (EC 3.4.21.-) (Allergen Der f III) (allergen Der f 3),DERF3,Dermatophagoides farinae (American house dust mite),259,proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508
g11752,18553.96931,4.746901274,1.128440746,4.206602155,2.59E-05,0.000207196,1484,18447,71466,122,747,96575,110,600,3473,566,2739,1236,sp,P70059,TRY2_XENLA,40.769,260,130,9,1,768,1,240,3.17E-52,173,P70059,reviewed,TRY2_XENLA,Trypsin (EC 3.4.21.4),,Xenopus laevis (African clawed frog),244,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586; GO:0046872
g4774,8421.655995,4.366257643,1.138470977,3.835194511,0.000125465,0.000821577,346,5341,32860,66,267,45382,102,447,1880,309,1362,1032,sp,Q6P8K8,CBPA4_MOUSE,36.765,408,230,10,61,1260,21,408,2.75E-77,249,Q6P8K8,reviewed,CBPA4_MOUSE,Carboxypeptidase A4 (EC 3.4.17.-),Cpa4,Mus musculus (Mouse),420,hormone catabolic process [GO:0042447]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0042447; GO:0043171
g19541,5551.652022,4.007329938,0.629337204,6.367540186,1.92E-10,5.65E-09,12536,4402,3601,1620,15936,7807,627,381,599,545,1524,834,sp,Q9ULZ9,MMP17_HUMAN,37.037,486,289,8,103,1536,47,523,1.07E-92,298,Q9ULZ9,reviewed,MMP17_HUMAN,Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP),MMP17 MT4MMP,Homo sapiens (Human),603,collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508],GO:0001822; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0042756; GO:0070006; GO:0098552
g19543,4.709831446,5.949949498,1.98304813,3.000405996,0.0026962,0.01093691,11,19,8,0,10,0,0,0,0,0,0,0,sp,Q99542,MMP19_HUMAN,36,250,146,7,1,729,230,472,2.07E-40,149,Q99542,reviewed,MMP19_HUMAN,Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18),MMP19 MMP18 RASI,Homo sapiens (Human),508,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0001525; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012
g11953,297.3882082,-1.130581544,0.221069622,-5.114142463,3.15E-07,4.34E-06,212,200,134,225,73,137,656,589,435,587,340,407,sp,A0A0R4IB93,UBP48_DANRE,51.579,760,332,7,1,2232,1,740,0,789,A0A0R4IB93,reviewed,UBP48_DANRE,Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Ubiquitin specific peptidase 48),usp48,Danio rerio (Zebrafish) (Brachydanio rerio),1047,cranial skeletal system development [GO:1904888]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016579; GO:1904888
g11952,140.4312821,-1.227259964,0.280960542,-4.368086548,1.25E-05,0.000111319,79,86,130,74,37,42,250,336,163,246,239,190,sp,Q86UV5,UBP48_HUMAN,43.446,267,127,8,4,750,774,1034,1.74E-44,163,Q86UV5,reviewed,UBP48_HUMAN,Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Deubiquitinating enzyme 48) (Ubiquitin thioesterase 48) (Ubiquitin-specific peptidase 48) (Ubiquitin-specific protease 48) (Ubiquitin-specific-processing protease 48),USP48 USP31,Homo sapiens (Human),1035,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005929; GO:0006508; GO:0016579; GO:0101005
g11951,629.5924367,4.692883768,1.295698325,3.621895374,0.000292452,0.001686765,53,652,2933,4,25,2851,0,28,189,4,25,61,sp,P07478,TRY2_HUMAN,45.175,228,113,3,64,747,24,239,7.40E-63,200,P07478,reviewed,TRY2_HUMAN,Trypsin-2 (EC 3.4.21.4) (Anionic trypsinogen) (Serine protease 2) (Trypsin II),PRSS2 TRY2 TRYP2,Homo sapiens (Human),247,antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508],GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0008236; GO:0019730; GO:0022617; GO:0030307; GO:0030574; GO:0031012; GO:0035578; GO:0045785
g11950,3083.121072,4.588018987,1.199343077,3.825443341,0.000130537,0.000848326,198,4049,16499,38,75,11650,6,213,1091,125,136,58,sp,Q8NHM4,TRY6_HUMAN,44.13,247,118,7,25,756,13,242,1.95E-52,174,Q8NHM4,reviewed,TRY6_HUMAN,Putative trypsin-6 (EC 3.4.21.4) (Serine protease 3 pseudogene 2) (Trypsinogen C),PRSS3P2 T6 TRY6,Homo sapiens (Human),247,endothelial cell migration [GO:0043542]; proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508; GO:0043542; GO:0046872
g11955,595.2236394,4.038986875,1.433739767,2.817099009,0.004845958,0.017760969,26,269,2193,0,11,3346,0,38,250,29,77,54,sp,P39675,DERP3_DERPT,39.516,248,133,6,64,792,25,260,1.45E-47,162,P39675,reviewed,DERP3_DERPT,Mite allergen Der p 3 (EC 3.4.21.-) (Allergen Der p III) (allergen Der p 3),DERP3,Dermatophagoides pteronyssinus (European house dust mite),261,proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508
g11954,901.2395204,4.328635588,1.130902955,3.827592428,0.000129403,0.000841561,122,826,2539,10,8,5379,15,71,213,27,180,57,sp,Q07943,VDP_BOMMO,35.032,157,88,3,142,606,105,249,1.19E-26,105,Q07943,reviewed,VDP_BOMMO,Vitellin-degrading protease (EC 3.4.21.-) [Cleaved into: Beta-VTN protease; Alpha-VTN protease chain 1; Alpha-VTN protease chain 2],,Bombyx mori (Silk moth),264,proteolysis [GO:0006508],GO:0004252; GO:0006508
g5273,217.7233766,-1.204791521,0.362415821,-3.324334785,0.000886297,0.004276992,137,251,177,44,34,93,569,415,272,433,282,299,sp,B2RYG6,OTUB1_RAT,62.302,252,94,1,55,807,19,270,3.59E-107,314,B2RYG6,reviewed,OTUB1_RAT,Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (Ubiquitin-specific-processing protease OTUB1),Otub1,Rattus norvegicus (Rat),271,adaptive immune response [GO:0002250]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508],GO:0002250; GO:0004843; GO:0005737; GO:0006281; GO:0006508; GO:0006974; GO:0016579; GO:0019784; GO:0031625; GO:0043130; GO:0055105; GO:0071108; GO:0071347; GO:1904263; GO:2000780
g7821,33.74957044,-2.63249008,0.844970054,-3.115483284,0.001836438,0.007915498,7,25,0,17,2,0,75,40,85,69,103,43,sp,P0C872,JMJD7_MOUSE,27.451,306,169,10,313,1191,28,293,4.11E-30,121,P0C872,reviewed,JMJD7_MOUSE,Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 (EC 1.14.11.63) (EC 3.4.-.-) (JmjC domain-containing protein 7) (Jumonji domain-containing protein 7) (L-lysine (3S)-hydroxylase Jmjd7),Jmjd7,Mus musculus (Mouse),316,proteolysis [GO:0006508],GO:0004175; GO:0004177; GO:0004497; GO:0005634; GO:0005737; GO:0006508; GO:0016706; GO:0035064; GO:0046872; GO:0106155
g1360,167.9180628,-1.410702046,0.319926767,-4.409453011,1.04E-05,9.47E-05,114,102,150,41,32,64,447,315,164,384,321,189,sp,B6MUN4,MYSM1_BRAFL,44.504,373,156,6,1834,2937,438,764,4.45E-91,311,B6MUN4,reviewed,MYSM1_BRAFL,"Histone H2A deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)",MYSM1 BRAFLDRAFT_86936,Branchiostoma floridae (Florida lancelet) (Amphioxus),809,chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508],GO:0003677; GO:0003713; GO:0005634; GO:0006338; GO:0006508; GO:0042393; GO:0045944; GO:0046872; GO:0140492; GO:0140950
g20679,361.5560455,-1.562336242,0.225691043,-6.922455677,4.44E-12,1.78E-10,161,219,237,98,70,188,1036,731,511,702,506,548,sp,P13676,ACPH_RAT,48.333,720,354,11,52,2175,13,726,0,629,P13676,reviewed,ACPH_RAT,Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase),Apeh,Rattus norvegicus (Rat),732,amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508],GO:0004252; GO:0005737; GO:0006508; GO:0008242; GO:0042802; GO:0050435
g3140,1068.943345,0.868411909,0.219408412,3.957969985,7.56E-05,0.000530704,1864,1169,1559,855,700,1142,1548,1130,806,917,478,811,sp,P10619,PPGB_HUMAN,43.167,461,232,7,139,1458,29,480,1.46E-128,385,P10619,reviewed,PPGB_HUMAN,Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain],CTSA PPGB,Homo sapiens (Human),480,intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647],GO:0004180; GO:0004185; GO:0005576; GO:0005764; GO:0005783; GO:0006508; GO:0006886; GO:0008047; GO:0016020; GO:0031647; GO:0035578; GO:0043202; GO:0043231; GO:0070062; GO:1904714; GO:1904715
g17411,1281.054384,0.946694321,0.320322921,2.95543734,0.003122261,0.012340658,880,2212,1883,976,950,1733,1757,966,573,1712,664,966,sp,Q70CQ4,UBP31_HUMAN,40.026,767,358,16,733,2880,126,841,1.46E-169,535,Q70CQ4,reviewed,UBP31_HUMAN,Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31),USP31 KIAA1203,Homo sapiens (Human),1352,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004843; GO:0005634; GO:0006508; GO:0016579
g22762,793.6411153,1.784344763,0.550833283,3.239355387,0.001198002,0.005537997,2122,1070,799,143,1110,959,616,470,625,513,84,348,sp,A0A182C2Z2,OVCH_HALRO,35,340,186,13,2041,2979,545,876,1.04E-41,171,A0A182C2Z2,reviewed,OVCH_HALRO,Ovochymase (HrOVCH) (EC 3.4.21.-),OVCH,Halocynthia roretzi (Sea squirt) (Cynthia roretzi),1575,acrosome reaction [GO:0007340]; fertilization [GO:0009566]; oogenesis [GO:0048477]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007340; GO:0009566; GO:0048477
g23544,122.3508877,3.426552798,1.30688595,2.621921827,0.008743548,0.028731759,275,225,33,27,98,480,120,0,3,66,0,0,sp,Q8R4K8,PAPP1_MOUSE,35.924,1055,565,33,1468,4470,620,1617,0,605,Q8R4K8,reviewed,PAPP1_MOUSE,Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A),Pappa,Mus musculus (Mouse),1624,cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548]; response to follicle-stimulating hormone [GO:0032354],GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0007166; GO:0007565; GO:0030163; GO:0032354; GO:0046872; GO:0071548
g21781,1339.474909,1.510116395,0.281941285,5.356137881,8.50E-08,1.35E-06,2248,3163,1732,743,1252,1271,1229,648,886,887,689,795,sp,Q6TH47,STBPA_DANRE,51.282,195,91,3,829,1413,228,418,3.09E-66,221,Q6TH47,reviewed,STBPA_DANRE,STAM-binding protein-like A (EC 3.4.19.-),stambpa amsh stambp,Danio rerio (Zebrafish) (Brachydanio rerio),418,protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508],GO:0005768; GO:0006508; GO:0032154; GO:0046872; GO:0061578; GO:0070536; GO:0140492
g15116,343.2363649,3.051598389,0.922645461,3.307444211,0.000941515,0.004510622,135,424,1239,17,8,1471,112,27,133,34,66,156,sp,O57579,AMPN_CHICK,40.603,431,214,8,1,1206,550,967,5.11E-102,327,O57579,reviewed,AMPN_CHICK,Aminopeptidase Ey (EC 3.4.11.20) (Aminopeptidase N),ANPEP APDE,Gallus gallus (Chicken),972,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006
g15115,321.4210744,3.036201192,0.912700809,3.326611701,0.000879088,0.004247964,194,415,1213,41,12,1239,71,26,179,12,31,166,sp,P15145,AMPN_PIG,46.889,450,219,6,460,1791,71,506,2.66E-129,406,P15145,reviewed,AMPN_PIG,Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13),ANPEP,Sus scrofa (Pig),963,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],GO:0001525; GO:0001618; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0030154; GO:0042277; GO:0043171; GO:0070006
g19176,2635.5521,4.682984137,1.109144046,4.22216046,2.42E-05,0.000195211,218,1949,6377,19,164,17052,19,96,454,120,382,231,sp,P00730,CBPA1_BOVIN,35.865,237,146,4,16,717,22,255,3.50E-42,152,P00730,reviewed,CBPA1_BOVIN,Carboxypeptidase A1 (EC 3.4.17.1),CPA1 CPA,Bos taurus (Bovine),419,leukotriene metabolic process [GO:0006691]; proteolysis [GO:0006508],GO:0004181; GO:0005615; GO:0006508; GO:0006691; GO:0008270
g22787,276.0163014,-4.52466801,1.070668231,-4.226022477,2.38E-05,0.000192563,35,74,12,8,0,8,1002,665,1030,415,0,814,sp,Q8NF86,PRS33_HUMAN,33.333,267,143,11,364,1128,31,274,1.71E-30,123,Q8NF86,reviewed,PRS33_HUMAN,Serine protease 33 (EC 3.4.21.-) (Serine protease EOS),PRSS33,Homo sapiens (Human),280,protein kinase C signaling [GO:0070528]; proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0070528
g19847,85563.9495,8.713121243,0.945406375,9.216270882,3.08E-20,4.44E-18,153892,14989,57560,854,113118,462346,1071,427,130,83,502,859,sp,O77656,MMP13_BOVIN,42.586,263,125,7,514,1299,24,261,1.44E-49,184,O77656,reviewed,MMP13_BOVIN,Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13),MMP13,Bos taurus (Bovine),471,bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0004175; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0060349
g3626,81.11280127,2.064172978,0.829859735,2.487375746,0.01286894,0.039370361,84,353,96,24,0,185,69,48,12,44,29,36,sp,Q86V25,VASH2_HUMAN,58.661,254,105,0,61,822,41,294,5.32E-114,338,Q86V25,reviewed,VASH2_HUMAN,Tubulinyl-Tyr carboxypeptidase 2 (EC 3.4.17.17) (Vasohibin-2) (Vasohibin-like protein),VASH2 VASHL,Homo sapiens (Human),355,axon development [GO:0061564]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; syncytium formation by plasma membrane fusion [GO:0000768],GO:0000768; GO:0001938; GO:0003779; GO:0004181; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0006508; GO:0008017; GO:0045765; GO:0045766; GO:0060716; GO:0061564; GO:0106423; GO:0140253
g19283,23.58409797,-1.944802609,0.688149597,-2.826133472,0.004711363,0.017352238,11,6,23,12,0,3,39,53,9,67,66,36,sp,Q8I7P9,POL5_DROME,36.719,128,78,2,7,390,455,579,5.51E-18,82.8,Q8I7P9,reviewed,POL5_DROME,Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],pol,Drosophila melanogaster (Fruit fly),1003,DNA integration [GO:0015074]; DNA transposition [GO:0006313]; proteolysis [GO:0006508],GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0006508; GO:0008233; GO:0015074; GO:0042575
g23897,622.8358486,2.278637709,0.564686035,4.035229431,5.45E-05,0.000397595,1792,1693,1117,513,388,296,133,268,107,358,65,578,sp,Q3SYW2,CO2_BOVIN,30.631,444,261,15,628,1869,32,458,2.03E-48,185,Q3SYW2,reviewed,CO2_BOVIN,Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment],C2,Bos taurus (Bovine),750,"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]",GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006958; GO:0009617; GO:0045087; GO:0046872
g852,17818.50189,2.600052748,0.755829869,3.439997353,0.00058172,0.003008935,37616,2844,4966,16899,39870,33146,2927,5924,10253,1018,10363,3542,sp,P90850,YCF2E_CAEEL,47.465,434,204,13,31,1308,14,431,4.94E-125,373,P90850,reviewed,YCF2E_CAEEL,Uncharacterized peptidase C1-like protein F26E4.3,F26E4.3,Caenorhabditis elegans,452,proteolysis [GO:0006508],GO:0005615; GO:0006508; GO:0008234
g21351,3080.631414,0.550595277,0.222826793,2.470956343,0.013475227,0.040878705,4578,2988,5133,3544,1490,1933,4680,2784,3006,2518,3028,2424,sp,P53634,CATC_HUMAN,51.481,439,174,5,52,1257,24,460,1.89E-159,460,P53634,reviewed,CATC_HUMAN,Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)],CTSC CPPI,Homo sapiens (Human),463,immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913],GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006955; GO:0008234; GO:0008239; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235
g4298,24016.88942,4.582183607,1.143437549,4.00737549,6.14E-05,0.0004418,2791,35311,148219,266,547,71586,74,1677,7330,644,1638,1326,sp,P80146,SEPR_THESR,41.47,381,195,9,52,1119,30,407,4.46E-80,254,P80146,reviewed,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,Thermus sp. (strain Rt41A),410,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508
g4297,17774.42361,4.061551355,1.12021555,3.625687355,0.000288194,0.001665397,1303,16600,65815,102,958,91683,177,980,3525,788,5197,2450,sp,P80146,SEPR_THESR,40.938,320,168,8,205,1128,98,408,4.13E-50,176,P80146,reviewed,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,Thermus sp. (strain Rt41A),410,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508
g4296,5554.008604,4.260170494,1.122345928,3.795773111,0.000147184,0.000942929,463,4873,25529,42,330,25282,26,428,1352,184,1125,490,sp,P80146,SEPR_THESR,39.474,380,200,9,58,1119,33,408,5.03E-55,189,P80146,reviewed,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,Thermus sp. (strain Rt41A),410,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508
g22664,477.7752765,0.78055471,0.229636009,3.399095433,0.000676091,0.003399671,735,594,597,609,288,360,502,377,584,300,389,378,sp,P48147,PPCE_HUMAN,68.794,705,203,1,4,2067,4,708,0,1049,P48147,reviewed,PPCE_HUMAN,Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme),PREP PEP,Homo sapiens (Human),710,proteolysis [GO:0006508],GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012
g11962,259.3519209,-0.718223069,0.251062272,-2.860736749,0.004226578,0.0158284,181,216,212,172,84,166,555,302,308,548,190,499,sp,Q5T2D3,OTUD3_HUMAN,42.773,339,158,7,25,990,8,327,1.17E-85,269,Q5T2D3,reviewed,OTUD3_HUMAN,OTU domain-containing protein 3 (EC 3.4.19.12),OTUD3 KIAA0459,Homo sapiens (Human),398,cellular response to nutrient levels [GO:0031669]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K48-linked deubiquitination [GO:0071108]; protein K6-linked deubiquitination [GO:0044313]; protein stabilization [GO:0050821]; proteolysis [GO:0006508],GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0016579; GO:0031669; GO:0035871; GO:0044313; GO:0050821; GO:0051898; GO:0071108; GO:1990167
g14920,10.84119094,-2.700735068,0.904902147,-2.984560347,0.002839862,0.011434847,3,0,8,5,0,0,10,27,17,40,29,10,sp,P0CT40,TF29_SCHPO,34.884,129,82,1,16,396,545,673,7.50E-17,79.3,P0CT40,reviewed,TF29_SCHPO,Transposon Tf2-9 polyprotein (Retrotransposable element Tf2 155 kDa protein),Tf2-9 SPBC9B6.02c,Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),1333,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508],GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0015074; GO:0046872
g1886,1211.872337,-2.107676843,0.244116145,-8.633910084,5.93E-18,6.37E-16,405,524,668,308,198,330,4938,1841,2537,2434,1638,1659,sp,Q3UVK0,ERMP1_MOUSE,39.571,839,480,12,187,2697,85,898,0,604,Q3UVK0,reviewed,ERMP1_MOUSE,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),Ermp1 D19Wsu12e Fxna Kiaa1815,Mus musculus (Mouse),898,cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ovarian follicle development [GO:0001541]; proteolysis [GO:0006508],GO:0001541; GO:0005789; GO:0006508; GO:0008235; GO:0030968; GO:0034599; GO:0046872
g1147,483.0475469,1.915050831,0.325954458,5.875209818,4.22E-09,9.25E-08,1479,789,813,450,296,395,420,218,281,202,112,282,sp,Q8C1A5,THOP1_MOUSE,63.262,656,241,0,25,1992,22,677,0,870,Q8C1A5,reviewed,THOP1_MOUSE,Thimet oligopeptidase (EC 3.4.24.15),Thop1,Mus musculus (Mouse),687,intracellular signal transduction [GO:0035556]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508],GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0043171; GO:0046872
g2495,166.7728598,7.291800654,0.986936172,7.388320404,1.49E-13,7.78E-12,286,315,217,20,551,71,5,7,0,0,0,4,sp,P55112,NAS4_CAEEL,36.15,213,132,3,157,786,78,289,1.78E-43,153,P55112,reviewed,NAS4_CAEEL,Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4),nas-4 C05D11.6,Caenorhabditis elegans,315,proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008270
g2494,3341.230009,-3.076557126,0.630759681,-4.877542461,1.07E-06,1.29E-05,1265,297,832,224,832,44,7738,2978,6440,10328,5461,10375,sp,P55115,NAS15_CAEEL,29.56,477,276,9,268,1575,114,571,1.56E-52,196,P55115,reviewed,NAS15_CAEEL,Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15),nas-15 T04G9.2,Caenorhabditis elegans,571,proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008270
g22266,24810.35123,-1.374495052,0.46841259,-2.934368292,0.003342274,0.013022024,9410,3878,10566,6053,16034,16510,50184,49455,57622,31792,38203,30786,sp,Q5G265,NETR_SAGLB,36.823,554,264,17,2134,3681,365,870,9.83E-88,307,Q5G265,reviewed,NETR_SAGLB,Neurotrypsin (EC 3.4.21.-) (Serine protease 12),PRSS12,Saguinus labiatus (Red-chested mustached tamarin),875,exocytosis [GO:0006887]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424
g22260,15749.63398,2.966613824,0.719202499,4.124865848,3.71E-05,0.000282948,52047,15092,8110,1534,39414,13551,4977,4646,1588,3642,9007,1688,sp,P04813,CTR2_CANLF,37.121,264,127,10,250,987,19,261,1.27E-45,159,P04813,reviewed,CTR2_CANLF,Chymotrypsinogen 2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin 2 chain A; Chymotrypsin 2 chain B; Chymotrypsin 2 chain C],CTRB1 CTRB,Canis lupus familiaris (Dog) (Canis familiaris),263,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586
g15120,10.05127544,-6.529453772,2.527877095,-2.582979127,0.009795125,0.031600397,0,0,0,0,0,0,100,6,62,0,0,0,sp,P15145,AMPN_PIG,33.892,835,501,23,1,2430,150,958,1.50E-143,450,P15145,reviewed,AMPN_PIG,Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13),ANPEP,Sus scrofa (Pig),963,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],GO:0001525; GO:0001618; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0030154; GO:0042277; GO:0043171; GO:0070006
g6596,747.1687304,1.118427121,0.31461734,3.554880737,0.000378151,0.002092116,934,640,609,731,1024,896,776,576,383,669,566,497,sp,Q8CF97,VCIP1_RAT,44.811,1031,455,18,19,3045,36,974,0,862,Q8CF97,reviewed,VCIP1_RAT,Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein),Vcpip1 Vcip135,Rattus norvegicus (Rat),1221,DNA damage response [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; regulation of protein localization to chromatin [GO:1905634],GO:0004843; GO:0005634; GO:0005783; GO:0005795; GO:0006508; GO:0006974; GO:0007030; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0045202; GO:0071108; GO:0090168; GO:0106300; GO:1905634
g15917,60.30764403,3.565015236,1.299017625,2.744393276,0.006062286,0.021355862,492,25,149,0,12,14,29,17,19,0,0,8,sp,P70505,ADAM1_RAT,25.914,301,193,11,259,1122,138,421,3.18E-09,62.4,P70505,reviewed,ADAM1_RAT,Disintegrin and metalloproteinase domain-containing protein 1 (ADAM 1) (EC 3.4.24.-) (Fertilin subunit alpha),Adam1 Adam1a Ftna,Rattus norvegicus (Rat),789,binding of sperm to zona pellucida [GO:0007339]; male gonad development [GO:0008584]; proteolysis [GO:0006508],GO:0004222; GO:0005886; GO:0006508; GO:0007339; GO:0008237; GO:0008584; GO:0009897; GO:0016020; GO:0045121; GO:0046872; GO:1990913
g19685,135.5013559,2.606538405,1.065165554,2.447073505,0.014402146,0.043125193,477,188,631,13,4,96,64,0,24,11,26,150,sp,Q99542,MMP19_HUMAN,32.636,478,261,15,142,1500,31,472,6.10E-67,227,Q99542,reviewed,MMP19_HUMAN,Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18),MMP19 MMP18 RASI,Homo sapiens (Human),508,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0001525; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012
g782,961.7080236,5.688306707,2.277765988,2.49731831,0.012513657,0.038505366,2438,9116,21,0,18,9,0,220,23,11,0,0,sp,P17945,HGF_RAT,34.074,405,185,19,109,1290,134,467,1.20E-45,172,P17945,reviewed,HGF_RAT,Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain],Hgf,Rattus norvegicus (Rat),728,animal organ regeneration [GO:0031100]; cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; proteolysis [GO:0006508]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; skeletal muscle cell proliferation [GO:0014856],GO:0000902; GO:0001889; GO:0001934; GO:0005102; GO:0005615; GO:0006508; GO:0008083; GO:0008284; GO:0014856; GO:0030335; GO:0031100; GO:0031643; GO:0032715; GO:0032733; GO:0033137; GO:0035729; GO:0042056; GO:0042802; GO:0043066; GO:0043410; GO:0044877; GO:0045766; GO:0048012; GO:0050673; GO:0050728; GO:0051450; GO:0051897; GO:0060326; GO:0060665; GO:0070572; GO:0090201; GO:1900744; GO:1901299; GO:1902042; GO:2000573
g6415,628.5341261,2.907598749,0.756780282,3.842064623,0.000122004,0.000804752,1669,2983,485,52,59,1189,292,137,147,47,170,289,sp,P70627,FOLH1_RAT,46.023,704,364,8,181,2274,58,751,0,629,P70627,reviewed,FOLH1_RAT,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Folh1 Naalad1,Rattus norvegicus (Rat),752,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493
g18232,434.8537634,1.989177914,0.514122519,3.869073696,0.00010925,0.000730503,457,411,356,180,602,1248,313,149,116,150,345,200,sp,Q9JLG8,CAN15_MOUSE,43.556,838,386,13,1003,3297,272,1095,0,687,Q9JLG8,reviewed,CAN15_MOUSE,Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog),Capn15 Solh,Mus musculus (Mouse),1095,proteolysis [GO:0006508],GO:0004198; GO:0005737; GO:0006508; GO:0046872
g12190,907.1383443,0.757672614,0.293644403,2.580238567,0.009873208,0.031780921,1155,1206,704,1410,687,642,920,780,1016,562,947,600,sp,P56399,UBP5_MOUSE,55.164,852,323,12,16,2406,9,856,0,902,P56399,reviewed,UBP5_MOUSE,Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5),Usp5 Isot,Mus musculus (Mouse),858,negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation protein catabolic process at presynapse [GO:0140251],GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0008270; GO:0016579; GO:0032436; GO:0043130; GO:0098793; GO:0140251; GO:2000059
g11014,880.340805,0.735788706,0.247166622,2.976893479,0.002911852,0.011664858,1110,838,716,997,894,841,1121,697,627,1039,561,847,sp,Q14790,CASP8_HUMAN,40.392,255,134,6,913,1629,226,478,3.71E-51,185,Q14790,reviewed,CASP8_HUMAN,Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10],CASP8 MCH5,Homo sapiens (Human),479,activation of cysteine-type endopeptidase activity [GO:0097202]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell migration [GO:0030335]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteolysis [GO:0045862]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptotic inflammatory response [GO:0070269]; regulation of cytokine production [GO:0001817]; regulation of innate immune response [GO:0045088]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; self proteolysis [GO:0097264]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; TRAIL-activated apoptotic signaling pathway [GO:0036462],GO:0001525; GO:0001817; GO:0004197; GO:0005123; GO:0005164; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005856; GO:0006508; GO:0006915; GO:0007507; GO:0008233; GO:0008234; GO:0008625; GO:0010803; GO:0030027; GO:0030101; GO:0030225; GO:0030335; GO:0031264; GO:0031265; GO:0031625; GO:0032025; GO:0032355; GO:0032496; GO:0032731; GO:0032991; GO:0034612; GO:0035877; GO:0036462; GO:0042110; GO:0042113; GO:0042802; GO:0043065; GO:0043123; GO:0043124; GO:0043525; GO:0044297; GO:0044877; GO:0045088; GO:0045471; GO:0045651; GO:0045862; GO:0051603; GO:0051604; GO:0060546; GO:0060715; GO:0070269; GO:0071260; GO:0071407; GO:0097110; GO:0097153; GO:0097190; GO:0097191; GO:0097194; GO:0097199; GO:0097202; GO:0097264; GO:0097342
g23662,201.5757247,4.714613393,1.580282326,2.98339943,0.002850657,0.011470637,227,1296,392,0,0,356,3,69,21,0,0,9,sp,P42674,BP10_PARLI,29.455,404,258,14,145,1314,59,449,3.04E-37,147,P42674,reviewed,BP10_PARLI,Blastula protease 10 (EC 3.4.24.-),BP10,Paracentrotus lividus (Common sea urchin),597,proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0005938; GO:0006508; GO:0008270; GO:0048471
g10615,513.4827704,-0.893968425,0.252387264,-3.542050466,0.00039703,0.002173246,229,287,341,374,216,350,957,598,624,1176,724,805,sp,Q19AZ8,THRB_PIG,38.756,209,113,7,472,1056,376,583,1.93E-32,136,Q19AZ8,reviewed,THRB_PIG,Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain],F2,Sus scrofa (Pig),623,acute-phase response [GO:0006953]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; proteolysis [GO:0006508],GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0006953; GO:0030168; GO:0030194; GO:0062023
g19214,75.30427524,-1.792407868,0.563808262,-3.179108908,0.001477286,0.006592625,70,23,26,41,0,30,237,144,115,204,67,120,sp,D3ZPG5,UBP30_RAT,34.177,237,100,6,781,1440,305,502,1.10E-28,122,D3ZPG5,reviewed,UBP30_RAT,Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30),Usp30,Rattus norvegicus (Rat),517,mitochondrial fusion [GO:0008053]; negative regulation of mitophagy [GO:1901525]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; proteolysis [GO:0006508],GO:0004197; GO:0004843; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006508; GO:0008053; GO:0016579; GO:0035871; GO:0044313; GO:1901525
g17537,3766.244346,5.979602073,0.73827816,8.099389089,5.52E-16,4.30E-14,5559,11793,5636,626,4794,9398,36,134,79,29,425,71,sp,F1NV61,CASP7_CHICK,39.564,321,180,3,61,1023,3,309,4.25E-79,247,F1NV61,reviewed,CASP7_CHICK,Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7,Gallus gallus (Chicken),309,defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508],GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0042742; GO:0043525; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686
g12017,23114.44247,4.254119652,1.135263147,3.74725425,0.000178781,0.00110866,2238,24753,96413,154,811,110037,110,1338,5929,863,4671,2138,sp,P20231,TRYB2_HUMAN,31.174,247,146,6,64,762,31,267,1.05E-28,113,P20231,reviewed,TRYB2_HUMAN,Tryptase beta-2 (Tryptase-2) (EC 3.4.21.59) (Tryptase II),TPSB2 TPS2,Homo sapiens (Human),275,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508; GO:0008236; GO:0062023
g12015,8442.719969,4.519999011,1.165017599,3.879768866,0.000104556,0.000703287,545,7987,27911,43,225,47677,45,319,1842,248,1016,1161,sp,A1KXI1,BLOT3_BLOTA,41.509,159,78,5,220,678,111,260,5.01E-27,107,A1KXI1,reviewed,BLOT3_BLOTA,Trypsin Blo t 3 (EC 3.4.21.4) (Mite allergen Blo t 3) (allergen Blo t 3),,Blomia tropicalis (Mite),266,proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508
g13001,8177.662356,2.480350135,0.490760604,5.054093821,4.32E-07,5.75E-06,14436,5083,9601,3610,13412,19361,3171,2173,4080,1829,4104,2240,sp,Q61824,ADA12_MOUSE,39.175,776,427,14,223,2499,65,812,2.03E-162,504,Q61824,reviewed,ADA12_MOUSE,Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha),Adam12 Mltna,Mus musculus (Mouse),903,cell adhesion [GO:0007155]; proteolysis [GO:0006508],GO:0004222; GO:0005654; GO:0005886; GO:0006508; GO:0007155; GO:0017124; GO:0046872
g16695,179076.7756,7.568973623,0.662818443,11.4193769,3.35E-30,1.70E-27,443511,191989,129620,24617,371299,512007,1950,1135,4183,786,1985,3026,sp,O77656,MMP13_BOVIN,33.333,435,236,15,202,1488,66,452,1.25E-59,207,O77656,reviewed,MMP13_BOVIN,Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13),MMP13,Bos taurus (Bovine),471,bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0004175; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0060349
g16696,129974.8746,2.702258833,0.553705783,4.880315349,1.06E-06,1.27E-05,236222,60456,63442,67813,295566,273567,40045,37723,30964,39713,48471,49917,sp,O77656,MMP13_BOVIN,31.275,502,276,16,1,1473,1,444,3.08E-58,204,O77656,reviewed,MMP13_BOVIN,Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13),MMP13,Bos taurus (Bovine),471,bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0004175; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0060349
g16692,635.0387582,1.780079652,0.661635722,2.690422527,0.00713616,0.024386723,575,149,371,218,894,2231,402,611,291,174,200,395,sp,O35548,MMP16_RAT,30.528,511,267,22,139,1479,46,532,1.58E-60,212,O35548,reviewed,MMP16_RAT,Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP),Mmp16,Rattus norvegicus (Rat),607,bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to odorant [GO:1990834]; skeletal system development [GO:0001501],GO:0001501; GO:0001503; GO:0001958; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0060348; GO:0070006; GO:0097094; GO:1990834
g19523,146.9822298,1.74641881,0.317470338,5.501045608,3.78E-08,6.61E-07,181,204,228,103,177,230,139,76,46,121,73,54,sp,F8VPZ3,UBP32_MOUSE,50.737,339,159,5,1,1017,1,331,1.99E-104,340,F8VPZ3,reviewed,UBP32_MOUSE,Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32),Usp32,Mus musculus (Mouse),1604,positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0006508; GO:0016579; GO:1904263
g19521,64.50777609,1.593528753,0.518433989,3.07373511,0.00211397,0.008886751,79,106,126,14,67,103,84,26,24,62,11,43,sp,Q8NFA0,UBP32_HUMAN,58.333,96,38,2,1,282,1509,1604,2.67E-36,132,Q8NFA0,reviewed,UBP32_HUMAN,Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32),USP32 USP10,Homo sapiens (Human),1604,positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263
g21915,597.5623024,1.064321279,0.308197365,3.45337566,0.000553617,0.002890117,758,861,611,321,741,668,556,391,410,621,334,515,sp,Q8BL06,UBP54_MOUSE,58.311,367,149,3,43,1140,11,374,4.37E-143,472,Q8BL06,reviewed,UBP54_MOUSE,Ubiquitin carboxyl-terminal hydrolase 54 (EC 3.4.19.12) (Ubiquitin-specific peptidase 54),Usp54,Mus musculus (Mouse),1588,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004843; GO:0006508; GO:0016579
g2192,64427.44886,4.404370452,1.167875423,3.771267351,0.000162421,0.001024538,4058,48718,234347,348,2114,354088,370,2909,13909,1738,13353,5582,sp,P80146,SEPR_THESR,39.788,377,194,13,64,1104,35,408,1.45E-47,169,P80146,reviewed,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,Thermus sp. (strain Rt41A),410,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508
g2193,2003.134761,4.081143506,1.294977927,3.151515883,0.001624253,0.007138369,220,1632,9889,8,79,8597,0,122,651,54,363,267,sp,P80146,SEPR_THESR,40.323,372,189,12,82,1110,41,408,7.86E-64,212,P80146,reviewed,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,Thermus sp. (strain Rt41A),410,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508
g2190,769.7580321,6.294783181,1.861864385,3.380903159,0.00072248,0.003600828,22,449,3588,8,0,4010,0,72,5,4,0,51,sp,P80146,SEPR_THESR,40.053,377,195,11,58,1101,33,407,1.11E-56,193,P80146,reviewed,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,Thermus sp. (strain Rt41A),410,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508
g22259,677.2375282,5.926695307,1.135314325,5.220312276,1.79E-07,2.62E-06,5931,1478,301,10,214,265,141,34,5,11,0,7,sp,P80646,CTRB_GADMO,37.872,235,119,12,289,987,1,210,1.20E-35,133,P80646,reviewed,CTRB_GADMO,Chymotrypsin B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B],,Gadus morhua (Atlantic cod),245,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586
g3166,137.979567,-2.923276996,0.40203235,-7.271248177,3.56E-13,1.71E-11,70,13,40,17,9,28,396,387,293,339,228,158,sp,Q5G266,NETR_TRAPH,33.772,456,259,15,28,1338,168,599,4.77E-55,202,Q5G266,reviewed,NETR_TRAPH,Neurotrypsin (EC 3.4.21.-) (Serine protease 12),PRSS12,Trachypithecus phayrei (Phayre's leaf monkey),875,exocytosis [GO:0006887]; proteolysis [GO:0006508],GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195
g16613,252.9234539,-3.361445725,0.400486606,-8.393403601,4.72E-17,4.28E-15,18,93,42,44,18,23,772,717,316,641,615,342,sp,O05218,YWRD_BACSU,33.465,505,305,9,193,1701,49,524,6.77E-75,250,O05218,reviewed,YWRD_BACSU,Glutathione hydrolase-like YwrD proenzyme (EC 2.3.2.2) (Putative gamma-glutamyltransferase YwrD) (EC 3.4.19.13) [Cleaved into: Glutathione hydrolase-like YwrD large chain; Glutathione hydrolase-like YwrD small chain],ywrD BSU36100,Bacillus subtilis (strain 168),525,glutathione catabolic process [GO:0006751]; proteolysis [GO:0006508],GO:0006508; GO:0006751; GO:0036374; GO:0103068
g10978,157.8027661,1.338758411,0.447147633,2.993996415,0.002753492,0.011134274,211,533,220,65,86,133,131,56,170,117,82,93,sp,Q08CH3,MPND_DANRE,44.977,438,207,5,115,1422,34,439,7.93E-128,382,Q08CH3,reviewed,MPND_DANRE,MPN domain-containing protein (EC 3.4.-.-),mpnd zgc:153076,Danio rerio (Zebrafish) (Brachydanio rerio),458,double-strand break repair [GO:0006302]; proteolysis [GO:0006508],GO:0006302; GO:0006508; GO:0008237; GO:0031593; GO:0046872; GO:0070531; GO:0070552
g24127,313.072909,3.651944388,0.73823104,4.946885445,7.54E-07,9.42E-06,1731,203,241,37,457,394,50,32,29,17,55,140,sp,P37892,CBPE_LOPAM,51.942,206,94,4,1,609,225,428,1.57E-65,213,P37892,reviewed,CBPE_LOPAM,Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase),cpe,Lophius americanus (American angler) (Anglerfish),454,proteolysis [GO:0006508],GO:0004181; GO:0005576; GO:0006508; GO:0008270; GO:0030658
g23768,100.2809185,-0.956595887,0.276295,-3.46222656,0.000535726,0.002804516,65,69,122,36,28,47,229,156,108,186,134,168,sp,Q8N531,FBXL6_HUMAN,37.671,438,235,11,427,1665,111,535,1.63E-69,236,Q8N531,reviewed,FBXL6_HUMAN,F-box/LRR-repeat protein 6 (F-box and leucine-rich repeat protein 6) (F-box protein FBL6) (FBL6A),FBXL6 FBL6,Homo sapiens (Human),539,proteolysis [GO:0006508]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0004842; GO:0006508; GO:0019005; GO:0031146
g21337,5664.861989,6.590092229,0.585883616,11.24812514,2.37E-29,1.02E-26,19133,3976,5142,1233,9901,15463,225,100,165,86,70,213,sp,P19221,THRB_MOUSE,41.502,253,134,7,1000,1716,360,612,6.73E-55,199,P19221,reviewed,THRB_MOUSE,Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain],F2 Cf2,Mus musculus (Mouse),618,acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; G protein-coupled receptor signaling pathway [GO:0007186]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; thrombin-activated receptor signaling pathway [GO:0070493],GO:0001530; GO:0001934; GO:0004175; GO:0004252; GO:0005102; GO:0005509; GO:0005615; GO:0006508; GO:0006953; GO:0007166; GO:0007186; GO:0008201; GO:0008233; GO:0008284; GO:0008360; GO:0009897; GO:0010468; GO:0030168; GO:0030194; GO:0030307; GO:0032024; GO:0032967; GO:0042730; GO:0045861; GO:0048712; GO:0051281; GO:0051480; GO:0051838; GO:0051897; GO:0061844; GO:0062023; GO:0070053; GO:0070493; GO:0070945; GO:1900016; GO:1900182; GO:1900738; GO:1990806; GO:2000379
g10298,106.344977,6.732615787,0.891061332,7.555726578,4.17E-14,2.43E-12,390,122,77,144,137,207,6,0,9,0,0,0,sp,Q15485,FCN2_HUMAN,48.148,216,107,2,214,861,102,312,4.00E-62,202,Q15485,reviewed,FCN2_HUMAN,Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35),FCN2 FCNL,Homo sapiens (Human),313,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065
g11013,364.5879372,0.689077002,0.255256712,2.699545089,0.006943435,0.023872769,500,322,288,344,345,425,418,286,259,484,301,300,sp,O15519,CFLAR_HUMAN,26.471,170,116,4,286,789,9,171,2.04E-06,52.4,O15519,reviewed,CFLAR_HUMAN,CASP8 and FADD-like apoptosis regulator (Caspase homolog) (CASH) (Caspase-eight-related protein) (Casper) (Caspase-like apoptosis regulatory protein) (CLARP) (Cellular FLICE-like inhibitory protein) (c-FLIP) (FADD-like antiapoptotic molecule 1) (FLAME-1) (Inhibitor of FLICE) (I-FLICE) (MACH-related inducer of toxicity) (MRIT) (Usurpin) [Cleaved into: CASP8 and FADD-like apoptosis regulator subunit p43; CASP8 and FADD-like apoptosis regulator subunit p12],CFLAR CASH CASP8AP1 CLARP MRIT,Homo sapiens (Human),480,apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to nitric oxide [GO:0071732]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; keratinocyte differentiation [GO:0030216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cellular response to transforming growth factor beta stimulus [GO:1903845]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of myoblast fusion [GO:1901740]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron differentiation [GO:0030182]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteolysis [GO:0006508]; regulation of necroptotic process [GO:0060544]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; skeletal muscle tissue development [GO:0007519]; skeletal muscle tissue regeneration [GO:0043403]; skeletal myofibril assembly [GO:0014866]; wound healing [GO:0042060],GO:0002020; GO:0005123; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0007519; GO:0008047; GO:0010667; GO:0010976; GO:0014732; GO:0014842; GO:0014866; GO:0030182; GO:0030216; GO:0030218; GO:0031264; GO:0031265; GO:0032869; GO:0033574; GO:0042060; GO:0043066; GO:0043123; GO:0043403; GO:0043525; GO:0044877; GO:0051092; GO:0060544; GO:0070374; GO:0071364; GO:0071392; GO:0071456; GO:0071549; GO:0071732; GO:0072126; GO:0097194; GO:0097199; GO:0097200; GO:0097342; GO:1901740; GO:1902042; GO:1903055; GO:1903427; GO:1903845; GO:1903944; GO:2000347; GO:2001237
g14507,394.7348792,-1.190562328,0.312758919,-3.806645493,0.000140864,0.000907597,199,338,246,295,98,101,704,615,427,790,876,545,sp,Q9JJ22,ERAP1_RAT,36.433,914,533,11,175,2832,30,923,0,592,Q9JJ22,reviewed,ERAP1_RAT,Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP),Erap1 Appils Arts1,Rattus norvegicus (Rat),930,adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],GO:0002250; GO:0004175; GO:0004177; GO:0005138; GO:0005164; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005789; GO:0006508; GO:0006509; GO:0008233; GO:0008235; GO:0008270; GO:0016020; GO:0019882; GO:0030163; GO:0042277; GO:0043171; GO:0045766; GO:0070006
g5494,33.10361149,3.258783782,1.223964606,2.662482041,0.007756671,0.026004949,51,44,21,15,2,178,0,13,11,0,0,18,sp,P15684,AMPN_RAT,35.18,776,461,16,214,2451,66,829,1.59E-144,453,P15684,reviewed,AMPN_RAT,Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13),Anpep,Rattus norvegicus (Rat),965,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; metanephric proximal tubule development [GO:0072237]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485]; proteolysis [GO:0006508],GO:0001525; GO:0004177; GO:0005615; GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0072237
g12113,105.2597483,-2.992940931,0.591953207,-5.056043103,4.28E-07,5.70E-06,5,55,46,15,2,10,329,237,92,246,258,221,sp,P0C872,JMJD7_MOUSE,21.484,256,159,5,37,690,29,280,3.02E-10,65.5,P0C872,reviewed,JMJD7_MOUSE,Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 (EC 1.14.11.63) (EC 3.4.-.-) (JmjC domain-containing protein 7) (Jumonji domain-containing protein 7) (L-lysine (3S)-hydroxylase Jmjd7),Jmjd7,Mus musculus (Mouse),316,proteolysis [GO:0006508],GO:0004175; GO:0004177; GO:0004497; GO:0005634; GO:0005737; GO:0006508; GO:0016706; GO:0035064; GO:0046872; GO:0106155
g11949,42535.12025,4.650272578,1.153511966,4.031403847,5.54E-05,0.000403147,2947,40065,184449,289,886,207678,214,2306,9536,1108,3469,4855,sp,P07478,TRY2_HUMAN,44.503,191,98,5,58,627,24,207,5.02E-42,146,P07478,reviewed,TRY2_HUMAN,Trypsin-2 (EC 3.4.21.4) (Anionic trypsinogen) (Serine protease 2) (Trypsin II),PRSS2 TRY2 TRYP2,Homo sapiens (Human),247,antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508],GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0008236; GO:0019730; GO:0022617; GO:0030307; GO:0030574; GO:0031012; GO:0035578; GO:0045785
g18939,51.05116115,-4.213771311,1.033119327,-4.078687913,4.53E-05,0.000337752,0,17,0,4,3,3,254,8,136,58,11,269,sp,P10394,POL4_DROME,28.221,326,223,5,64,1035,890,1206,3.03E-37,146,P10394,reviewed,POL4_DROME,Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],POL ORF3,Drosophila melanogaster (Fruit fly),1237,DNA integration [GO:0015074]; proteolysis [GO:0006508],GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006508; GO:0015074; GO:0042575
g8117,4576.271643,-0.708923482,0.259369506,-2.733256868,0.00627114,0.021980049,3165,3586,4528,3735,1596,1733,10866,7833,6921,4531,7194,4525,sp,Q96KP4,CNDP2_HUMAN,66.525,472,156,1,16,1431,4,473,0,662,Q96KP4,reviewed,CNDP2_HUMAN,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase),CNDP2 CN2 CPGL HEL-S-13 PEPA,Homo sapiens (Human),475,proteolysis [GO:0006508],GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070062; GO:0070573; GO:0103046
g19475,786.8160768,2.190568155,0.328872658,6.660839994,2.72E-11,9.31E-10,1558,1176,670,1012,1250,622,381,302,415,293,310,332,sp,Q9H3F6,BACD3_HUMAN,71.483,263,68,4,88,873,28,284,2.79E-134,386,Q9H3F6,reviewed,BACD3_HUMAN,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10),KCTD10 ULR061 MSTP028,Homo sapiens (Human),313,negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260
g14478,60.73188569,-2.478275998,0.32038314,-7.735350866,1.03E-14,6.60E-13,21,17,11,21,10,15,102,125,144,120,137,100,sp,P0C2W1,FBSP1_HUMAN,72.727,220,59,1,25,681,39,258,3.93E-115,334,P0C2W1,reviewed,FBSP1_HUMAN,F-box/SPRY domain-containing protein 1 (F-box only protein 45) (hFbxo45),FBXO45 FBX45,Homo sapiens (Human),286,anterior commissure morphogenesis [GO:0021960]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; DNA damage response [GO:0006974]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of synaptic vesicle exocytosis [GO:2000300]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001764; GO:0005576; GO:0005634; GO:0005737; GO:0006511; GO:0006974; GO:0014069; GO:0016567; GO:0019005; GO:0021799; GO:0021800; GO:0021957; GO:0021960; GO:0042734; GO:0042995; GO:0043161; GO:0045202; GO:0045211; GO:0060386; GO:0070936; GO:0098978; GO:0099523; GO:0099524; GO:1990756; GO:2000300
g21847,49.23760315,-1.265813626,0.393256096,-3.218802304,0.001287272,0.005860595,37,29,53,8,16,13,137,70,48,107,69,91,sp,Q5PQN1,HERC4_RAT,49.198,374,172,6,13,1131,3,359,1.72E-103,335,Q5PQN1,reviewed,HERC4_RAT,Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4),Herc4,Rattus norvegicus (Rat),1057,cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630
g9753,1168.050089,0.922136671,0.311011014,2.964964681,0.003027177,0.012028063,1688,1093,1144,938,1463,1091,1776,752,697,1428,591,902,sp,Q6I6G8,HECW2_MOUSE,58.853,802,264,8,2803,5103,808,1578,0,840,Q6I6G8,reviewed,HECW2_MOUSE,"E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2)",Hecw2 Kiaa1301 Nedl2,Mus musculus (Mouse),1578,protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0048814; GO:0061630; GO:0072686
g13596,29.35415368,4.14458131,1.146105405,3.616230491,0.000298924,0.001713142,32,114,106,5,0,63,2,9,4,0,0,7,sp,Q4G0X4,KCD21_HUMAN,56.757,111,44,1,1,333,1,107,1.08E-36,128,Q4G0X4,reviewed,KCD21_HUMAN,BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21),KCTD21,Homo sapiens (Human),260,negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0006511; GO:0016567; GO:0042802; GO:0042826; GO:0045879; GO:0051260; GO:0097602
g13599,49.97825539,0.947854941,0.333269063,2.844113203,0.004453522,0.016534194,52,43,64,74,48,45,51,24,54,35,32,50,sp,Q3URF8,KCD21_MOUSE,55.263,114,50,1,13,351,2,115,4.63E-34,125,Q3URF8,reviewed,KCD21_MOUSE,BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21),Kctd21,Mus musculus (Mouse),260,protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0006511; GO:0016567; GO:0042826; GO:0051260; GO:0097602
g17328,162.3532508,1.42792885,0.365713512,3.904501214,9.44E-05,0.000643503,220,159,155,155,224,219,125,84,111,97,52,168,sp,Q9HAU4,SMUF2_HUMAN,70.5,200,50,2,1,600,1,191,5.31E-96,300,Q9HAU4,reviewed,SMUF2_HUMAN,E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2),SMURF2,Homo sapiens (Human),748,"negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0000122; GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016607; GO:0017015; GO:0030512; GO:0030514; GO:0042802; GO:0043161; GO:0045121; GO:0045892; GO:0046332; GO:0060071; GO:0061630; GO:0090263; GO:1901165
g4809,221.6429406,-1.015098004,0.294281919,-3.449406637,0.00056182,0.002926166,165,158,249,90,40,106,663,312,235,475,296,276,sp,Q5ND34,WDR81_MOUSE,33.333,1047,592,22,1246,4323,55,1016,8.51E-144,494,Q5ND34,reviewed,WDR81_MOUSE,WD repeat-containing protein 81,Wdr81,Mus musculus (Mouse),1934,aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0010008; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0045022; GO:0050821; GO:0070530; GO:0141039
g13964,979.0957353,-1.627383103,0.271217765,-6.0002821,1.97E-09,4.64E-08,572,784,467,246,206,316,2959,2135,1251,2140,1019,1643,sp,P49407,ARRB1_HUMAN,57.045,440,145,12,187,1488,4,405,3.35E-151,441,P49407,reviewed,ARRB1_HUMAN,Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2),ARRB1 ARR1,Homo sapiens (Human),418,G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],GO:0000139; GO:0000785; GO:0001664; GO:0001934; GO:0002031; GO:0002092; GO:0003713; GO:0004857; GO:0005096; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0006357; GO:0006511; GO:0007165; GO:0007601; GO:0015031; GO:0016567; GO:0016604; GO:0030659; GO:0031143; GO:0031397; GO:0031410; GO:0031625; GO:0031701; GO:0032088; GO:0032715; GO:0032717; GO:0035025; GO:0043149; GO:0043161; GO:0045746; GO:0045944; GO:0070374; GO:1990763
g14365,2398.618788,1.032084419,0.295498475,3.492689497,0.000478182,0.002543399,3293,2798,2152,2118,2994,2305,3089,1657,1239,2736,1159,1990,sp,B4F6W9,TRIPC_XENTR,62.873,905,320,6,3469,6138,1153,2056,0,1182,B4F6W9,reviewed,TRIPC_XENTR,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),trip12,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),2056,DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0008270; GO:0033696; GO:0045995; GO:0061630; GO:0140861
g1423,399.2307952,1.238133767,0.255208219,4.851465097,1.23E-06,1.45E-05,1038,409,480,453,257,369,310,314,243,308,313,229,sp,Q15386,UBE3C_HUMAN,48.457,1102,529,16,1,3246,1,1083,0,953,Q15386,reviewed,UBE3C_HUMAN,Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (Homologous to E6AP carboxyl terminus homologous protein 2) (HectH2) (RTA-associated ubiquitin ligase) (RAUL),UBE3C KIAA0010 KIAA10,Homo sapiens (Human),1083,protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0000502; GO:0006511; GO:0035519; GO:0061630; GO:0070936
g11349,399.7075767,1.814055314,0.339468316,5.343813334,9.10E-08,1.43E-06,567,1232,468,261,362,394,328,236,122,188,234,200,sp,Q9P2G1,AKIB1_HUMAN,48.886,763,342,9,1,2238,1,732,0,749,Q9P2G1,reviewed,AKIB1_HUMAN,Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31),ANKIB1 KIAA1386,Homo sapiens (Human),1089,protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0008270; GO:0031624; GO:0061630
g3038,61.01063256,-1.596726183,0.523440936,-3.050441938,0.002285049,0.009490972,34,46,18,32,0,37,155,94,65,140,119,105,sp,Q6J1I7,RN166_RAT,51.208,207,99,2,121,738,31,236,9.61E-66,207,Q6J1I7,reviewed,RN166_RAT,E3 ubiquitin-protein ligase RNF166 (EC 2.3.2.27) (RING finger protein 166) (RING-type E3 ubiquitin transferase RNF166),Rnf166,Rattus norvegicus (Rat),237,autophagy [GO:0006914]; innate immune response [GO:0045087]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0005737; GO:0006511; GO:0006914; GO:0045087; GO:0046872; GO:0061630
g2851,687.8405896,1.371739583,0.292905393,4.683217225,2.82E-06,3.03E-05,973,682,557,1020,911,627,618,437,477,457,379,437,sp,Q9JLV2,TP4AP_MOUSE,42.51,781,393,14,112,2382,36,784,0,592,Q9JLV2,reviewed,TP4AP_MOUSE,Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (Rabex-5/Rin2-interacting protein) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS),Trpc4ap Trrp4ap,Mus musculus (Mouse),797,hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0080008; GO:0140627; GO:1990756
g15362,1318.780669,1.136812388,0.2622506,4.334832358,1.46E-05,0.000126443,2367,1293,1359,1304,1413,1341,1389,717,1011,885,1244,761,sp,O43242,PSMD3_HUMAN,65.868,501,163,2,22,1503,34,533,0,587,O43242,reviewed,PSMD3_HUMAN,26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58),PSMD3,Homo sapiens (Human),534,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813
g15763,1512.59845,2.159748258,0.321396847,6.719880034,1.82E-11,6.49E-10,1968,2431,1777,3466,1639,1106,912,624,772,952,404,438,sp,P53804,TTC3_HUMAN,34.715,193,118,3,184,759,1822,2007,2.01E-23,102,P53804,reviewed,TTC3_HUMAN,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3),TTC3 DCRR1 RNF105 TPRD,Homo sapiens (Human),2025,protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0046872; GO:0070936
g15764,7624.244303,1.921248086,0.230084415,8.350187839,6.82E-17,5.97E-15,10710,12188,9872,12283,8683,6790,5258,3339,3215,5187,3889,2611,sp,P53804,TTC3_HUMAN,29.796,245,167,4,1180,1905,490,732,1.26E-28,130,P53804,reviewed,TTC3_HUMAN,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3),TTC3 DCRR1 RNF105 TPRD,Homo sapiens (Human),2025,protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0046872; GO:0070936
g15765,615.4362869,2.205511769,0.380200902,5.800911457,6.60E-09,1.40E-07,617,868,699,1825,478,618,370,355,298,258,214,121,sp,O88196,TTC3_MOUSE,36.029,136,73,3,562,957,226,351,1.56E-12,74.3,O88196,reviewed,TTC3_MOUSE,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Mtprd),Ttc3 Kiaa4119,Mus musculus (Mouse),1979,negative regulation of axon extension [GO:0030517]; negative regulation of neuron differentiation [GO:0045665]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005634; GO:0005773; GO:0005794; GO:0006511; GO:0030517; GO:0045665; GO:0046872; GO:0070936
g21739,3405.623432,1.817961185,0.369549932,4.919392562,8.68E-07,1.07E-05,5037,2304,3290,4889,5468,3889,2498,2095,2306,1490,1053,1597,sp,P25867,UBCD1_DROME,91.156,147,13,0,1,441,1,147,1.02E-88,258,P25867,reviewed,UBCD1_DROME,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),eff UbcD1 CG7425,Drosophila melanogaster (Fruit fly),147,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039
g11649,1218.598221,1.375924638,0.341829125,4.025182576,5.69E-05,0.000412791,2198,1249,1323,1492,1523,922,2253,595,612,699,530,677,sp,Q9ES00,UBE4B_MOUSE,49.164,1076,493,9,337,3435,106,1170,0,1051,Q9ES00,reviewed,UBE4B_MOUSE,Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2),Ube4b Ufd2 Ufd2a,Mus musculus (Mouse),1173,ERAD pathway [GO:0036503]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030163; GO:0031175; GO:0034450; GO:0034976; GO:0036503; GO:0043161; GO:0051082; GO:0051117; GO:0051865; GO:0061630
g11648,10502.00376,1.118790013,0.376970974,2.967841263,0.002998992,0.011937098,15901,20519,11256,4941,9416,12327,7133,4719,6691,7245,13877,6905,sp,Q9BXM7,PINK1_HUMAN,38.514,444,225,11,673,1998,179,576,3.96E-83,276,Q9BXM7,reviewed,PINK1_HUMAN,"Serine/threonine-protein kinase PINK1, mitochondrial (EC 2.7.11.1) (BRPK) (PTEN-induced putative kinase protein 1)",PINK1,Homo sapiens (Human),581,"activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; dopamine secretion [GO:0014046]; establishment of protein localization to mitochondrion [GO:0072655]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cristae formation [GO:1903852]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0000287; GO:0000422; GO:0000423; GO:0000785; GO:0002020; GO:0002082; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0006979; GO:0007005; GO:0010310; GO:0010629; GO:0010821; GO:0010857; GO:0010952; GO:0014046; GO:0016020; GO:0016239; GO:0016242; GO:0016301; GO:0016504; GO:0016567; GO:0018105; GO:0022904; GO:0030097; GO:0030424; GO:0030426; GO:0031396; GO:0031398; GO:0031625; GO:0032148; GO:0032226; GO:0033138; GO:0033603; GO:0034599; GO:0035307; GO:0035556; GO:0036289; GO:0038203; GO:0042981; GO:0043123; GO:0043254; GO:0043422; GO:0043524; GO:0044297; GO:0044877; GO:0045727; GO:0046329; GO:0048471; GO:0050821; GO:0051443; GO:0051881; GO:0051897; GO:0055131; GO:0061136; GO:0071456; GO:0072655; GO:0072656; GO:0090141; GO:0090200; GO:0090258; GO:0097237; GO:0097413; GO:0097449; GO:0098779; GO:0099074; GO:0106310; GO:1900407; GO:1901525; GO:1902803; GO:1902902; GO:1902958; GO:1903146; GO:1903214; GO:1903298; GO:1903377; GO:1903384; GO:1903751; GO:1903852; GO:1903955; GO:1904544; GO:1904841; GO:1904881; GO:2000377; GO:2000378; GO:2001171; GO:2001243
g12645,344.3604404,0.499874898,0.190384092,2.625612738,0.008649316,0.028479148,436,326,306,322,283,352,498,379,319,312,254,338,sp,Q9P0J7,KCMF1_HUMAN,60.641,343,116,5,1,1017,1,328,8.36E-130,380,Q9P0J7,reviewed,KCMF1_HUMAN,E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (ZZ-type zinc finger-containing protein 1),KCMF1 FIGC ZZZ1,Homo sapiens (Human),381,negative regulation of HRI-mediated signaling [GO:0141191]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to oxidative stress [GO:0006979]; synaptic signaling [GO:0099536]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0005829; GO:0005886; GO:0006511; GO:0006979; GO:0008270; GO:0043161; GO:0045202; GO:0061630; GO:0070534; GO:0070936; GO:0099536; GO:0141191; GO:1904813
g5945,184.5696942,1.663916294,0.616880366,2.697307918,0.00699026,0.024006322,164,694,243,32,28,403,192,101,78,125,57,118,sp,Q9N1T2,RPGR_CANLF,48.087,366,186,3,1,1089,1,365,3.47E-98,332,Q9N1T2,reviewed,RPGR_CANLF,X-linked retinitis pigmentosa GTPase regulator,RPGR,Canis lupus familiaris (Dog) (Canis familiaris),1003,cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],GO:0001750; GO:0005085; GO:0005737; GO:0005794; GO:0005813; GO:0006511; GO:0007601; GO:0016567; GO:0036064; GO:0036126; GO:0042073; GO:0060271; GO:0061630
g11157,123.7390592,-1.033169552,0.350771569,-2.945419882,0.003225167,0.012647614,85,105,108,82,20,45,257,156,97,362,197,166,sp,Q8BM54,MYLIP_MOUSE,29.36,344,224,7,1,1011,1,332,2.21E-39,148,Q8BM54,reviewed,MYLIP_MOUSE,E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain-interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP),Mylip,Mus musculus (Mouse),445,cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005737; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0046872; GO:0061630; GO:0071404
g16729,199.7291642,1.262087244,0.313762796,4.022424778,5.76E-05,0.00041732,431,210,141,227,230,172,199,135,146,101,131,145,sp,Q9VBP9,NPL4_DROME,51.266,316,143,1,1,915,337,652,4.29E-112,341,Q9VBP9,reviewed,NPL4_DROME,Nuclear protein localization protein 4 homolog,Npl4 CG4673,Drosophila melanogaster (Fruit fly),652,cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0031625; GO:0043130; GO:0043161; GO:0045879; GO:0046872; GO:0071795; GO:0098586
g16728,131.6924371,1.739631347,0.324588333,5.359500548,8.35E-08,1.34E-06,215,128,115,262,141,143,125,76,89,60,52,50,sp,P60670,NPL4_MOUSE,45.148,237,94,3,1,606,1,236,6.48E-67,196,P60670,reviewed,NPL4_MOUSE,Nuclear protein localization protein 4 homolog (Protein NPL4),Nploc4 Kiaa1499 Npl4,Mus musculus (Mouse),608,"ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0051117
g3771,821.2952088,0.758735642,0.295214214,2.570118939,0.01016636,0.032559415,951,1341,1085,461,545,1011,1144,740,687,931,285,786,sp,Q7TPD1,FBX11_MOUSE,71.357,803,219,5,310,2709,136,930,0,1198,Q7TPD1,reviewed,FBX11_MOUSE,F-box only protein 11,Fbxo11,Mus musculus (Mouse),930,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756
g19294,278.951034,-1.207535426,0.493040226,-2.44916208,0.0143189,0.042925778,151,116,122,393,47,51,635,749,443,450,380,211,sp,Q96AB6,NTAN1_HUMAN,40.78,282,163,3,73,909,26,306,7.30E-75,235,Q96AB6,reviewed,NTAN1_HUMAN,Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein N-terminal asparagine amidase) (Protein NTN-amidase),NTAN1,Homo sapiens (Human),310,adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418
g3351,823.2799639,0.888800295,0.18865941,4.711136831,2.46E-06,2.67E-05,1091,973,808,774,742,981,942,525,725,733,612,688,sp,Q9R049,AMFR_MOUSE,44.376,649,297,10,46,1986,16,602,2.28E-167,499,Q9R049,reviewed,AMFR_MOUSE,E3 ubiquitin-protein ligase AMFR (EC 2.3.2.36) (Autocrine motility factor receptor) (AMF receptor) (RING-type E3 ubiquitin transferase AMFR),Amfr,Mus musculus (Mouse),643,endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical NF-kappaB signal transduction [GO:0038061]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of SREBP signaling pathway [GO:2000638]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],GO:0000151; GO:0000166; GO:0000209; GO:0004842; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006511; GO:0007611; GO:0016055; GO:0030425; GO:0030426; GO:0030674; GO:0030968; GO:0032991; GO:0034450; GO:0036503; GO:0036513; GO:0038023; GO:0038061; GO:0042802; GO:0043025; GO:0043130; GO:0044314; GO:0046872; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1990381; GO:2000638
g1443,136.8993088,-1.388729965,0.384345183,-3.613236298,0.000302399,0.001728117,46,105,119,28,43,56,300,113,243,337,285,168,sp,F6UA42,UHRF1_XENTR,60.884,611,226,3,742,2565,175,775,0,722,F6UA42,reviewed,UHRF1_XENTR,E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase UHRF1) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (Ubiquitin-like-containing PHD and RING finger domains protein 1),uhrf1,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),775,heterochromatin formation [GO:0031507]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000122; GO:0000785; GO:0000791; GO:0000792; GO:0004842; GO:0005634; GO:0005657; GO:0006511; GO:0008270; GO:0016567; GO:0031507; GO:0035064; GO:0042393; GO:0044027; GO:0044729
g22141,178.150983,-0.983540893,0.385974847,-2.54819945,0.010828054,0.0342231,163,142,166,144,22,33,369,345,262,275,262,219,sp,Q5RFS2,CSN3_PONAB,69.108,314,95,1,1,942,1,312,2.05E-157,452,Q5RFS2,reviewed,CSN3_PONAB,COP9 signalosome complex subunit 3 (SGN3) (Signalosome subunit 3),COPS3 CSN3,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),423,"in utero embryonic development [GO:0001701]; protein deneddylation [GO:0000338]; regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902162]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0000338; GO:0001701; GO:0005654; GO:0005829; GO:0006511; GO:0008180; GO:0048471; GO:1902162
g21569,1217.950281,4.178373132,0.484756982,8.619521299,6.72E-18,7.10E-16,1445,2102,3158,1032,2437,991,283,157,31,144,221,121,sp,Q6NW85,ARI1L_DANRE,31.313,198,111,7,520,1092,179,358,4.45E-21,100,Q6NW85,reviewed,ARI1L_DANRE,E3 ubiquitin-protein ligase arih1l (EC 2.3.2.31),arih1l zgc:85905,Danio rerio (Zebrafish) (Brachydanio rerio),533,protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0061630
g8682,228.0414242,1.001528805,0.324655655,3.084895612,0.002036236,0.008600036,351,292,293,246,243,114,172,220,248,145,118,181,sp,Q9CPX9,APC11_MOUSE,82.143,84,12,1,1,243,1,84,2.63E-41,132,Q9CPX9,reviewed,APC11_MOUSE,Anaphase-promoting complex subunit 11 (APC11) (Cyclosome subunit 11),Anapc11,Mus musculus (Mouse),84,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005654; GO:0005680; GO:0005730; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031145; GO:0034450; GO:0045842; GO:0051301; GO:0061630; GO:0070936; GO:0070979; GO:0097602; GO:0141198
g12673,1259.460511,2.525007812,0.315373339,8.006408603,1.18E-15,8.70E-14,1297,1731,1745,1625,1963,1889,695,407,489,513,209,466,sp,Q3ULA2,FBW1A_MOUSE,74.409,508,103,2,7,1449,98,605,0,787,Q3ULA2,reviewed,FBW1A_MOUSE,F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit),Btrc Fbw1 Fbxw1 Fwd1 Kiaa4123,Mus musculus (Mouse),605,branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-templated transcription [GO:0045892]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006508; GO:0006511; GO:0008013; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0033598; GO:0038061; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:0071407; GO:1990756; GO:1990757
g11249,1489.931134,1.809767044,0.261373822,6.924056233,4.39E-12,1.76E-10,2167,1808,1514,2057,1977,1756,928,749,994,803,677,637,sp,Q9H0E2,TOLIP_HUMAN,47.855,303,119,6,1,888,1,271,7.64E-82,251,Q9H0E2,reviewed,TOLIP_HUMAN,Toll-interacting protein,TOLLIP,Homo sapiens (Human),274,autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; leukocyte activation [GO:0045321]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005150; GO:0005576; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0016310; GO:0016604; GO:0019897; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0032991; GO:0033235; GO:0035325; GO:0035578; GO:0035580; GO:0036010; GO:0043130; GO:0045087; GO:0045321; GO:0048471; GO:0060090; GO:0070062; GO:0070498
g10192,1250.012759,0.707383028,0.202129017,3.499660953,0.00046585,0.002487337,1875,1202,1395,1555,989,916,1474,1009,1289,1160,1128,857,sp,F6P3G4,PS11A_DANRE,72.115,416,116,0,7,1254,5,420,0,595,F6P3G4,reviewed,PS11A_DANRE,26S proteasome non-ATPase regulatory subunit 11A (26S proteasome regulatory subunit RPN6-A),psmd11a,Danio rerio (Zebrafish) (Brachydanio rerio),421,proteasome assembly [GO:0043248]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005198; GO:0005634; GO:0005829; GO:0006511; GO:0008541; GO:0022624; GO:0043248; GO:0048863
g17979,665.2467304,0.90818644,0.368886207,2.461969094,0.013817657,0.041728123,960,402,464,521,940,774,732,461,562,531,596,483,sp,Q8BW70,UBP38_MOUSE,53.205,312,146,0,37,972,233,544,1.66E-110,367,Q8BW70,reviewed,UBP38_MOUSE,Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38),Usp38,Mus musculus (Mouse),1042,negative regulation of innate immune response [GO:0045824]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0032435; GO:0045824; GO:0140311
g19281,36.49433415,-2.297274078,0.785400195,-2.924972636,0.003444865,0.013354235,11,18,15,25,0,0,87,62,22,119,106,49,sp,Q5SPX3,RN215_MOUSE,33.208,265,159,7,214,966,112,372,3.82E-38,142,Q5SPX3,reviewed,RN215_MOUSE,RING finger protein 215,Rnf215,Mus musculus (Mouse),379,ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005737; GO:0006511; GO:0016020; GO:0046872; GO:0061630
g19706,98.42564315,-1.01902892,0.344618114,-2.956980145,0.003106681,0.01230333,86,65,111,48,26,20,219,115,121,137,186,184,sp,Q810L3,CHFR_MOUSE,48.223,197,94,4,1249,1830,471,662,4.19E-54,199,Q810L3,reviewed,CHFR_MOUSE,E3 ubiquitin-protein ligase CHFR (EC 2.3.2.27) (Checkpoint with forkhead and RING finger domains protein) (RING-type E3 ubiquitin transferase CHFR),Chfr,Mus musculus (Mouse),664,cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic cell cycle [GO:0000278]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000166; GO:0000209; GO:0000278; GO:0004842; GO:0005634; GO:0006511; GO:0016567; GO:0016605; GO:0031398; GO:0031648; GO:0032436; GO:0044779; GO:0044818; GO:0046872; GO:0051301; GO:0061630
g10576,623.9806381,0.943700043,0.276948318,3.407495123,0.000655621,0.003312427,1237,548,888,709,446,490,665,511,658,481,536,255,sp,Q5E964,PSD13_BOVIN,58.245,376,156,1,1,1128,1,375,9.27E-165,469,Q5E964,reviewed,PSD13_BOVIN,26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5),PSMD13,Bos taurus (Bovine),376,ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005198; GO:0005634; GO:0005829; GO:0006511; GO:0008541; GO:0022624
g14231,1517.820971,2.002393637,0.40588317,4.93342367,8.08E-07,1.00E-05,2152,1228,1274,1382,2750,2379,777,617,956,549,832,591,sp,Q9UBF6,RBX2_HUMAN,91.86,86,7,0,103,360,28,113,8.51E-55,169,Q9UBF6,reviewed,RBX2_HUMAN,RING-box protein 2 (Rbx2) (EC 2.3.2.27) (EC 2.3.2.32) (CKII beta-binding protein 1) (CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein),RNF7 RBX2 ROC2 SAG,Homo sapiens (Human),113,endoplasmic reticulum unfolded protein response [GO:0030968]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; reelin-mediated signaling pathway [GO:0038026]; regulation of neuron migration [GO:2001222]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0019788; GO:0030968; GO:0031466; GO:0038026; GO:0043161; GO:0043687; GO:0045116; GO:0051775; GO:0061630; GO:0061663; GO:0070979; GO:0097602; GO:2001222
g6268,35.01084523,-2.118305457,0.797786904,-2.655227161,0.007925502,0.026457923,14,0,16,27,0,13,62,76,69,72,101,25,sp,Q9WVS6,PRKN_MOUSE,49.415,427,188,11,118,1371,57,464,9.12E-135,399,Q9WVS6,reviewed,PRKN_MOUSE,E3 ubiquitin-protein ligase parkin (EC 2.3.2.31) (Parkin RBR E3 ubiquitin-protein ligase),Prkn Park2,Mus musculus (Mouse),464,"adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to L-glutamate [GO:1905232]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; mitophagy [GO:0000423]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitophagy [GO:1901526]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein metabolic process [GO:0019538]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation protein catabolic process at presynapse [GO:0140251]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0000122; GO:0000139; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0001664; GO:0001933; GO:0001963; GO:0001964; GO:0003714; GO:0003779; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007612; GO:0007626; GO:0008013; GO:0008021; GO:0008270; GO:0008344; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010918; GO:0010994; GO:0014069; GO:0015631; GO:0016235; GO:0016567; GO:0016607; GO:0019538; GO:0019900; GO:0019901; GO:0030163; GO:0030165; GO:0030424; GO:0030544; GO:0030672; GO:0031624; GO:0031625; GO:0031648; GO:0032232; GO:0032436; GO:0032991; GO:0034599; GO:0034976; GO:0035249; GO:0035774; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043025; GO:0043065; GO:0043123; GO:0043130; GO:0043161; GO:0043195; GO:0043274; GO:0043524; GO:0043653; GO:0044828; GO:0044877; GO:0045202; GO:0045944; GO:0046329; GO:0046676; GO:0046928; GO:0048471; GO:0050804; GO:0050821; GO:0051582; GO:0051583; GO:0051646; GO:0051865; GO:0051881; GO:0051967; GO:0061630; GO:0061734; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0090258; GO:0090394; GO:0097237; GO:0097602; GO:0097708; GO:0098691; GO:0098793; GO:0098794; GO:0098978; GO:0099072; GO:0099073; GO:0099074; GO:0140251; GO:1900242; GO:1900407; GO:1901526; GO:1902236; GO:1902254; GO:1902530; GO:1903265; GO:1903377; GO:1903382; GO:1903427; GO:1903542; GO:1903861; GO:1904049; GO:1904881; GO:1905232; GO:1905366; GO:1905477; GO:1990381; GO:1990444; GO:1990452; GO:2001171
g13023,124.1473063,0.659841234,0.227844846,2.89601123,0.003779389,0.014423055,121,123,159,197,67,118,177,110,112,109,105,98,sp,Q708Y0,EBF2_ARATH,28.745,247,153,8,301,1023,188,417,4.92E-10,65.9,Q708Y0,reviewed,EBF2_ARATH,EIN3-binding F-box protein 2,EBF2 At5g25350 F18G18.90,Arabidopsis thaliana (Mouse-ear cress),623,ethylene-activated signaling pathway [GO:0009873]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein ubiquitination [GO:0016567]; response to ethylene [GO:0009723]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0006511; GO:0009723; GO:0009873; GO:0010105; GO:0016567; GO:0019005
g6193,672.9773614,1.30838148,0.280100235,4.671118815,3.00E-06,3.20E-05,1049,939,559,641,868,643,684,409,402,560,494,311,sp,O08759,UBE3A_MOUSE,43.541,418,213,6,2155,3396,471,869,1.91E-92,319,O08759,reviewed,UBE3A_MOUSE,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (HECT-type ubiquitin transferase E3A) (Oncogenic protein-associated protein E6-AP),Ube3a,Mus musculus (Mouse),870,androgen receptor signaling pathway [GO:0030521]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008021; GO:0016567; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0043161; GO:0045944; GO:0046872; GO:0048167; GO:0048511; GO:0050804; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:1990416; GO:2000058
g11424,216.8127239,1.227768874,0.424197766,2.894331303,0.00379967,0.014485139,275,171,233,261,363,109,166,130,105,169,232,127,sp,Q9Y5A7,NUB1_HUMAN,34.307,548,321,9,34,1632,12,535,3.58E-78,263,Q9Y5A7,reviewed,NUB1_HUMAN,NEDD8 ultimate buster 1 (Negative regulator of ubiquitin-like proteins 1) (Renal carcinoma antigen NY-REN-18),NUB1 NYREN18,Homo sapiens (Human),615,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005654; GO:0005730; GO:0005829; GO:0006511; GO:0016567; GO:0032436; GO:0034341; GO:0034612; GO:2000058
g20470,437.4401187,0.881542978,0.210354265,4.190754001,2.78E-05,0.000220456,517,563,464,440,464,365,568,346,329,394,354,286,sp,O95376,ARI2_HUMAN,57.639,432,180,2,130,1425,62,490,0,541,O95376,reviewed,ARI2_HUMAN,E3 ubiquitin-protein ligase ARIH2 (ARI-2) (Protein ariadne-2 homolog) (EC 2.3.2.31) (Triad1 protein),ARIH2 ARI2 TRIAD1 HT005,Homo sapiens (Human),493,developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; positive regulation of protein targeting to mitochondrion [GO:1903955]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0043161; GO:0048588; GO:0061630; GO:0070534; GO:0070936; GO:0071425; GO:1903955
g11856,284.4299154,-1.821696465,0.33051714,-5.511655061,3.55E-08,6.27E-07,94,61,82,159,108,96,733,490,609,564,445,410,sp,Q923V4,FBX6_RAT,36.187,257,147,6,136,897,4,246,5.33E-49,167,Q923V4,reviewed,FBX6_RAT,F-box only protein 6 (F-box only protein 6b) (F-box protein that recognizes sugar chains 2) (F-box/G-domain protein 2),Fbxo6 Fbg2 Fbs2 Fbxo6b,Rattus norvegicus (Rat),284,DNA repair [GO:0006281]; ERAD pathway [GO:0036503]; glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005737; GO:0006281; GO:0006511; GO:0006516; GO:0006986; GO:0016567; GO:0019005; GO:0030246; GO:0031146; GO:0036503; GO:0044322; GO:0061630
g1093,124.6482565,6.151619807,1.249113324,4.9247892,8.45E-07,1.04E-05,139,101,705,18,61,320,0,21,0,0,0,3,sp,Q3T0J1,FBX4_BOVIN,30.986,213,128,5,373,957,46,257,5.44E-20,93.2,Q3T0J1,reviewed,FBX4_BOVIN,F-box only protein 4,FBXO4,Bos taurus (Bovine),387,positive regulation of protein ubiquitination [GO:0031398]; protein polyubiquitination [GO:0000209]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0000723; GO:0005737; GO:0006511; GO:0019005; GO:0031146; GO:0031398
g19466,367.9968301,1.128147726,0.37002103,3.04887462,0.002297003,0.009534043,771,232,367,435,358,388,605,382,167,290,117,229,sp,Q92890,UFD1_HUMAN,62.662,308,107,4,4,909,1,306,5.32E-130,375,Q92890,reviewed,UFD1_HUMAN,Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1),UFD1 UFD1L,Homo sapiens (Human),307,"cellular response to misfolded protein [GO:0071218]; ERAD pathway [GO:0036503]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0043161; GO:0071218
g6469,1759.132367,1.81561195,0.35690263,5.087135258,3.64E-07,4.92E-06,3034,1867,1879,1339,2688,2375,1655,778,505,1257,545,1159,sp,O95628,CNOT4_HUMAN,85.106,235,35,0,46,750,10,244,2.60E-143,437,O95628,reviewed,CNOT4_HUMAN,CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4),CNOT4 NOT4,Homo sapiens (Human),575,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0016567; GO:0030014; GO:0045652; GO:0046872; GO:0051865
g21198,4325.274026,1.643714653,0.189315289,8.68241897,3.87E-18,4.24E-16,7978,6432,4564,5312,4418,4661,3487,2130,2894,2304,2156,2370,sp,Q29504,UBA1_RABIT,62.417,1059,359,5,31,3096,2,1058,0,1390,Q29504,reviewed,UBA1_RABIT,Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1),UBA1 UBE1,Oryctolagus cuniculus (Rabbit),1058,DNA damage response [GO:0006974]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006511; GO:0006974
g16116,4512.928363,1.019573035,0.253247886,4.025988338,5.67E-05,0.000411545,5130,6295,4521,5347,4089,4941,4890,3484,3461,4153,1599,4433,sp,P18101,RL40_DROME,97.656,128,3,0,1,384,1,128,1.06E-89,258,P18101,reviewed,RL40_DROME,Ubiquitin-ribosomal protein eL40 fusion protein (CEP52) [Cleaved into: Ubiquitin; Large ribosomal subunit protein eL40 (60S ribosomal protein L40)],RpL40 Ubi-f UBI-F52 CG2960,Drosophila melanogaster (Fruit fly),128,cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; translation [GO:0006412]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0006412; GO:0006511; GO:0016567; GO:0019941; GO:0022625; GO:0022627; GO:0031386; GO:0031625; GO:0036211
g19751,119.4657795,0.792930139,0.2099114,3.777451524,0.000158441,0.001004705,163,115,195,91,83,140,144,83,89,120,95,111,sp,Q91YT2,RN185_MOUSE,68.235,170,45,2,217,717,29,192,3.35E-48,160,Q91YT2,reviewed,RN185_MOUSE,E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185),Rnf185,Mus musculus (Mouse),192,autophagy [GO:0006914]; defense response to virus [GO:0051607]; ERAD pathway [GO:0036503]; innate immune response [GO:0045087]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005741; GO:0005783; GO:0005789; GO:0006511; GO:0006914; GO:0036503; GO:0043130; GO:0044314; GO:0044390; GO:0044877; GO:0045087; GO:0046872; GO:0051607; GO:0051865; GO:0060340; GO:0061630; GO:1904294
g20332,2258.257008,0.88129353,0.264772124,3.328498163,0.000873156,0.004228023,3290,3166,2414,1352,2377,2116,2721,1632,1262,2464,2059,1601,sp,Q7Z6Z7,HUWE1_HUMAN,63.043,1334,430,15,1,3963,1,1284,0,1603,Q7Z6Z7,reviewed,HUWE1_HUMAN,"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272,Homo sapiens (Human),4374,base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:0140852; GO:1903955; GO:1904813
g14809,358.2547401,-1.480607861,0.359346526,-4.120278765,3.78E-05,0.000287668,150,128,238,162,37,285,705,652,699,600,671,473,sp,Q5RKH6,OS9_RAT,53.689,244,108,3,82,798,31,274,6.82E-84,281,Q5RKH6,reviewed,OS9_RAT,Protein OS-9,Os9,Rattus norvegicus (Rat),666,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0002020; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030968; GO:0030970; GO:0034976; GO:0036503; GO:1904153
g22410,594.6476438,1.274182375,0.321463547,3.963691639,7.38E-05,0.000519852,935,732,693,258,532,1115,561,385,360,460,305,484,sp,Q9NV58,RN19A_HUMAN,56.314,586,220,9,25,1692,42,621,2.85E-176,530,Q9NV58,reviewed,RN19A_HUMAN,E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38),RNF19A RNF19,Homo sapiens (Human),838,"microtubule cytoskeleton organization [GO:0000226]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0000151; GO:0000209; GO:0000226; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0008270; GO:0016020; GO:0031624; GO:0061630; GO:0098686; GO:0098794; GO:0098978; GO:0099576
g2814,2947.511951,1.35354283,0.469062752,2.885632732,0.003906277,0.014815572,2455,1555,2387,8431,3262,2015,2256,1696,2302,1376,2276,1950,sp,Q6TEM9,MYLIA_DANRE,40.315,444,244,9,1,1299,1,434,5.67E-90,284,Q6TEM9,reviewed,MYLIA_DANRE,E3 ubiquitin-protein ligase MYLIP-A (EC 2.3.2.27) (Myosin regulatory light chain-interacting protein A) (MIR-A) (RING-type E3 ubiquitin transferase MYLIP-A),mylipa mir mylip si:ch211-266j17.1,Danio rerio (Zebrafish) (Brachydanio rerio),472,gastrulation [GO:0007369]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005737; GO:0005829; GO:0005856; GO:0006511; GO:0007369; GO:0016567; GO:0030178; GO:0046872
g18086,339.7330394,-1.008173984,0.310636467,-3.245510723,0.001172401,0.005439159,256,298,314,162,86,113,686,665,765,374,486,312,sp,P15374,UCHL3_HUMAN,50.442,226,112,0,16,693,5,230,8.11E-73,224,P15374,reviewed,UCHL3_HUMAN,Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3),UCHL3,Homo sapiens (Human),230,post-translational protein modification [GO:0043687]; protein catabolic process [GO:0030163]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004843; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008233; GO:0016567; GO:0016579; GO:0019784; GO:0030163; GO:0043130; GO:0043687
g15594,2139.17528,1.398395875,0.293882979,4.758342516,1.95E-06,2.18E-05,2928,1893,2049,2674,2898,2402,2607,1431,1206,1346,919,1373,sp,P22682,CBL_MOUSE,67.089,395,120,2,76,1260,49,433,0,588,P22682,reviewed,CBL_MOUSE,E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL),Cbl,Mus musculus (Mouse),913,bone resorption [GO:0045453]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; DNA damage response [GO:0006974]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent endocytosis [GO:0070086]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0001784; GO:0005509; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0006468; GO:0006511; GO:0006513; GO:0006974; GO:0007165; GO:0007166; GO:0008584; GO:0010332; GO:0014823; GO:0016567; GO:0016600; GO:0017124; GO:0019901; GO:0030424; GO:0030426; GO:0030971; GO:0032487; GO:0033574; GO:0036120; GO:0036312; GO:0042059; GO:0042594; GO:0043066; GO:0043303; GO:0045121; GO:0045453; GO:0045471; GO:0046875; GO:0048260; GO:0048471; GO:0051865; GO:0051897; GO:0061630; GO:0070086; GO:0071456; GO:1990090; GO:1990782; GO:2000583
g22170,39.69443849,-1.347208815,0.44756624,-3.010076931,0.002611815,0.010640052,29,39,29,12,6,10,150,75,71,83,40,24,sp,P25867,UBCD1_DROME,76.027,146,35,0,1,438,1,146,1.69E-70,211,P25867,reviewed,UBCD1_DROME,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),eff UbcD1 CG7425,Drosophila melanogaster (Fruit fly),147,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039
g9023,190.5896121,-0.591322709,0.230349222,-2.567070574,0.010256174,0.032759852,172,133,107,106,120,122,454,274,203,267,289,214,sp,Q8C7R4,UBA6_MOUSE,58.537,205,85,0,1,615,844,1048,1.65E-71,237,Q8C7R4,reviewed,UBA6_MOUSE,Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2),Uba6 Ube1l2,Mus musculus (Mouse),1053,amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004792; GO:0004839; GO:0005524; GO:0005737; GO:0006511; GO:0007612; GO:0007626; GO:0016567; GO:0016779; GO:0019780; GO:0021764; GO:0021766; GO:0060996
g9022,688.2371499,-0.561757479,0.182905841,-3.071293275,0.002131337,0.008938935,681,457,420,498,282,535,1706,1029,774,980,923,734,sp,A0AVT1,UBA6_HUMAN,54.388,752,335,6,16,2259,38,785,0,855,A0AVT1,reviewed,UBA6_HUMAN,Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2),UBA6 MOP4 UBE1L2,Homo sapiens (Human),1052,amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004792; GO:0004839; GO:0005524; GO:0005737; GO:0005829; GO:0006511; GO:0007612; GO:0007626; GO:0016567; GO:0016779; GO:0019780; GO:0021764; GO:0021766; GO:0060996
g23479,309.6371803,1.882700851,0.368000157,5.116032733,3.12E-07,4.30E-06,463,205,275,406,496,434,194,138,198,177,124,130,sp,P46379,BAG6_HUMAN,43.094,181,92,4,4,534,17,190,8.74E-27,112,P46379,reviewed,BAG6_HUMAN,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),BAG6 BAT3 G3,Homo sapiens (Human),1132,apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140677; GO:1904294; GO:1990381
g23478,1715.613008,1.833383052,0.365832506,5.011536757,5.40E-07,7.02E-06,2700,1074,1432,2661,2802,1851,1439,839,898,910,755,744,sp,P46379,BAG6_HUMAN,28.741,421,238,8,1366,2592,756,1126,1.12E-39,162,P46379,reviewed,BAG6_HUMAN,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),BAG6 BAT3 G3,Homo sapiens (Human),1132,apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140677; GO:1904294; GO:1990381
g2493,873.9948659,1.009048373,0.236299563,4.270208369,1.95E-05,0.000162614,1828,786,1170,1031,599,748,1166,779,785,633,464,507,sp,Q9PTW9,PSA7_CARAU,86.758,219,29,0,4,660,3,221,7.87E-135,383,Q9PTW9,reviewed,PSA7_CARAU,Proteasome subunit alpha type-7 (Proteasome subunit alpha 4),psma7,Carassius auratus (Goldfish),251,proteasomal protein catabolic process [GO:0010498]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0010498; GO:0019773
g20134,218.8541245,-0.744715796,0.212984084,-3.496579572,0.000471264,0.002514011,142,184,129,201,75,117,436,315,287,444,253,287,sp,Q5F3N6,BAP1_CHICK,42.838,740,343,11,1,2154,1,682,1.08E-161,487,Q5F3N6,reviewed,BAP1_CHICK,Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1),BAP1 RCJMB04_11f19,Gallus gallus (Chicken),700,chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005737; GO:0006325; GO:0006511; GO:0016579; GO:0035517; GO:0045892; GO:0051726; GO:0071108
g9303,2581.872791,1.153947796,0.208790703,5.526815979,3.26E-08,5.82E-07,4054,2700,2690,3377,2527,2534,2663,1976,2131,1928,1271,1805,sp,Q9UMX0,UBQL1_HUMAN,58.609,302,111,2,481,1344,179,480,6.68E-102,323,Q9UMX0,reviewed,UBQL1_HUMAN,Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1),UBQLN1 DA41 PLIC1,Homo sapiens (Human),589,aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0036503; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1904294
g6282,495.6749398,0.713119104,0.169148568,4.215933445,2.49E-05,0.000200319,593,722,428,571,379,449,621,447,392,461,427,406,sp,Q9Z2A5,ATE1_MOUSE,53.036,247,113,1,103,834,269,515,5.63E-89,276,Q9Z2A5,reviewed,ATE1_MOUSE,Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1),Ate1,Mus musculus (Mouse),516,proteasomal protein catabolic process [GO:0010498]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004057; GO:0005634; GO:0005737; GO:0006511; GO:0010498
g6283,641.2477463,0.809265012,0.184062853,4.396677544,1.10E-05,9.98E-05,789,1032,667,726,458,556,833,582,605,640,354,445,sp,O95260,ATE1_HUMAN,58.163,98,41,0,10,303,10,107,3.77E-36,137,O95260,reviewed,ATE1_HUMAN,Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1),ATE1,Homo sapiens (Human),518,proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004057; GO:0005634; GO:0005737; GO:0006511; GO:0006979; GO:0010498; GO:0016598
g22627,88.05611698,-1.235365344,0.410000759,-3.013080628,0.002586102,0.010554361,40,57,79,54,21,28,149,150,63,121,279,115,sp,Q5XIU5,PSMF1_RAT,33.333,75,50,0,100,324,65,139,2.39E-17,62.4,Q5XIU5,reviewed,PSMF1_RAT,Proteasome inhibitor PI31 subunit,Psmf1,Rattus norvegicus (Rat),271,negative regulation of proteasomal protein catabolic process [GO:1901799]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000502; GO:0004866; GO:0005783; GO:0005829; GO:0006511; GO:0042803; GO:0043161; GO:0046982; GO:0048471; GO:0070628; GO:1901799
g9683,417.6186251,-2.077412442,0.320864181,-6.474429264,9.52E-11,2.95E-09,127,232,221,164,60,59,1165,879,438,992,868,656,sp,Q6ZT12,UBR3_HUMAN,33.293,817,434,17,1789,3951,1082,1883,8.02E-122,421,Q6ZT12,reviewed,UBR3_HUMAN,E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650),UBR3 KIAA2024 ZNF650,Homo sapiens (Human),1888,embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; olfactory behavior [GO:0042048]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],GO:0000151; GO:0001701; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016020; GO:0016567; GO:0042048; GO:0045732; GO:0061630; GO:0071596; GO:1904878
g16612,121.5612444,-1.696595168,0.378906506,-4.477608967,7.55E-06,7.15E-05,35,95,81,41,30,22,199,223,124,229,267,281,sp,Q5ZHY5,CHIP_CHICK,59.286,280,112,1,4,837,35,314,2.25E-117,342,Q5ZHY5,reviewed,CHIP_CHICK,E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1),STUB1 RCJMB04_32b21,Gallus gallus (Chicken),314,cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006281; GO:0006511; GO:0006515; GO:0030018; GO:0034450; GO:0042803; GO:0043161; GO:0045862; GO:0051087; GO:0061630; GO:0071218
g12805,435.2743774,1.547804504,0.37047576,4.177883332,2.94E-05,0.000231173,528,841,558,263,576,448,549,177,131,398,267,183,sp,Q8TDB6,DTX3L_HUMAN,64.211,95,34,0,799,1083,646,740,9.39E-26,112,Q8TDB6,reviewed,DTX3L_HUMAN,E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2),DTX3L BBAP,Homo sapiens (Human),740,defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008333; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646
g7741,603.167444,-0.670170084,0.151742163,-4.416505402,1.00E-05,9.19E-05,448,492,502,425,264,284,1314,899,890,975,766,634,sp,Q3U1J4,DDB1_MOUSE,74.781,1142,285,3,1,3423,1,1140,0,1806,Q3U1J4,reviewed,DDB1_MOUSE,DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor),Ddb1,Mus musculus (Mouse),1140,apoptotic process [GO:0006915]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; ectopic germ cell programmed cell death [GO:0035234]; epigenetic programming in the zygotic pronuclei [GO:0044725]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; spindle assembly involved in female meiosis [GO:0007056]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055],GO:0003684; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006281; GO:0006511; GO:0006915; GO:0006974; GO:0007056; GO:0010498; GO:0016055; GO:0016567; GO:0019076; GO:0031464; GO:0031465; GO:0034644; GO:0035234; GO:0035861; GO:0042752; GO:0043066; GO:0043161; GO:0044725; GO:0044877; GO:0045070; GO:0045722; GO:0045732; GO:0046726; GO:0048511; GO:0051093; GO:0051702; GO:0070914; GO:0071987; GO:0080008; GO:0097602; GO:0160072; GO:1901990; GO:2000242
g19157,1461.49255,1.293438355,0.349483006,3.701005003,0.000214747,0.001297036,1795,2274,1202,839,1893,2061,1222,786,634,1367,1208,954,sp,Q8CJB9,BRE1B_RAT,65.13,347,121,0,1888,2928,656,1002,1.20E-139,446,Q8CJB9,reviewed,BRE1B_RAT,E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B) (Syntaxin-1-interacting RING finger protein) (Protein staring),Rnf40 Bre1b,Rattus norvegicus (Rat),1002,chromatin organization [GO:0006325]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0003730; GO:0004842; GO:0005634; GO:0006325; GO:0006511; GO:0016567; GO:0017075; GO:0031624; GO:0031625; GO:0032991; GO:0033503; GO:0042803; GO:0043434; GO:0045944; GO:0046872; GO:0061630; GO:1901800; GO:1902916
g4903,302.5518872,-0.841703174,0.210800617,-3.992887613,6.53E-05,0.000466901,307,246,224,164,62,178,618,484,421,569,423,345,sp,Q6NRG0,RNF8B_XENLA,42.135,178,91,4,1279,1812,292,457,3.69E-34,140,Q6NRG0,reviewed,RNF8B_XENLA,E3 ubiquitin-protein ligase rnf8-B (EC 2.3.2.27) (RING finger protein 8-B) (RING-type E3 ubiquitin transferase rnf8-B),rnf8-B,Xenopus laevis (African clawed frog),532,DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168
g18018,808.1465234,0.886963733,0.210495547,4.213693563,2.51E-05,0.000201687,1089,1063,751,815,712,868,892,575,639,587,852,567,sp,Q5U2S1,NFIP1_RAT,31.98,197,127,2,34,624,23,212,1.70E-24,99.4,Q5U2S1,reviewed,NFIP1_RAT,NEDD4 family-interacting protein 1,Ndfip1 N4wbp5,Rattus norvegicus (Rat),221,"CD4-positive, alpha-beta T cell proliferation [GO:0035739]; intracellular iron ion homeostasis [GO:0006879]; metal ion transport [GO:0030001]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of protein transport [GO:0051224]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; protein catabolic process [GO:0030163]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of lymphocyte differentiation [GO:0045619]; regulation of myeloid leukocyte differentiation [GO:0002761]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034]",GO:0000139; GO:0002761; GO:0002829; GO:0005576; GO:0005783; GO:0005794; GO:0005938; GO:0006511; GO:0006879; GO:0007034; GO:0010008; GO:0010629; GO:0030001; GO:0030163; GO:0030425; GO:0031398; GO:0032713; GO:0035739; GO:0045202; GO:0045619; GO:0045732; GO:0048294; GO:0048302; GO:0048471; GO:0050699; GO:0050728; GO:0051224; GO:2000562
g1007,174.9504684,0.691970757,0.271305231,2.550524938,0.010756083,0.034049294,249,123,213,175,164,158,275,167,105,174,98,185,sp,Q80Z37,TOPRS_MOUSE,37.38,313,138,7,91,906,104,399,3.64E-53,203,Q80Z37,reviewed,TOPRS_MOUSE,E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3),Topors,Mus musculus (Mouse),1033,DNA damage response [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of DNA-templated transcription [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0000922; GO:0000930; GO:0003677; GO:0003823; GO:0004842; GO:0005634; GO:0005814; GO:0006511; GO:0006513; GO:0006974; GO:0008630; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0032391; GO:0034504; GO:0036064; GO:0042127; GO:0042771; GO:0043161; GO:0044547; GO:0045893; GO:0046872; GO:0051457; GO:0061630; GO:0070936
g4138,211.3295892,-0.967656844,0.330124542,-2.931187239,0.003376692,0.013141936,180,133,181,146,43,92,461,249,235,290,576,217,sp,Q5R4I2,RNF8_PONAB,42.708,96,55,0,211,498,387,482,5.38E-20,92.8,Q5R4I2,reviewed,RNF8_PONAB,E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8),RNF8,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),486,cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168
g1559,2302.600417,0.968905328,0.377222925,2.568521855,0.010213327,0.032669251,2416,1391,1641,3143,3140,2403,2775,1803,2263,1512,1855,1217,sp,P18433,PTPRA_HUMAN,50.585,342,168,1,1,1026,462,802,3.10E-124,378,P18433,reviewed,PTPRA_HUMAN,Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48),PTPRA PTPA PTPRL2,Homo sapiens (Human),802,insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; regulation of focal adhesion assembly [GO:0051893],GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0050804; GO:0051893; GO:0070062; GO:0097060; GO:0098685
g20017,939.3457368,5.550850612,0.751747912,7.383925544,1.54E-13,8.02E-12,2747,5514,2006,68,190,482,61,72,35,57,11,55,sp,Q99JY8,PLPP3_MOUSE,44.8,125,67,2,4,378,176,298,5.05E-30,113,Q99JY8,reviewed,PLPP3_MOUSE,Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b),Plpp3 Lpp3 Ppap2b,Mus musculus (Mouse),312,"Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingosine metabolic process [GO:0006670]; wound healing [GO:0042060]",GO:0000139; GO:0001568; GO:0001702; GO:0001933; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007155; GO:0007165; GO:0007229; GO:0008195; GO:0010595; GO:0016020; GO:0016323; GO:0022409; GO:0030111; GO:0033116; GO:0033631; GO:0034109; GO:0042060; GO:0042392; GO:0042577; GO:0045121; GO:0046839; GO:0050731; GO:0050821; GO:0051091; GO:0060020; GO:0070971; GO:0098609; GO:0106235; GO:1902068
g14363,1106.996185,0.546852485,0.176437182,3.099417475,0.001939016,0.008284427,1327,1043,974,1163,874,1207,1594,1015,1020,1070,866,1071,sp,Q6GPF3,CUL3B_XENLA,78.609,762,150,3,10,2256,7,768,0,1233,Q6GPF3,reviewed,CUL3B_XENLA,Cullin-3-B (CUL-3-B),cul3b,Xenopus laevis (African clawed frog),768,cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149],GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005827; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0016477; GO:0016567; GO:0017145; GO:0031463; GO:0031625; GO:0035024; GO:0040016; GO:0043149; GO:0043161; GO:0045842; GO:0048208; GO:0072686; GO:1901992
g4022,5125.957863,-1.226686674,0.388375924,-3.158503392,0.001585815,0.006990522,2286,1228,1727,2924,3406,2457,14897,7979,9633,7301,6763,7028,sp,Q9VZI3,UN112_DROME,47.486,716,273,14,40,1917,5,707,0,621,Q9VZI3,reviewed,UN112_DROME,Unc-112-related protein (Fermitin-1),Fit1 CG14991,Drosophila melanogaster (Fruit fly),708,cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229],GO:0005178; GO:0005737; GO:0007160; GO:0007229; GO:0030055; GO:0048738; GO:0050829; GO:0050839
g16923,90.13291553,-2.157769752,0.83946655,-2.570405876,0.010157943,0.032544007,22,83,31,36,0,16,158,134,399,144,196,7,sp,Q96RT1,ERBIN_HUMAN,32.759,406,256,3,94,1311,18,406,8.01E-42,167,Q96RT1,reviewed,ERBIN_HUMAN,Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2),ERBIN ERBB2IP KIAA1225 LAP2,Homo sapiens (Human),1412,basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165],GO:0005102; GO:0005176; GO:0005200; GO:0005604; GO:0005634; GO:0005737; GO:0005886; GO:0006605; GO:0007155; GO:0007165; GO:0007173; GO:0007229; GO:0009925; GO:0016323; GO:0016607; GO:0030054; GO:0030056; GO:0031594; GO:0031965; GO:0032088; GO:0032495; GO:0032496; GO:0045104; GO:0045175; GO:0045197; GO:0070433; GO:0071356; GO:0071638; GO:0098978; GO:0099072; GO:0099572
g5240,135.793515,7.61506917,1.142073694,6.667756389,2.60E-11,8.95E-10,119,144,177,5,252,545,0,5,0,5,0,0,sp,Q8CFN2,CDC42_RAT,52.326,172,73,2,4,495,3,173,1.47E-58,186,Q8CFN2,reviewed,CDC42_RAT,Cell division control protein 42 homolog (EC 3.6.5.2),Cdc42,Rattus norvegicus (Rat),191,"actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cellular response to type II interferon [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; embryonic heart tube development [GO:0035050]; endocytosis [GO:0006897]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of localization in cell [GO:0051649]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; Golgi organization [GO:0007030]; heart contraction [GO:0060047]; heart process [GO:0003015]; integrin-mediated signaling pathway [GO:0007229]; modification of synaptic structure [GO:0099563]; modulation by host of viral process [GO:0044788]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; nucleus localization [GO:0051647]; organelle transport along microtubule [GO:0072384]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of synapse structural plasticity [GO:0051835]; protein localization [GO:0008104]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exocytosis [GO:0017157]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; regulation of mitotic nuclear division [GO:0007088]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of postsynapse organization [GO:0099175]; regulation of stress fiber assembly [GO:0051492]; response to glucose [GO:0009749]; sprouting angiogenesis [GO:0002040]; submandibular salivary gland formation [GO:0060661]",GO:0000139; GO:0000322; GO:0002040; GO:0003015; GO:0003161; GO:0003253; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0006897; GO:0006911; GO:0007015; GO:0007030; GO:0007088; GO:0007097; GO:0007163; GO:0007229; GO:0008104; GO:0009749; GO:0010591; GO:0010592; GO:0016020; GO:0017119; GO:0017157; GO:0019901; GO:0030010; GO:0030036; GO:0030141; GO:0030175; GO:0030307; GO:0030335; GO:0030496; GO:0030742; GO:0031252; GO:0031256; GO:0031258; GO:0031274; GO:0031333; GO:0031435; GO:0031996; GO:0032427; GO:0032467; GO:0032488; GO:0032956; GO:0032991; GO:0034191; GO:0034329; GO:0034332; GO:0035050; GO:0035088; GO:0036336; GO:0036464; GO:0038189; GO:0042802; GO:0042995; GO:0043005; GO:0043025; GO:0043197; GO:0043410; GO:0043525; GO:0044788; GO:0045177; GO:0045198; GO:0045335; GO:0045740; GO:0046330; GO:0046847; GO:0048549; GO:0048664; GO:0051233; GO:0051489; GO:0051491; GO:0051492; GO:0051496; GO:0051647; GO:0051649; GO:0051683; GO:0051835; GO:0051897; GO:0051988; GO:0060047; GO:0060501; GO:0060661; GO:0060997; GO:0061630; GO:0071346; GO:0071944; GO:0072384; GO:0072686; GO:0086101; GO:0090135; GO:0090316; GO:0098685; GO:0098794; GO:0098978; GO:0099159; GO:0099175; GO:0099563; GO:1900026
g68,220.4775708,-1.499894285,0.333733821,-4.494283144,6.98E-06,6.68E-05,100,111,113,45,77,136,866,369,184,381,323,385,sp,Q03001,DYST_HUMAN,24.37,238,157,5,112,756,6422,6659,4.70E-08,58.5,Q03001,reviewed,DYST_HUMAN,Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein),DST BP230 BP240 BPAG1 DMH DT KIAA0728,Homo sapiens (Human),7570,cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115
g9859,1393.230174,-1.535826588,0.293466663,-5.233393705,1.66E-07,2.46E-06,867,935,841,307,489,311,3607,2150,1611,3048,2660,2233,sp,B0FYY4,ITB1_SHEEP,41.191,789,417,18,109,2409,32,795,0,555,B0FYY4,reviewed,ITB1_SHEEP,Integrin beta-1 (Fibronectin receptor subunit beta) (Integrin subunit beta-1) (VLA-4 subunit beta) (CD antigen CD29),ITGB1,Ovis aries (Sheep),798,cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fusion [GO:0007520]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710],GO:0001968; GO:0005925; GO:0007229; GO:0007517; GO:0007520; GO:0009986; GO:0010710; GO:0016020; GO:0016477; GO:0019960; GO:0030027; GO:0030335; GO:0031623; GO:0032587; GO:0033627; GO:0034679; GO:0042470; GO:0043236; GO:0045445; GO:0045906; GO:0046872; GO:0046982; GO:0055037; GO:0071404; GO:0098639; GO:0098640; GO:1903078
g9829,60219.40972,-1.538367393,0.387531256,-3.969660171,7.20E-05,0.00050954,20887,11266,17184,45209,23517,28558,134583,110162,126134,99300,100362,80273,sp,A2ARA8,ITA8_MOUSE,31.943,1055,622,31,64,3063,29,1042,4.11E-142,456,A2ARA8,reviewed,ITA8_MOUSE,Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain],Itga8,Mus musculus (Mouse),1062,cell adhesion mediated by integrin [GO:0033627]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0001656; GO:0005178; GO:0005783; GO:0005886; GO:0007160; GO:0007179; GO:0007229; GO:0007399; GO:0007613; GO:0008305; GO:0009897; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0033627; GO:0034446; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609; GO:0098839; GO:0098978
g63,3194.105326,-1.242425769,0.399632134,-3.108923592,0.001877703,0.008062551,1067,1744,1858,926,961,3009,13077,5458,2783,5339,2484,6006,sp,Q03001,DYST_HUMAN,24.726,639,453,7,1837,3741,3833,4447,1.92E-51,206,Q03001,reviewed,DYST_HUMAN,Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein),DST BP230 BP240 BPAG1 DMH DT KIAA0728,Homo sapiens (Human),7570,cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115
g23499,2171.41329,-1.087615904,0.321906525,-3.37866995,0.000728374,0.003626197,1014,855,1295,1461,1334,687,6281,3652,2820,2930,3576,2815,sp,Q61001,LAMA5_MOUSE,34.302,172,90,6,127,606,593,753,1.97E-15,81.6,Q61001,reviewed,LAMA5_MOUSE,Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha),Lama5,Mus musculus (Mouse),3718,animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; postsynapse organization [GO:0099173]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of epithelial cell proliferation [GO:0050678]; skeletal system morphogenesis [GO:0048705]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; trunk neural crest cell migration [GO:0036484],GO:0001658; GO:0001738; GO:0001755; GO:0001822; GO:0001942; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005610; GO:0005615; GO:0007229; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0016331; GO:0030155; GO:0030324; GO:0030334; GO:0031012; GO:0031594; GO:0034446; GO:0036484; GO:0042475; GO:0043083; GO:0043259; GO:0045995; GO:0048705; GO:0048754; GO:0050678; GO:0060271; GO:0060445; GO:0062023; GO:0072659; GO:0098965; GO:0098978; GO:0099173
g19545,5595.151113,-1.407262183,0.363888127,-3.867293486,0.00011005,0.00073531,2506,1390,2040,4039,2785,1793,17549,10566,9660,10401,5567,7658,sp,Q66H76,PAXI_RAT,78.528,163,35,0,1,489,423,585,1.93E-93,285,Q66H76,reviewed,PAXI_RAT,Paxillin,Pxn,Rattus norvegicus (Rat),586,branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; focal adhesion assembly [GO:0048041]; growth hormone receptor signaling pathway [GO:0060396]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; positive regulation of angiogenesis [GO:0045766]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0001725; GO:0005078; GO:0005178; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008013; GO:0008360; GO:0016477; GO:0017166; GO:0019901; GO:0019903; GO:0030027; GO:0030032; GO:0031252; GO:0034446; GO:0034614; GO:0038191; GO:0043542; GO:0044877; GO:0045766; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:0051496; GO:0060396; GO:1901652
g19546,9345.182524,-1.361122348,0.406605618,-3.347524697,0.000815367,0.004002974,4143,2092,3074,7227,5066,2924,29531,17962,15594,18384,8439,12146,sp,Q8VI36,PAXI_MOUSE,53.977,176,70,3,715,1209,251,426,3.25E-52,187,Q8VI36,reviewed,PAXI_MOUSE,Paxillin,Pxn,Mus musculus (Mouse),591,branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; positive regulation of angiogenesis [GO:0045766]; regulation of cell shape [GO:0008360]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0005078; GO:0005178; GO:0005856; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008360; GO:0016477; GO:0019901; GO:0030027; GO:0030032; GO:0030159; GO:0031252; GO:0034446; GO:0038191; GO:0043542; GO:0044877; GO:0045766; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:1901652
g1433,4607.88785,2.375714574,0.35445235,6.702493502,2.05E-11,7.19E-10,6999,4291,4111,5941,8515,5984,2214,1881,1723,1373,1591,2000,sp,D3ZIE4,FYB1_RAT,37.5,80,48,1,124,363,503,580,2.91E-08,54.7,D3ZIE4,reviewed,FYB1_RAT,FYN-binding protein 1 (Adhesion and degranulation promoting adaptor protein) (ADAP) (FYB-120/130) (p120/p130) (FYN-T-binding protein) (SLAP-130) (SLP-76-associated phosphoprotein),Fyb1 Fyb,Rattus norvegicus (Rat),830,integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852],GO:0005634; GO:0005737; GO:0005886; GO:0007229; GO:0008289; GO:0032991; GO:0044877; GO:0050852; GO:0070161; GO:0072659
g18233,1316.729476,1.89891959,0.526271934,3.608247877,0.000308272,0.001757783,1838,1252,1708,361,1820,3005,1403,578,400,1144,173,647,sp,Q9EQH1,GAB2_RAT,47.826,115,57,2,4,342,7,120,4.01E-28,124,Q9EQH1,reviewed,GAB2_RAT,GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2),Gab2,Rattus norvegicus (Rat),665,cell migration [GO:0016477]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mast cell degranulation [GO:0043306]; signal transduction [GO:0007165],GO:0005068; GO:0005547; GO:0005737; GO:0005886; GO:0007165; GO:0007229; GO:0008284; GO:0010634; GO:0016477; GO:0019903; GO:0019904; GO:0030316; GO:0032991; GO:0035556; GO:0043306; GO:0043325; GO:0043491; GO:0045121
g15377,5160.302464,-1.048395139,0.218149099,-4.805865083,1.54E-06,1.77E-05,3865,2149,3998,2824,2406,1858,13117,7367,7372,8253,7864,7565,sp,P26039,TLN1_MOUSE,60.601,599,215,7,7,1800,2,580,0,773,P26039,reviewed,TLN1_MOUSE,Talin-1,Tln1 Tln,Mus musculus (Mouse),2541,cell-cell adhesion [GO:0098609]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229],GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0043622; GO:0051015; GO:0098609
g15375,4007.143004,-0.998011895,0.225690308,-4.422041445,9.78E-06,8.99E-05,3185,1750,2738,2152,2097,1511,10751,6158,5621,6213,5603,5496,sp,Q9Y490,TLN1_HUMAN,53.552,366,169,1,13,1110,959,1323,1.59E-121,390,Q9Y490,reviewed,TLN1_HUMAN,Talin-1,TLN1 KIAA1027 TLN,Homo sapiens (Human),2541,cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893],GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609
g15374,19297.88998,-1.050502799,0.228116632,-4.605112694,4.12E-06,4.22E-05,14160,8017,12433,12647,9174,6801,43166,31125,32565,28826,26706,28307,sp,Q9Y490,TLN1_HUMAN,59.725,1162,428,8,58,3444,1342,2496,0,1215,Q9Y490,reviewed,TLN1_HUMAN,Talin-1,TLN1 KIAA1027 TLN,Homo sapiens (Human),2541,cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893],GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609
g759,663.066157,1.575469153,0.277211407,5.683276776,1.32E-08,2.61E-07,815,1219,651,745,678,878,406,349,248,468,362,567,sp,B1A8Z2,CIB1_SHEEP,54.082,98,42,1,1,285,94,191,2.29E-08,52.4,B1A8Z2,reviewed,CIB1_SHEEP,Calcium and integrin-binding protein 1 (Calmyrin),CIB1,Ovis aries (Sheep),191,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein localization to plasma membrane [GO:1903078]; spermatogenesis [GO:0007283],GO:0000287; GO:0001525; GO:0005509; GO:0005634; GO:0005813; GO:0006915; GO:0007155; GO:0007229; GO:0007283; GO:0016324; GO:0030027; GO:0030154; GO:0030426; GO:0032433; GO:0032587; GO:0042383; GO:0043204; GO:0043495; GO:0048471; GO:0051301; GO:0070886; GO:0071363; GO:1903078
g20847,1484.714152,-2.335321549,0.229612764,-10.17069568,2.68E-24,6.72E-22,466,504,494,632,205,279,4032,3389,3313,3170,1991,2343,sp,P14234,FGR_MOUSE,47.368,57,30,0,1,171,67,123,2.34E-09,62,P14234,reviewed,FGR_MOUSE,Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr),Fgr,Mus musculus (Mouse),517,bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; myoblast proliferation [GO:0051450]; negative regulation of natural killer cell activation [GO:0032815]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production [GO:0001819]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of innate immune response [GO:0045088]; regulation of phagocytosis [GO:0050764]; regulation of protein kinase activity [GO:0045859]; skeletal system morphogenesis [GO:0048705],GO:0001784; GO:0001819; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005743; GO:0005758; GO:0005829; GO:0005856; GO:0005886; GO:0007169; GO:0007229; GO:0008360; GO:0016235; GO:0018108; GO:0019901; GO:0030154; GO:0030282; GO:0030335; GO:0032587; GO:0032815; GO:0032956; GO:0034987; GO:0034988; GO:0043306; GO:0045087; GO:0045088; GO:0045859; GO:0048705; GO:0050764; GO:0050830; GO:0051450; GO:0051897
g11877,718.3634453,1.444666664,0.33419779,4.322789403,1.54E-05,0.00013253,1023,580,724,887,969,854,824,432,541,510,203,402,sp,Q06124,PTN11_HUMAN,77.143,175,30,1,1,495,1,175,1.90E-91,280,Q06124,reviewed,PTN11_HUMAN,Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3),PTPN11 PTP2C SHPTP2,Homo sapiens (Human),593,atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; negative regulation of type I interferon production [GO:0032480]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641],GO:0000077; GO:0001784; GO:0004721; GO:0004725; GO:0004726; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0006641; GO:0007173; GO:0007229; GO:0007409; GO:0007420; GO:0007507; GO:0008543; GO:0009755; GO:0019221; GO:0019901; GO:0021697; GO:0030159; GO:0030220; GO:0030971; GO:0031295; GO:0032331; GO:0032480; GO:0032528; GO:0032728; GO:0032755; GO:0032760; GO:0032991; GO:0033628; GO:0033629; GO:0035264; GO:0035265; GO:0035335; GO:0035855; GO:0036302; GO:0038127; GO:0042445; GO:0042593; GO:0043254; GO:0045296; GO:0045778; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048609; GO:0048806; GO:0048839; GO:0048873; GO:0050731; GO:0050839; GO:0051428; GO:0051463; GO:0060020; GO:0060090; GO:0060125; GO:0060325; GO:0060338; GO:0061582; GO:0070374; GO:0071364; GO:1990782
g9996,8273.84962,-1.784702415,0.318756252,-5.59895658,2.16E-08,4.02E-07,3679,1549,3096,3208,3060,3477,17875,14556,17055,13881,18433,10533,sp,P12606,ITB1A_XENLA,39.951,811,411,23,142,2484,31,795,0,554,P12606,reviewed,ITB1A_XENLA,Integrin beta-1-A,itgb1-a,Xenopus laevis (African clawed frog),798,cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fusion [GO:0007520],GO:0007155; GO:0007229; GO:0007517; GO:0007520; GO:0030027; GO:0032154; GO:0032587; GO:0042470; GO:0045445; GO:0046872; GO:0070161
g9995,298.0946213,-3.164702938,0.564046529,-5.610712548,2.01E-08,3.79E-07,59,26,91,26,75,9,1235,696,740,897,207,339,sp,Q00651,ITA4_MOUSE,40,420,202,12,178,1413,40,417,1.79E-81,275,Q00651,reviewed,ITA4_MOUSE,Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (Lymphocyte Peyer patch adhesion molecules subunit alpha) (LPAM subunit alpha) (VLA-4 subunit alpha) (CD antigen CD49d),Itga4,Mus musculus (Mouse),1039,axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; chorio-allantoic fusion [GO:0060710]; clathrin-dependent extracellular exosome endocytosis [GO:1990771]; diapedesis [GO:0050904]; face development [GO:0060324]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; import into cell [GO:0098657]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; mesenchyme development [GO:0060485]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of vasoconstriction [GO:0045906]; neuron projection extension [GO:1990138]; pericyte cell migration [GO:1905351]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of T cell migration [GO:2000406]; T cell migration [GO:0072678]; vascular associated smooth muscle cell migration [GO:1904738]; visceral serous pericardium development [GO:0061032],GO:0001968; GO:0001974; GO:0002687; GO:0003823; GO:0005178; GO:0005911; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007229; GO:0007507; GO:0008305; GO:0009897; GO:0009986; GO:0016477; GO:0030426; GO:0033627; GO:0034668; GO:0043025; GO:0045906; GO:0046872; GO:0050839; GO:0050904; GO:0060324; GO:0060385; GO:0060485; GO:0060710; GO:0061032; GO:0072678; GO:0090074; GO:0098609; GO:0098657; GO:1903039; GO:1903238; GO:1904738; GO:1905351; GO:1990138; GO:1990405; GO:1990771; GO:2000406
g9994,533.8527336,-2.859902477,0.6451672,-4.432808237,9.30E-06,8.62E-05,84,21,205,90,174,19,2112,1280,1229,1538,243,787,sp,Q13797,ITA9_HUMAN,28.1,637,398,22,1,1866,436,1027,1.25E-50,193,Q13797,reviewed,ITA9_HUMAN,Integrin alpha-9 (Integrin alpha-RLC),ITGA9,Homo sapiens (Human),1035,cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593],GO:0005178; GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009925; GO:0030593; GO:0033627; GO:0034679; GO:0045906; GO:0046872; GO:0098609; GO:0098640
g18407,1156.534239,-2.048106164,0.548115293,-3.736633864,0.0001865,0.001149511,228,240,667,880,208,88,2762,2018,1659,1235,4322,1283,sp,Q9DF58,ILK_CHICK,63.333,450,162,2,1,1341,1,450,0,625,Q9DF58,reviewed,ILK_CHICK,Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (Beta-integrin-linked kinase) (ILK-1) (ILK-2) (p59ILK),ILK ILK1 ILK2,Gallus gallus (Chicken),452,branching involved in ureteric bud morphogenesis [GO:0001658]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; neural precursor cell proliferation [GO:0061351]; outflow tract morphogenesis [GO:0003151]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0000902; GO:0001658; GO:0001934; GO:0003151; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0008284; GO:0010761; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030030; GO:0030513; GO:0033209; GO:0034446; GO:0043123; GO:0043491; GO:0045197; GO:0045669; GO:0045893; GO:0061351; GO:0090263; GO:1900026; GO:2000178
g9599,832.7843704,1.354003923,0.257804806,5.252050738,1.50E-07,2.25E-06,1059,1640,900,1258,486,949,956,733,530,485,292,516,sp,P53708,ITA8_HUMAN,36.032,1013,588,27,28,2949,52,1043,2.19E-177,548,P53708,reviewed,ITA8_HUMAN,Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain],ITGA8,Homo sapiens (Human),1063,cell adhesion mediated by integrin [GO:0033627]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0001656; GO:0001822; GO:0005178; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0007399; GO:0007613; GO:0008305; GO:0009897; GO:0009986; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0033627; GO:0034446; GO:0034678; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609; GO:0098839; GO:0098978
g10318,21275.21336,1.098378379,0.380198764,2.888958313,0.003865203,0.01468224,17670,13159,19267,43224,24993,18713,18773,16205,18112,13532,12958,18172,sp,B8JK39,ITA9_MOUSE,33.163,781,460,26,4,2235,41,796,2.04E-105,357,B8JK39,reviewed,ITA9_MOUSE,Integrin alpha-9,Itga9,Mus musculus (Mouse),1036,cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593],GO:0005178; GO:0005518; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009925; GO:0030593; GO:0033627; GO:0034679; GO:0043236; GO:0045906; GO:0046872; GO:0098609; GO:0098640
g2428,327.1345717,0.718443451,0.214365741,3.35148447,0.000803795,0.00395477,504,396,404,311,234,273,469,286,160,385,323,222,sp,Q92636,FAN_HUMAN,44.457,911,490,10,31,2751,18,916,0,754,Q92636,reviewed,FAN_HUMAN,Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation),NSMAF FAN,Homo sapiens (Human),917,ceramide metabolic process [GO:0006672]; positive regulation of amide metabolic process [GO:0034250]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipid metabolic process [GO:0045834]; regulation of membrane lipid metabolic process [GO:1905038]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0005737; GO:0005829; GO:0006672; GO:0007165; GO:0016230; GO:0033209; GO:0034250; GO:0043065; GO:0045834; GO:1905038
g11617,5657.946543,2.156610361,0.382728601,5.634829375,1.75E-08,3.33E-07,8222,3971,4720,10037,9797,6113,3224,2479,2558,2067,2768,1947,sp,Q60855,RIPK1_MOUSE,33.559,295,167,8,76,888,19,308,2.35E-39,157,Q60855,reviewed,RIPK1_MOUSE,Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1),Ripk1 Rinp Rip,Mus musculus (Mouse),656,amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA processing [GO:1903800]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; regulation of reactive oxygen species metabolic process [GO:2000377]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0001934; GO:0004672; GO:0004674; GO:0004706; GO:0005123; GO:0005524; GO:0005739; GO:0006915; GO:0006954; GO:0008625; GO:0030163; GO:0031264; GO:0031625; GO:0032757; GO:0032760; GO:0032991; GO:0033209; GO:0035591; GO:0036289; GO:0042327; GO:0042803; GO:0043065; GO:0043066; GO:0043123; GO:0043124; GO:0043235; GO:0043410; GO:0043525; GO:0044877; GO:0045651; GO:0045944; GO:0046330; GO:0046777; GO:0050729; GO:0051092; GO:0060545; GO:0060546; GO:0070105; GO:0070231; GO:0070266; GO:0070301; GO:0070513; GO:0071356; GO:0071363; GO:0097300; GO:0097342; GO:0097343; GO:0097527; GO:0106310; GO:1900119; GO:1901026; GO:1901224; GO:1903265; GO:1903800; GO:1990000; GO:2000377; GO:2001237; GO:2001238; GO:2001240
g20747,100.5535046,-1.815561618,0.337099567,-5.385831944,7.21E-08,1.18E-06,46,48,40,62,8,35,309,217,135,224,97,198,sp,Q3MHX1,COMD7_BOVIN,50,182,65,2,28,552,38,200,3.20E-53,171,Q3MHX1,reviewed,COMD7_BOVIN,COMM domain-containing protein 7,COMMD7,Bos taurus (Bovine),200,negative regulation of DNA-templated transcription [GO:0045892]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0031410; GO:0033209; GO:0045892; GO:0051059
g21675,1071.08591,2.006867508,0.330054946,6.080404284,1.20E-09,2.98E-08,1649,1081,1053,988,1806,1499,642,409,415,624,522,502,sp,P92208,JNK_DROME,76.816,358,81,1,118,1191,7,362,0,585,P92208,reviewed,JNK_DROME,Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket),bsk JNK CG5680,Drosophila melanogaster (Fruit fly),372,"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; defense response to Gram-negative bacterium [GO:0050829]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; follicle cell of egg chamber development [GO:0030707]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; JNK cascade [GO:0007254]; long-term memory [GO:0007616]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of programmed cell death [GO:0043068]; regulation of cellular response to phosphate starvation [GO:0140255]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]",GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006979; GO:0007254; GO:0007391; GO:0007395; GO:0007411; GO:0007616; GO:0008284; GO:0009408; GO:0010508; GO:0010628; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0033209; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043065; GO:0043068; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048010; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0050829; GO:0061057; GO:0071243; GO:0071276; GO:0071907; GO:0106310; GO:0140255; GO:1903688; GO:1904801
g19565,3.470822737,4.490284105,1.493820139,3.005906795,0.002647901,0.01076519,0,11,9,6,2,7,0,2,0,0,0,0,sp,P70191,TRAF5_MOUSE,54.545,44,19,1,124,255,30,72,5.14E-07,48.9,P70191,reviewed,TRAF5_MOUSE,TNF receptor-associated factor 5,Traf5,Mus musculus (Mouse),558,apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0005164; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0048255; GO:0051092; GO:0070534; GO:0097400
g8414,171.3823367,2.74386251,0.774740892,3.541651845,0.00039763,0.002175213,118,688,396,34,10,431,93,44,75,7,43,65,sp,Q9WU72,TN13B_MOUSE,25,192,117,6,805,1308,120,308,8.04E-08,57.4,Q9WU72,reviewed,TN13B_MOUSE,"Tumor necrosis factor ligand superfamily member 13B (B-cell-activating factor) (BAFF) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]",Tnfsf13b Baff,Mus musculus (Mouse),309,B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; germinal center formation [GO:0002467]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of germinal center formation [GO:0002636]; positive regulation of T cell proliferation [GO:0042102]; regulation of immune response [GO:0050776]; skin development [GO:0043588]; T cell costimulation [GO:0031295]; T cell proliferation [GO:0042098]; transitional one stage B cell differentiation [GO:0002333]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0001782; GO:0002333; GO:0002467; GO:0002636; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0005925; GO:0030183; GO:0030890; GO:0031295; GO:0031296; GO:0033209; GO:0042098; GO:0042100; GO:0042102; GO:0043231; GO:0043588; GO:0048018; GO:0048471; GO:0050776
g13957,4776.531964,-1.759369087,0.250649685,-7.019235174,2.23E-12,9.41E-11,1867,1355,2246,2970,1270,1312,11823,8895,7816,9015,8973,7418,sp,P48059,LIMS1_HUMAN,69.536,302,91,1,37,942,8,308,2.90E-146,418,P48059,reviewed,LIMS1_HUMAN,LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48),LIMS1 PINCH PINCH1,Homo sapiens (Human),325,cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0033209; GO:0043123; GO:0043547; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051894; GO:0071560; GO:0098609; GO:1900026; GO:2001046
g24037,2261.25584,2.185614509,0.425502626,5.136547636,2.80E-07,3.93E-06,3284,2857,1409,2246,4907,2052,997,828,813,1265,1086,883,sp,P39429,TRAF2_MOUSE,59.77,174,70,0,4,525,328,501,1.56E-78,245,P39429,reviewed,TRAF2_MOUSE,TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2),Traf2,Mus musculus (Mouse),501,apoptotic process [GO:0006915]; cellular response to nitric oxide [GO:0071732]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin production [GO:0002637]; regulation of JNK cascade [GO:0046328]; regulation of protein-containing complex assembly [GO:0043254]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005737; GO:0005829; GO:0005938; GO:0006915; GO:0007165; GO:0008270; GO:0009898; GO:0012506; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0032991; GO:0033209; GO:0034351; GO:0035591; GO:0035631; GO:0038061; GO:0042802; GO:0042981; GO:0043066; GO:0043120; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045087; GO:0045121; GO:0046328; GO:0046625; GO:0048255; GO:0051092; GO:0051865; GO:0065003; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1903265; GO:1990604; GO:2001238
g16626,35.97481302,-1.612708387,0.581537621,-2.773179806,0.005551144,0.019853645,12,38,29,8,0,14,77,53,37,63,99,63,sp,B5DF45,TRAF6_RAT,31.95,482,278,16,19,1359,41,507,2.70E-63,216,B5DF45,reviewed,TRAF6_RAT,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Traf6,Rattus norvegicus (Rat),530,animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; cell development [GO:0048468]; cellular response to angiotensin [GO:1904385]; cellular response to cytokine stimulus [GO:0071345]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; DNA damage response [GO:0006974]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation protein catabolic process at postsynapse [GO:0140252]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0000045; GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002753; GO:0002931; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007254; GO:0007416; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0030316; GO:0031234; GO:0031624; GO:0031663; GO:0031666; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0032991; GO:0033209; GO:0034142; GO:0034450; GO:0035631; GO:0038061; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0045087; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046849; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070301; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:0098696; GO:0098794; GO:0098978; GO:0140252; GO:0140374; GO:1904385; GO:1904996
g14241,893.5735506,0.957902698,0.340599041,2.812405745,0.004917243,0.017986907,1474,549,744,1231,841,1012,924,537,903,619,951,447,sp,Q63486,RRAGA_RAT,90.397,302,28,1,1,906,6,306,0,570,Q63486,reviewed,RRAGA_RAT,Ras-related GTP-binding protein A (Rag A) (RagA) (EC 3.6.5.-),Rraga,Rattus norvegicus (Rat),313,apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization [GO:0008104]; protein localization to lysosome [GO:0061462]; protein localization to membrane [GO:0072657]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0006915; GO:0008104; GO:0009267; GO:0010507; GO:0031625; GO:0031669; GO:0032008; GO:0033209; GO:0034198; GO:0035556; GO:0042593; GO:0042803; GO:0043200; GO:0043495; GO:0046982; GO:0051219; GO:0061462; GO:0071230; GO:0072657; GO:1903432; GO:1904263; GO:1990130; GO:1990131; GO:1990877
g5040,773.4072201,1.326088323,0.297182895,4.462195999,8.11E-06,7.63E-05,1125,754,706,1156,894,777,1098,461,317,602,511,384,sp,Q60803,TRAF3_MOUSE,39.33,567,321,8,82,1779,23,567,9.63E-127,387,Q60803,reviewed,TRAF3_MOUSE,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Traf3 Cap-1 Craf1 Trafamn,Mus musculus (Mouse),567,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0001817; GO:0002224; GO:0005164; GO:0005737; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0050688; GO:0061630; GO:0070534
g5983,5418.909686,3.510431061,0.430808573,8.148470767,3.69E-16,3.00E-14,12393,8691,4064,3005,11900,6823,1531,833,736,1026,1241,1050,sp,Q13490,BIRC2_HUMAN,27.511,229,128,6,208,783,391,618,2.51E-17,84.7,Q13490,reviewed,BIRC2_HUMAN,Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2),BIRC2 API1 MIHB RNF48,Homo sapiens (Human),618,"apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; non-canonical NF-kappaB signal transduction [GO:0038061]; placenta development [GO:0001890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]",GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0045088; GO:0045471; GO:0045595; GO:0050727; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:2000116; GO:2000377
g22024,1348.466282,1.716222771,0.306145973,5.60589694,2.07E-08,3.88E-07,1500,1684,1258,2721,1558,1363,1346,566,523,728,829,714,sp,Q5ZJB4,IKKA_CHICK,40.63,635,362,8,94,1977,43,669,6.86E-163,493,Q5ZJB4,reviewed,IKKA_CHICK,Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA),CHUK IKKA RCJMB04_19h23,Gallus gallus (Chicken),759,cellular response to tumor necrosis factor [GO:0071356]; positive regulation of transcription by RNA polymerase II [GO:0045944]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0002224; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008384; GO:0008385; GO:0033209; GO:0042803; GO:0045944; GO:0046982; GO:0071356
g2565,2891.159556,1.70398463,0.343489488,4.960805752,7.02E-07,8.80E-06,4607,3480,2293,2553,4383,3822,2725,1296,832,2108,1625,1596,sp,Q924T7,RNF31_MOUSE,37.829,608,338,14,931,2715,432,1012,2.84E-110,367,Q924T7,reviewed,RNF31_MOUSE,E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (Putative Ariadne-like ubiquitin ligase) (PAUL) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31),Rnf31 Paul,Mus musculus (Mouse),1066,CD40 signaling pathway [GO:0023035]; defense response to bacterium [GO:0042742]; negative regulation of necroptotic process [GO:0060546]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of xenophagy [GO:1904417]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell receptor signaling pathway [GO:0050852]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0000209; GO:0004842; GO:0005829; GO:0008270; GO:0009898; GO:0016567; GO:0023035; GO:0031625; GO:0033209; GO:0035631; GO:0036435; GO:0042742; GO:0042802; GO:0043123; GO:0043130; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0070530; GO:0071797; GO:0097039; GO:1904417; GO:1990450
g7808,2343.849113,3.722031578,0.580216022,6.414906587,1.41E-10,4.20E-09,4500,4003,1917,1155,4779,4198,415,605,856,235,148,110,sp,Q9Y4K3,TRAF6_HUMAN,45.378,238,127,2,109,816,48,284,1.84E-64,224,Q9Y4K3,reviewed,TRAF6_HUMAN,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6),TRAF6 RNF85,Homo sapiens (Human),522,activation of protein kinase activity [GO:0032147]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; DNA damage response [GO:0006974]; Fc-epsilon receptor signaling pathway [GO:0038095]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0000045; GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002223; GO:0002637; GO:0002726; GO:0002753; GO:0002755; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006974; GO:0007249; GO:0008270; GO:0009898; GO:0010008; GO:0019886; GO:0023035; GO:0030316; GO:0030674; GO:0031234; GO:0031398; GO:0031624; GO:0031663; GO:0031666; GO:0032147; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0032991; GO:0033209; GO:0034138; GO:0034142; GO:0034450; GO:0035631; GO:0035666; GO:0038061; GO:0038095; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045087; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0048471; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:0140374; GO:1904996; GO:2000679
g18407,1156.534239,-2.048106164,0.548115293,-3.736633864,0.0001865,0.001149511,228,240,667,880,208,88,2762,2018,1659,1235,4322,1283,sp,Q9DF58,ILK_CHICK,63.333,450,162,2,1,1341,1,450,0,625,Q9DF58,reviewed,ILK_CHICK,Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (Beta-integrin-linked kinase) (ILK-1) (ILK-2) (p59ILK),ILK ILK1 ILK2,Gallus gallus (Chicken),452,branching involved in ureteric bud morphogenesis [GO:0001658]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; neural precursor cell proliferation [GO:0061351]; outflow tract morphogenesis [GO:0003151]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0000902; GO:0001658; GO:0001934; GO:0003151; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0008284; GO:0010761; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030030; GO:0030513; GO:0033209; GO:0034446; GO:0043123; GO:0043491; GO:0045197; GO:0045669; GO:0045893; GO:0061351; GO:0090263; GO:1900026; GO:2000178
g24035,1983.742197,2.01327021,0.433858848,4.640380669,3.48E-06,3.65E-05,2673,2462,1185,2265,4068,1766,925,707,791,1144,1309,755,sp,Q3ZCC3,TRAF6_BOVIN,32.367,207,126,5,31,651,62,254,9.11E-29,115,Q3ZCC3,reviewed,TRAF6_BOVIN,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),TRAF6,Bos taurus (Bovine),542,DNA damage response [GO:0006974]; innate immune response [GO:0045087]; intracellular signaling cassette [GO:0141124]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0006974; GO:0008270; GO:0031663; GO:0033209; GO:0042981; GO:0043122; GO:0043123; GO:0045087; GO:0051092; GO:0061630; GO:0070534; GO:0141124
g22658,571.182607,-0.552332,0.17765089,-3.109086598,0.001876667,0.008060021,524,423,491,404,227,356,1139,978,474,1008,707,723,sp,Q9VAC5,ADA17_DROME,36.932,352,179,7,49,1005,378,719,1.34E-63,219,Q9VAC5,reviewed,ADA17_DROME,ADAM 17-like protease (EC 3.4.24.-),Tace CG7908,Drosophila melanogaster (Fruit fly),732,commissural neuron axon guidance [GO:0071679]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of programmed cell death [GO:0043068]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0007220; GO:0016020; GO:0033209; GO:0040015; GO:0043068; GO:0046872; GO:0071679; GO:1903427
g22659,355.8535711,-0.61708238,0.192459213,-3.206302111,0.001344527,0.006085951,322,278,349,222,146,165,695,581,358,673,361,519,sp,Q9VAC5,ADA17_DROME,38.849,278,138,8,28,819,6,265,3.59E-48,174,Q9VAC5,reviewed,ADA17_DROME,ADAM 17-like protease (EC 3.4.24.-),Tace CG7908,Drosophila melanogaster (Fruit fly),732,commissural neuron axon guidance [GO:0071679]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of programmed cell death [GO:0043068]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0007220; GO:0016020; GO:0033209; GO:0040015; GO:0043068; GO:0046872; GO:0071679; GO:1903427
g20837,2441.090597,1.664330142,0.28776793,5.78358451,7.31E-09,1.53E-07,3918,2366,2163,2708,2880,4101,1823,1264,1733,1177,1154,1359,sp,P09215,KPCD_RAT,52.525,693,295,7,7,2061,4,670,0,683,P09215,reviewed,KPCD_RAT,Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],Prkcd Pkcd,Rattus norvegicus (Rat),673,apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; post-translational protein modification [GO:0043687]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of phosphorylation [GO:0042325]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; termination of signal transduction [GO:0023021],GO:0001666; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006915; GO:0006974; GO:0006979; GO:0008047; GO:0009410; GO:0009612; GO:0009749; GO:0014070; GO:0016020; GO:0016064; GO:0016363; GO:0018105; GO:0019899; GO:0019901; GO:0023021; GO:0030837; GO:0032869; GO:0032930; GO:0032956; GO:0032963; GO:0034351; GO:0034599; GO:0034644; GO:0035307; GO:0035556; GO:0036019; GO:0042100; GO:0042119; GO:0042149; GO:0042307; GO:0042325; GO:0042542; GO:0042742; GO:0043065; GO:0043200; GO:0043410; GO:0043560; GO:0043687; GO:0045471; GO:0046326; GO:0046627; GO:0046872; GO:0048471; GO:0050732; GO:0051490; GO:0060326; GO:0070301; GO:0070779; GO:0070976; GO:0071447; GO:0090331; GO:0090398; GO:0099524; GO:0106310; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235
g3345,11006.1684,1.591631074,0.459259042,3.465649942,0.000528951,0.002777861,12417,9458,7189,33475,12042,5311,9446,7919,7711,5438,5176,4613,sp,A0A481NSZ4,BPI_SEBSC,30.851,470,316,6,46,1452,10,471,1.59E-68,230,A0A481NSZ4,reviewed,BPI_SEBSC,Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP),BPI LBP,Sebastes schlegelii (Korean rockfish),473,defense response to bacterium [GO:0042742]; innate immune response [GO:0045087],GO:0005615; GO:0008289; GO:0042742; GO:0045087
g7488,5459.565617,0.886944409,0.344238705,2.576538882,0.009979498,0.032071408,5938,3451,4547,7875,6649,5078,5433,4842,4063,3268,4524,5473,sp,Q9JI48,PLAC8_MOUSE,38.596,114,63,2,133,474,6,112,2.48E-17,76.3,Q9JI48,reviewed,PLAC8_MOUSE,Placenta-specific gene 8 protein (Onzin) (Protein C15),Plac8,Mus musculus (Mouse),112,brown fat cell differentiation [GO:0050873]; defense response to bacterium [GO:0042742]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cold [GO:0009409]; transcription by RNA polymerase II [GO:0006366],GO:0003682; GO:0005634; GO:0005654; GO:0006366; GO:0008284; GO:0009409; GO:0040015; GO:0042742; GO:0043066; GO:0045944; GO:0050873; GO:0120162
g18475,982.7510555,-2.216059742,0.566843459,-3.909473962,9.25E-05,0.00063351,281,137,80,279,299,542,1406,3481,1461,2159,503,2583,sp,Q0Q028,DFP3_ANTMY,37.791,172,91,6,1,510,1,158,7.91E-26,101,Q0Q028,reviewed,DFP3_ANTMY,Putative defense protein 3 (DFP-3),,Antheraea mylitta (Tasar silkworm),163,defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087],GO:0005576; GO:0042742; GO:0042832; GO:0045087
g14045,1113.036931,1.849821315,0.355523847,5.203086457,1.96E-07,2.85E-06,1868,853,1048,1055,1543,1993,745,408,451,546,771,579,sp,Q5XJ85,MYD88_DANRE,32.558,129,75,5,1456,1824,138,260,1.47E-08,60.1,Q5XJ85,reviewed,MYD88_DANRE,Myeloid differentiation primary response protein MyD88,myd88,Danio rerio (Zebrafish) (Brachydanio rerio),284,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response to wounding [GO:0090594]; innate immune response [GO:0045087]; monocyte activation [GO:0042117]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; response to molecule of bacterial origin [GO:0002237]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142],GO:0002218; GO:0002237; GO:0002283; GO:0002755; GO:0005737; GO:0005886; GO:0008063; GO:0030593; GO:0034142; GO:0035325; GO:0042117; GO:0042742; GO:0043123; GO:0045087; GO:0050830; GO:0070976; GO:0090594; GO:1901224; GO:1901532; GO:1901534
g11899,732.5988525,2.007372252,0.633517833,3.16861207,0.001531687,0.006793402,2373,2083,916,353,264,738,940,248,742,203,60,96,sp,Q8VI93,OAS3_MOUSE,25.963,701,425,24,4,1965,452,1105,4.66E-43,171,Q8VI93,reviewed,OAS3_MOUSE,"2'-5'-oligoadenylate synthase 3 ((2-5')oligo(A) synthase 3) (2-5A synthase 3) (EC 2.7.7.84) (2',5'-oligoadenylate synthetase-like 10)",Oas3 oasl10,Mus musculus (Mouse),1138,defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060339; GO:0071639; GO:0071650; GO:0071659; GO:2000342
g2677,37046.80892,2.312233727,0.395391725,5.847956805,4.98E-09,1.08E-07,43385,34816,26545,55295,72214,47128,19421,15331,13491,11370,16772,13679,sp,P17676,CEBPB_HUMAN,52.055,73,35,0,646,864,262,334,1.68E-16,82,P17676,reviewed,CEBPB_HUMAN,CCAAT/enhancer-binding protein beta (C/EBP beta) (Liver activator protein) (LAP) (Liver-enriched inhibitory protein) (LIP) (Nuclear factor NF-IL6) (Transcription factor 5) (TCF-5),CEBPB TCF5 PP9092,Homo sapiens (Human),345,acute-phase response [GO:0006953]; brown fat cell differentiation [GO:0050873]; cellular response to amino acid stimulus [GO:0071230]; defense response to bacterium [GO:0042742]; embryonic placenta development [GO:0001892]; granuloma formation [GO:0002432]; hepatocyte proliferation [GO:0072574]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; mammary gland epithelial cell differentiation [GO:0060644]; mammary gland epithelial cell proliferation [GO:0033598]; myeloid cell development [GO:0061515]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of dendritic cell differentiation [GO:2001198]; regulation of DNA-templated transcription [GO:0006355]; regulation of interleukin-6 production [GO:0032675]; regulation of odontoblast differentiation [GO:1901329]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; T-helper 1 cell activation [GO:0035711]; transcription by RNA polymerase II [GO:0006366],GO:0000122; GO:0000779; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001541; GO:0001892; GO:0002432; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0006366; GO:0006953; GO:0006954; GO:0006955; GO:0016363; GO:0019900; GO:0030182; GO:0031490; GO:0032496; GO:0032675; GO:0032753; GO:0033598; GO:0034976; GO:0035035; GO:0035711; GO:0036488; GO:0042130; GO:0042742; GO:0042803; GO:0042826; GO:0043524; GO:0044389; GO:0045595; GO:0045600; GO:0045669; GO:0045670; GO:0045893; GO:0045944; GO:0050729; GO:0050873; GO:0060644; GO:0061515; GO:0070059; GO:0070169; GO:0071230; GO:0072574; GO:0090575; GO:0097421; GO:0120162; GO:0140467; GO:1901329; GO:1990647; GO:1990837; GO:2000120; GO:2001198
g16346,79.83988078,3.047662896,1.151262041,2.6472365,0.008115258,0.026966683,146,554,93,5,5,51,43,17,0,30,0,44,sp,Q8R481,PERL_MESAU,36.033,605,337,22,283,1998,95,682,1.10E-91,304,Q8R481,reviewed,PERL_MESAU,Lactoperoxidase (LPO) (EC 1.11.1.7) (Lacrimal gland peroxidase),LPO,Mesocricetus auratus (Golden hamster),710,defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to oxidative stress [GO:0006979],GO:0001580; GO:0004601; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0020037; GO:0036393; GO:0042742; GO:0046872; GO:0140825
g16630,754.5976924,-0.535307626,0.209641178,-2.553446949,0.010666253,0.03382426,684,881,731,374,258,398,1549,813,854,1193,1110,1058,sp,B9EKI3,TMF1_MOUSE,43.919,740,354,9,1285,3456,392,1086,5.55E-163,515,B9EKI3,reviewed,TMF1_MOUSE,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),Tmf1 Ara160 Gm153,Mus musculus (Mouse),1091,acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; apoptotic process [GO:0006915]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; male gonad development [GO:0008584]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289],GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0006915; GO:0007286; GO:0007289; GO:0008584; GO:0010629; GO:0030317; GO:0030374; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:0071407; GO:1904019; GO:1904036; GO:2000845
g580,847.5842895,2.048156337,0.454506643,4.506328716,6.60E-06,6.39E-05,1330,1215,881,281,1661,1009,801,330,359,318,227,471,sp,Q9V9J3,SRC42_DROME,71.645,462,128,2,157,1533,52,513,0,709,Q9V9J3,reviewed,SRC42_DROME,Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41),Src42A Src41 TK5 CG44128,Drosophila melanogaster (Fruit fly),517,"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]",GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045087; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136; GO:0106016
g12365,370.0836472,2.304336347,0.277518081,8.303373756,1.01E-16,8.61E-15,616,935,430,374,327,532,164,213,139,129,158,96,sp,Q9SAL0,RGLG4_ARATH,54.545,264,105,4,238,987,53,315,3.30E-97,296,Q9SAL0,reviewed,RGLG4_ARATH,E3 ubiquitin-protein ligase RGLG4 (EC 2.3.2.27) (RING domain ligase 4),RGLG4 At1g79380 T8K14.20,Arabidopsis thaliana (Mouse-ear cress),401,defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; response to wounding [GO:0009611],GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0009611; GO:0009867; GO:0042742; GO:0046872
g12643,1335.138348,0.722219875,0.218649128,3.30309973,0.000956224,0.004568962,1692,1566,1144,1795,1114,1067,1419,1240,1257,1036,1249,1069,sp,Q5RAZ4,DHX15_PONAB,81.884,690,115,2,181,2250,115,794,0,1167,Q5RAZ4,reviewed,DHX15_PONAB,ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (DEAH box protein 15),DHX15,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),795,antiviral innate immune response [GO:0140374]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; RNA splicing [GO:0008380],GO:0003724; GO:0003725; GO:0005524; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0016607; GO:0016887; GO:0042742; GO:0043123; GO:0051607; GO:0071008; GO:0140374
g3209,1423.27628,0.712001026,0.203356337,3.501248277,0.000463084,0.002474765,2147,1319,1220,1265,1190,1758,1924,1285,1228,1299,1123,1107,sp,A9JTG5,HOIL1_DANRE,37.931,609,336,10,262,2007,121,714,3.27E-135,416,A9JTG5,reviewed,HOIL1_DANRE,RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog),rbck1 zgc:175152,Danio rerio (Zebrafish) (Brachydanio rerio),714,defense response to bacterium [GO:0042742]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039],GO:0004842; GO:0042742; GO:0043123; GO:0043130; GO:0043161; GO:0046872; GO:0048701; GO:0071600; GO:0071797; GO:0097039
g3588,127.7170268,-2.426945764,0.770987091,-3.147842282,0.001644804,0.007211803,26,24,116,18,8,31,648,63,60,55,83,751,sp,Q9JI48,PLAC8_MOUSE,33.333,111,68,2,145,477,1,105,6.89E-15,70.1,Q9JI48,reviewed,PLAC8_MOUSE,Placenta-specific gene 8 protein (Onzin) (Protein C15),Plac8,Mus musculus (Mouse),112,brown fat cell differentiation [GO:0050873]; defense response to bacterium [GO:0042742]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cold [GO:0009409]; transcription by RNA polymerase II [GO:0006366],GO:0003682; GO:0005634; GO:0005654; GO:0006366; GO:0008284; GO:0009409; GO:0040015; GO:0042742; GO:0043066; GO:0045944; GO:0050873; GO:0120162
g3589,68.06847764,-2.068839309,0.620459837,-3.334364587,0.000854945,0.004156572,29,46,32,24,6,9,323,104,49,88,17,277,sp,Q9JI48,PLAC8_MOUSE,37.615,109,62,2,46,372,3,105,4.32E-18,77,Q9JI48,reviewed,PLAC8_MOUSE,Placenta-specific gene 8 protein (Onzin) (Protein C15),Plac8,Mus musculus (Mouse),112,brown fat cell differentiation [GO:0050873]; defense response to bacterium [GO:0042742]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cold [GO:0009409]; transcription by RNA polymerase II [GO:0006366],GO:0003682; GO:0005634; GO:0005654; GO:0006366; GO:0008284; GO:0009409; GO:0040015; GO:0042742; GO:0043066; GO:0045944; GO:0050873; GO:0120162
g6741,35366.41415,3.544719061,0.525549681,6.744783962,1.53E-11,5.54E-10,49234,22382,23373,142727,52322,18315,9592,7652,6979,7688,4528,4904,sp,Q5RBP9,MPEG1_PONAB,41.548,633,320,10,19,1887,8,600,1.82E-160,484,Q5RBP9,reviewed,MPEG1_PONAB,"Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2) [Cleaved into: Macrophage-expressed gene 1 protein, processed form]",MPEG1,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),716,adaptive immune response [GO:0002250]; antibacterial innate immune response [GO:0140367]; antigen processing and presentation of exogenous peptide antigen [GO:0002478]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendritic cell antigen processing and presentation [GO:0002468],GO:0002250; GO:0002468; GO:0002478; GO:0022829; GO:0030670; GO:0031410; GO:0042590; GO:0042742; GO:0045335; GO:0050829; GO:0050830; GO:0061474; GO:0140367
g12481,537.0536861,0.75242072,0.242399153,3.104056715,0.001908867,0.008178853,830,577,471,446,386,740,651,507,600,521,293,371,sp,P81799,NAGK_RAT,52.632,342,159,2,13,1032,2,342,1.71E-115,341,P81799,reviewed,NAGK_RAT,N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase) (Muramyl dipeptide kinase) (EC 2.7.1.-) (N-acetyl-D-mannosamine kinase) (EC 2.7.1.60),Nagk,Rattus norvegicus (Rat),343,defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylneuraminate catabolic process [GO:0019262]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; response to muramyl dipeptide [GO:0032495],GO:0005524; GO:0006044; GO:0009384; GO:0019262; GO:0032495; GO:0042742; GO:0045087; GO:0045127; GO:0070434; GO:0160047
g17238,828.169033,2.050324614,0.483702461,4.238813695,2.25E-05,0.000183661,1234,611,630,536,1860,1045,444,429,415,228,499,287,sp,F6R2G2,NLRC4_XENTR,24.377,361,194,14,688,1683,245,555,1.75E-07,59.3,F6R2G2,reviewed,NLRC4_XENTR,NLR family CARD domain-containing protein 4 (Ice protease-activating factor) (Ipaf),nlrc4 ipaf TGas028l14.1,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),997,apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981],GO:0005524; GO:0005829; GO:0006915; GO:0006954; GO:0016045; GO:0042742; GO:0042981; GO:0045087
g15854,1453.260119,2.991674456,0.496668963,6.023477772,1.71E-09,4.11E-08,2120,1646,1032,1967,3483,1289,435,351,469,439,111,556,sp,P20749,BCL3_HUMAN,46.371,248,122,5,793,1527,121,360,6.20E-60,207,P20749,reviewed,BCL3_HUMAN,B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3),BCL3 BCL4 D19S37,Homo sapiens (Human),454,"antimicrobial humoral response [GO:0019730]; canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]",GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0070231; GO:0070233; GO:0140297; GO:1901222
g6234,57.8551162,2.477350422,0.903521071,2.741884503,0.006108782,0.021498671,105,266,70,10,0,116,35,14,7,9,14,51,sp,F1NV61,CASP7_CHICK,46.125,271,134,3,277,1065,43,309,2.64E-78,246,F1NV61,reviewed,CASP7_CHICK,Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7,Gallus gallus (Chicken),309,defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508],GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0042742; GO:0043525; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686
g2468,3084.514576,1.908167056,0.369371164,5.165988154,2.39E-07,3.41E-06,4439,4796,3129,3085,2665,6531,4014,1813,784,1818,1138,700,sp,Q8R151,ZNFX1_MOUSE,43.643,1054,504,19,3316,6351,897,1902,0,833,Q8R151,reviewed,ZNFX1_MOUSE,NFX1-type zinc finger-containing protein 1,Znfx1,Mus musculus (Mouse),1909,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607
g2469,282.7934256,1.579607798,0.48185393,3.278188056,0.001044758,0.00494097,335,267,295,201,265,718,296,131,74,133,334,78,sp,Q8R151,ZNFX1_MOUSE,43.886,1014,488,17,1,2931,933,1902,0,789,Q8R151,reviewed,ZNFX1_MOUSE,NFX1-type zinc finger-containing protein 1,Znfx1,Mus musculus (Mouse),1909,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607
g24110,1070.157444,1.480151839,0.334657015,4.422892018,9.74E-06,8.96E-05,1448,1027,1083,1317,1355,1386,931,743,830,743,241,683,sp,Q5R8Z8,RAB14_PONAB,90.233,215,21,0,1,645,1,215,6.46E-147,410,Q5R8Z8,reviewed,RAB14_PONAB,Ras-related protein Rab-14 (EC 3.6.5.2),RAB14,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),215,defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; phagosome maturation [GO:0090382]; protein transport [GO:0015031]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880],GO:0000139; GO:0003924; GO:0005525; GO:0005802; GO:0005829; GO:0006895; GO:0008543; GO:0015031; GO:0019003; GO:0031901; GO:0032456; GO:0032880; GO:0042742; GO:0045335; GO:0045995; GO:0055037; GO:0090382
g16225,63.90367889,3.957882269,1.114334679,3.551789552,0.000382621,0.002113608,160,44,69,12,102,194,51,0,0,9,0,10,sp,Q04721,NOTC2_HUMAN,26.503,366,203,21,58,1047,728,1063,7.32E-07,57,Q04721,reviewed,NOTC2_HUMAN,Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)],NOTCH2,Homo sapiens (Human),2471,animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060],GO:0000122; GO:0000139; GO:0000987; GO:0001228; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204
g4581,4885.480336,1.066509226,0.286381917,3.724080193,0.000196029,0.001198824,6773,3881,4243,6467,5721,4927,4675,3373,4540,3580,3639,3081,sp,Q6NYB7,RAB1A_RAT,89.268,205,22,0,1,615,1,205,5.67E-137,384,Q6NYB7,reviewed,RAB1A_RAT,Ras-related protein Rab-1A (EC 3.6.5.2),Rab1A Rab1,Rattus norvegicus (Rat),205,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496],GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0012505; GO:0016477; GO:0030252; GO:0032402; GO:0032482; GO:0032757; GO:0034446; GO:0042470; GO:0042742; GO:0043025; GO:0047496; GO:0090110; GO:0098793; GO:1903020
g8842,938.2816815,3.029094424,0.795931899,3.805720602,0.000141392,0.000910671,4444,3890,945,300,62,525,697,471,182,112,31,144,sp,A7X4K1,WAP1_PHIOL,40.26,77,43,2,142,363,55,131,4.58E-09,53.9,A7X4K1,reviewed,WAP1_PHIOL,Waprin-Phi1,,Philodryas olfersii (Green snake),134,defense response to bacterium [GO:0042742]; disruption of cell wall in another organism [GO:0044278],GO:0004867; GO:0005576; GO:0005615; GO:0042742; GO:0044278
g21382,561.2039504,1.198318667,0.350165756,3.422146932,0.000621287,0.003174511,940,324,504,522,801,625,699,414,397,400,297,342,sp,Q8WWQ8,STAB2_HUMAN,38.346,665,388,12,4,1971,1538,2189,1.44E-129,436,Q8WWQ8,reviewed,STAB2_HUMAN,"Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)]",STAB2 FEEL2 FELL FEX2 HARE,Homo sapiens (Human),2551,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830
g2565,2891.159556,1.70398463,0.343489488,4.960805752,7.02E-07,8.80E-06,4607,3480,2293,2553,4383,3822,2725,1296,832,2108,1625,1596,sp,Q924T7,RNF31_MOUSE,37.829,608,338,14,931,2715,432,1012,2.84E-110,367,Q924T7,reviewed,RNF31_MOUSE,E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (Putative Ariadne-like ubiquitin ligase) (PAUL) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31),Rnf31 Paul,Mus musculus (Mouse),1066,CD40 signaling pathway [GO:0023035]; defense response to bacterium [GO:0042742]; negative regulation of necroptotic process [GO:0060546]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of xenophagy [GO:1904417]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell receptor signaling pathway [GO:0050852]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0000209; GO:0004842; GO:0005829; GO:0008270; GO:0009898; GO:0016567; GO:0023035; GO:0031625; GO:0033209; GO:0035631; GO:0036435; GO:0042742; GO:0042802; GO:0043123; GO:0043130; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0070530; GO:0071797; GO:0097039; GO:1904417; GO:1990450
g2563,771.6386589,1.689778627,0.286867963,5.89044035,3.85E-09,8.51E-08,1197,1006,766,664,1094,986,784,395,288,479,356,447,sp,Q96EP0,RNF31_HUMAN,33.158,190,123,2,370,927,5,194,3.47E-23,105,Q96EP0,reviewed,RNF31_HUMAN,E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) (Zinc in-between-RING-finger ubiquitin-associated domain protein),RNF31 ZIBRA,Homo sapiens (Human),1072,CD40 signaling pathway [GO:0023035]; defense response to bacterium [GO:0042742]; negative regulation of necroptotic process [GO:0060546]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of xenophagy [GO:1904417]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852],GO:0000209; GO:0004842; GO:0005829; GO:0008270; GO:0009898; GO:0023035; GO:0031625; GO:0035631; GO:0036435; GO:0042742; GO:0042802; GO:0043123; GO:0043130; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0070530; GO:0071797; GO:0097039; GO:1903955; GO:1904417; GO:1990450
g15687,15105.61694,2.902447917,0.472564809,6.141904479,8.15E-10,2.10E-08,25530,11440,9278,13943,39182,17132,6180,4590,3899,4473,3772,3383,sp,Q9Z2F6,BCL3_MOUSE,30.859,256,153,6,151,918,125,356,4.78E-24,104,Q9Z2F6,reviewed,BCL3_MOUSE,B-cell lymphoma 3 protein homolog (BCL-3),Bcl3,Mus musculus (Mouse),448,"antimicrobial humoral response [GO:0019730]; canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]",GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006606; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032996; GO:0033257; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0045064; GO:0045727; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0070231; GO:0070233; GO:0140297; GO:1901222
g1388,188.8421604,4.172888553,1.578208847,2.644066126,0.008191665,0.027195545,156,1098,299,0,0,490,0,88,16,0,23,7,sp,Q9ULY5,CLC4E_HUMAN,34.127,126,72,5,787,1146,87,207,3.35E-11,67.4,Q9ULY5,reviewed,CLC4E_HUMAN,C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (MINCLE),CLEC4E CLECSF9 MINCLE UNQ218/PRO244,Homo sapiens (Human),219,antifungal innate immune response [GO:0061760]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production [GO:0001819]; T cell differentiation involved in immune response [GO:0002292],GO:0001819; GO:0001891; GO:0002221; GO:0002292; GO:0005509; GO:0005886; GO:0009897; GO:0016020; GO:0030246; GO:0030670; GO:0038094; GO:0038187; GO:0042742; GO:0042995; GO:0045087; GO:0051861; GO:0061760
g17537,3766.244346,5.979602073,0.73827816,8.099389089,5.52E-16,4.30E-14,5559,11793,5636,626,4794,9398,36,134,79,29,425,71,sp,F1NV61,CASP7_CHICK,39.564,321,180,3,61,1023,3,309,4.25E-79,247,F1NV61,reviewed,CASP7_CHICK,Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7,Gallus gallus (Chicken),309,defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508],GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0042742; GO:0043525; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686
g20844,14656.7146,8.17002156,0.706544528,11.56334985,6.32E-31,3.56E-28,37138,8225,11472,1189,31684,45483,167,109,86,37,187,142,sp,O75179,ANR17_HUMAN,36.134,119,76,0,259,615,268,386,5.21E-13,75.1,O75179,reviewed,ANR17_HUMAN,Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16),ANKRD17 GTAR KIAA0697,Homo sapiens (Human),2603,blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],GO:0000785; GO:0001673; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246
g19986,543.4457571,1.092890347,0.370101929,2.952944208,0.003147588,0.012403475,623,314,423,891,723,495,573,455,357,371,456,323,sp,F1MHT9,NLRC4_BOVIN,24.889,450,278,20,412,1686,93,507,1.52E-17,91.7,F1MHT9,reviewed,NLRC4_BOVIN,NLR family CARD domain-containing protein 4 (Ice protease-activating factor) (Ipaf),NLRC4 IPAF,Bos taurus (Bovine),1017,activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; protein homooligomerization [GO:0051260]; pyroptotic inflammatory response [GO:0070269]; regulation of apoptotic process [GO:0042981],GO:0002218; GO:0005524; GO:0005829; GO:0006915; GO:0006954; GO:0016045; GO:0032731; GO:0042742; GO:0042981; GO:0045087; GO:0051260; GO:0070269; GO:0072557
g6532,12487.87756,0.895595194,0.238220511,3.759521752,0.000170238,0.001066028,13585,18490,11925,11332,11425,14617,10744,8028,9401,10978,10286,13183,sp,P62282,RS11_RAT,81.132,159,25,5,1,465,1,158,1.59E-87,255,P62282,reviewed,RS11_RAT,Small ribosomal subunit protein uS17 (40S ribosomal protein S11),Rps11,Rattus norvegicus (Rat),158,osteoblast differentiation [GO:0001649]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],GO:0001649; GO:0003735; GO:0005730; GO:0006412; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0032040; GO:0042274; GO:0045202
g5593,16103.45693,1.078256824,0.219783081,4.90600468,9.30E-07,1.13E-05,18805,19309,14643,18062,17363,18923,15989,12198,12036,12260,10187,12875,sp,Q4R8Z2,RL13A_MACFA,62.755,196,73,0,34,621,5,200,6.58E-90,265,Q4R8Z2,reviewed,RL13A_MACFA,Large ribosomal subunit protein uL13 (60S ribosomal protein L13a),RPL13A QtsA-11103,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),203,negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412],GO:0003729; GO:0003735; GO:0006412; GO:0017148; GO:0022625; GO:0097452; GO:1901194
g10884,6690.414654,0.979568377,0.253339347,3.866625494,0.000110352,0.000737053,7299,10133,5577,7010,5980,8420,5944,4247,4441,6812,4141,7083,sp,Q9NB33,RL44_OCHTR,79.808,104,21,0,1,312,1,104,1.63E-55,170,Q9NB33,reviewed,RL44_OCHTR,Large ribosomal subunit protein eL42 (60S ribosomal protein L44),RpL44,Ochlerotatus triseriatus (Eastern treehole mosquito) (Aedes triseriatus),104,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412; GO:1990904
g6606,9147.076113,0.984752852,0.241568756,4.076490966,4.57E-05,0.000340535,11193,11708,8086,10185,8813,10444,7456,6273,6615,7639,9424,6494,sp,P23358,RL12_RAT,77.301,163,37,0,1,489,1,163,4.93E-93,270,P23358,reviewed,RL12_RAT,Large ribosomal subunit protein uL11 (60S ribosomal protein L12),Rpl12,Rattus norvegicus (Rat),165,positive regulation of translational elongation [GO:0045901]; translation [GO:0006412],GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0006412; GO:0014069; GO:0022625; GO:0022626; GO:0045202; GO:0045901; GO:0070180
g7952,10566.94532,0.897418761,0.250638062,3.580536629,0.000342889,0.001925964,10999,16055,11199,11001,8341,12274,10955,7864,7787,11779,4352,11524,sp,G1SNY0,RL27A_RABIT,79.72,143,28,1,22,447,6,148,8.77E-64,194,G1SNY0,reviewed,RL27A_RABIT,Large ribosomal subunit protein uL15 (60S ribosomal protein L27a),RPL27A,Oryctolagus cuniculus (Rabbit),148,translation [GO:0006412],GO:0003735; GO:0006412; GO:0022625
g20093,13383.63629,1.118949068,0.265045938,4.221717471,2.42E-05,0.000195507,14964,15915,11759,15594,14815,16252,9702,8378,10597,11785,8483,11579,sp,Q02543,RL18A_HUMAN,70.455,176,51,1,1,525,1,176,5.35E-86,253,Q02543,reviewed,RL18A_HUMAN,Large ribosomal subunit protein eL20 (60S ribosomal protein L18a),RPL18A,Homo sapiens (Human),176,cytoplasmic translation [GO:0002181]; translation [GO:0006412],GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626
g18063,32.21448853,-1.507549047,0.476272415,-3.165308338,0.001549187,0.006855855,14,22,16,15,0,24,75,52,35,54,75,57,sp,Q8BX17,GEMI5_MOUSE,40.413,678,329,15,16,1956,8,641,7.15E-160,501,Q8BX17,reviewed,GEMI5_MOUSE,Gem-associated protein 5 (Gemin5),Gemin5,Mus musculus (Mouse),1502,regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412],GO:0000340; GO:0000387; GO:0003730; GO:0005634; GO:0005829; GO:0006412; GO:0006417; GO:0017069; GO:0030619; GO:0030621; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0097504
g5662,61.54747645,-0.854075689,0.297621585,-2.869669847,0.004109006,0.015487725,42,53,65,23,11,44,141,70,84,122,78,95,sp,Q2HJI0,RM19_BOVIN,46.226,212,97,2,37,672,22,216,3.42E-58,189,Q2HJI0,reviewed,RM19_BOVIN,"Large ribosomal subunit protein bL19m (39S ribosomal protein L19, mitochondrial) (L19mt) (MRP-L19)",MRPL19,Bos taurus (Bovine),292,translation [GO:0006412],GO:0003735; GO:0005743; GO:0005762; GO:0006412
g6343,7.345948569,-3.292160774,1.347557907,-2.443056998,0.014563437,0.043528709,2,6,0,0,0,0,43,11,25,22,0,6,sp,Q6PQD5,ATM_PIG,37.202,336,192,9,7,978,1095,1423,4.97E-52,189,Q6PQD5,reviewed,ATM_PIG,Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated homolog) (A-T mutated homolog),ATM,Sus scrofa (Pig),3057,DNA damage checkpoint signaling [GO:0000077]; double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of TORC1 signaling [GO:1904262]; pexophagy [GO:0000425]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of primary metabolic process [GO:0080090]; response to ionizing radiation [GO:0010212]; signal transduction in response to DNA damage [GO:0042770]; telomere maintenance [GO:0000723]; translation [GO:0006412],GO:0000077; GO:0000425; GO:0000723; GO:0002331; GO:0003677; GO:0003735; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005782; GO:0005813; GO:0005840; GO:0006302; GO:0006412; GO:0006468; GO:0007094; GO:0008630; GO:0010212; GO:0016303; GO:0031410; GO:0035861; GO:0035979; GO:0042770; GO:0046777; GO:0071044; GO:0080090; GO:0106310; GO:1904262
g12249,9365.654672,0.803253876,0.257781491,3.116026179,0.00183306,0.007904941,11593,10309,7314,11035,8432,10459,8548,6572,7334,7348,10607,8286,sp,P13732,RL22_TRIGR,82.653,98,17,0,88,381,25,122,3.14E-40,134,P13732,reviewed,RL22_TRIGR,Large ribosomal subunit protein eL22 (60S ribosomal protein L22) (Development-specific protein 217),RPL22,Tripneustes gratilla (Hawaian sea urchin) (Echinus gratilla),130,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412; GO:1990904
g22899,86928.25112,0.833826398,0.27322028,3.051846659,0.002274383,0.009455375,100763,75612,69765,104021,91140,98715,90689,73048,76898,60565,84687,64827,sp,P08736,EF1A1_DROME,83.333,462,76,1,1,1383,1,462,0,807,P08736,reviewed,EF1A1_DROME,Elongation factor 1-alpha 1 (EF-1-alpha-1) (50 kDa female-specific protein),eEF1alpha1 Ef1alpha48D EF1B F1 CG8280,Drosophila melanogaster (Fruit fly),463,translation [GO:0006412]; translational elongation [GO:0006414],GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414
g16638,3315.794203,0.645337346,0.205196873,3.144966758,0.001661057,0.007274229,3194,4752,3151,3266,2539,3570,3421,2861,2952,3667,2233,3624,sp,P27659,RL3_MOUSE,87.013,77,10,0,1,231,1,77,3.56E-42,144,P27659,reviewed,RL3_MOUSE,Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (J1 protein),Rpl3,Mus musculus (Mouse),403,cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412],GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0008097; GO:0022625; GO:0045202; GO:0071353
g8470,97.17913411,-0.990114342,0.343375624,-2.883473007,0.003933164,0.01489337,109,45,89,64,14,39,223,107,125,198,187,115,sp,P82924,RT30_BOVIN,30.556,432,270,10,1,1230,1,424,1.06E-53,187,P82924,reviewed,RT30_BOVIN,"Large ribosomal subunit protein mL65 (28S ribosomal protein S30, mitochondrial) (MRP-S30) (S30mt)",MRPS30,Bos taurus (Bovine),435,translation [GO:0006412],GO:0003735; GO:0005743; GO:0005762; GO:0006412
g16570,12676.62257,0.626006657,0.261477606,2.394111937,0.016660663,0.048527274,15585,23201,13888,10143,6408,12820,11790,10113,14933,10247,8445,15662,sp,Q90YS3,RS2_ICTPU,89.732,224,23,0,118,789,39,262,6.42E-151,426,Q90YS3,reviewed,RS2_ICTPU,Small ribosomal subunit protein uS5 (40S ribosomal protein S2),rps2,Ictalurus punctatus (Channel catfish) (Silurus punctatus),277,translation [GO:0006412],GO:0003723; GO:0003735; GO:0005730; GO:0006412; GO:0022627
g21796,14396.64259,0.661671638,0.22166168,2.985051983,0.002835301,0.011424131,15319,16370,13476,15278,12501,14943,14954,11878,12627,12369,16899,11332,sp,P63245,RACK1_RAT,80.769,312,60,0,1,936,1,312,0,540,P63245,reviewed,RACK1_RAT,"Small ribosomal subunit protein RACK1 (Guanine nucleotide-binding protein subunit beta-2-like 1) (Receptor for activated C kinase) (Receptor of activated protein C kinase 1) (Receptor of activated protein kinase C 1) [Cleaved into: Small ribosomal subunit protein RACK1, N-terminally processed (Receptor of activated protein C kinase 1, N-terminally processed)]",Rack1 Gnb2l1,Rattus norvegicus (Rat),317,cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein ubiquitination [GO:0016567]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]; translation [GO:0006412],GO:0001649; GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006412; GO:0007205; GO:0007369; GO:0008047; GO:0008200; GO:0008656; GO:0010629; GO:0015935; GO:0016020; GO:0016567; GO:0017148; GO:0019899; GO:0019903; GO:0030178; GO:0030292; GO:0030308; GO:0030332; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032436; GO:0032880; GO:0033137; GO:0035591; GO:0042169; GO:0042803; GO:0042998; GO:0043005; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043473; GO:0043547; GO:0044297; GO:0045182; GO:0045879; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051434; GO:0051726; GO:0051898; GO:0051901; GO:0071333; GO:0071363; GO:0072344; GO:0106070; GO:1903076; GO:1903751; GO:1990630; GO:2000114; GO:2000543; GO:2001244
g5860,19093.54831,0.912719971,0.227856909,4.00567169,6.18E-05,0.000444643,22478,26624,16098,18263,19182,20989,20423,14693,14320,20281,10919,16740,sp,Q90YS0,RS4_ICTPU,79.923,259,52,0,1,777,1,259,3.75E-160,447,Q90YS0,reviewed,RS4_ICTPU,Small ribosomal subunit protein eS4 (40S ribosomal protein S4),rps4,Ictalurus punctatus (Channel catfish) (Silurus punctatus),263,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412; GO:0019843; GO:1990904
g18494,10009.54356,0.968372373,0.293023549,3.304759548,0.000950579,0.004546807,10841,12488,8243,10219,10700,12189,10258,7375,8119,10377,3824,9834,sp,Q4R4Z6,RS3A_MACFA,81.633,98,17,1,1,291,1,98,1.75E-43,145,Q4R4Z6,reviewed,RS3A_MACFA,Small ribosomal subunit protein eS1 (40S ribosomal protein S3a),RPS3A QnpA-15704,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),264,cell differentiation [GO:0030154]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],GO:0003735; GO:0005730; GO:0006412; GO:0022627; GO:0030154; GO:0032040; GO:0042274; GO:1990904
g18493,12906.68431,0.888277736,0.258913009,3.430796075,0.000601813,0.003096925,14573,15115,9351,13375,13607,15626,12673,9178,9935,11094,10578,12035,sp,Q6PBY1,RS3A_DANRE,71.613,155,44,0,1,465,113,267,4.93E-75,228,Q6PBY1,reviewed,RS3A_DANRE,Small ribosomal subunit protein eS1 (40S ribosomal protein S3a),rps3a,Danio rerio (Zebrafish) (Brachydanio rerio),267,chordate embryonic development [GO:0043009]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0022627; GO:0032040; GO:0042274; GO:0043009
g1311,2027.707404,1.557045233,0.442708949,3.517085515,0.000436313,0.002354708,3010,1899,1596,3783,3055,1028,2436,979,568,2075,1097,764,sp,Q7T3T8,ZAR1_DANRE,41.837,98,54,2,19,309,230,325,9.49E-20,84.7,Q7T3T8,reviewed,ZAR1_DANRE,Zygote arrest protein 1,zar1,Danio rerio (Zebrafish) (Brachydanio rerio),329,negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of oogenesis [GO:1905881]; translation [GO:0006412],GO:0003729; GO:0005737; GO:0006412; GO:0017148; GO:0030371; GO:0032991; GO:0036464; GO:0046872; GO:0048477; GO:1905881
g23633,8677.181335,1.189700243,0.368240318,3.230771279,0.001234567,0.005667827,9964,11277,7620,10249,9387,10669,8842,5657,6355,8363,1581,8503,sp,P17702,RL28_RAT,57.143,133,56,1,130,528,2,133,1.26E-37,129,P17702,reviewed,RL28_RAT,Large ribosomal subunit protein eL28 (60S ribosomal protein L28),Rpl28,Rattus norvegicus (Rat),137,translation [GO:0006412],GO:0003735; GO:0005737; GO:0006412; GO:0022625; GO:0022626; GO:0030425; GO:0036464; GO:0044297; GO:0045202
g22795,26523.48762,0.797462219,0.222133868,3.590007345,0.000330669,0.001866618,29687,33996,22783,25119,24640,31028,25688,18543,21654,26546,22312,25215,sp,Q8WQI5,RS8_SPOFR,77.404,208,47,0,1,624,1,208,5.35E-110,316,Q8WQI5,reviewed,RS8_SPOFR,Small ribosomal subunit protein eS8 (40S ribosomal protein S8),RpS8,Spodoptera frugiperda (Fall armyworm),208,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412]",GO:0000462; GO:0003735; GO:0005730; GO:0006412; GO:0016020; GO:0022627; GO:0032040; GO:0042274
g17927,11073.57315,1.070317711,0.237374051,4.508992066,6.51E-06,6.32E-05,13148,14281,9062,12154,11368,13877,9597,7184,8041,9222,8085,9476,sp,Q9IA76,RL31_PAROL,81.356,118,22,0,7,360,5,122,1.93E-66,199,Q9IA76,reviewed,RL31_PAROL,Large ribosomal subunit protein eL31 (60S ribosomal protein L31),rpl31,Paralichthys olivaceus (Bastard halibut) (Hippoglossus olivaceus),124,translation [GO:0006412],GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:1990904
g628,132.3763234,-1.045978632,0.408164185,-2.562641875,0.010387914,0.033110328,45,85,110,152,14,55,272,227,217,249,168,175,sp,Q6AZN4,RM15_XENLA,50,300,123,4,1,831,1,296,7.35E-97,289,Q6AZN4,reviewed,RM15_XENLA,"Large ribosomal subunit protein uL15m (39S ribosomal protein L15, mitochondrial) (L15mt) (MRP-L15)",mrpl15,Xenopus laevis (African clawed frog),296,translation [GO:0006412],GO:0003735; GO:0005762; GO:0006412
g10281,11591.27992,1.155904667,0.254642624,4.539321213,5.64E-06,5.57E-05,14294,16142,9607,12242,12522,14018,9306,7784,9421,10384,5812,9331,sp,P61354,RL27_RAT,75.735,136,33,0,1,408,1,136,1.05E-72,216,P61354,reviewed,RL27_RAT,Large ribosomal subunit protein eL27 (60S ribosomal protein L27),Rpl27,Rattus norvegicus (Rat),136,response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412],GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005840; GO:0006364; GO:0006412; GO:0022625; GO:0022626; GO:0045202; GO:0098556; GO:1904044; GO:1990904
g17889,65.61578785,-1.510892916,0.552680372,-2.733755335,0.006261655,0.021955332,22,39,41,52,0,32,158,112,136,166,67,82,sp,Q58DV5,RM30_BOVIN,49.533,107,53,1,145,462,51,157,2.01E-24,96.3,Q58DV5,reviewed,RM30_BOVIN,"Large ribosomal subunit protein uL30m (39S ribosomal protein L30, mitochondrial) (L30mt) (MRP-L30)",MRPL30,Bos taurus (Bovine),161,translation [GO:0006412],GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412
g18064,67.93039567,-0.738863029,0.272293218,-2.713483037,0.006657998,0.023053892,49,55,44,38,38,34,117,111,96,156,80,61,sp,Q8TEQ6,GEMI5_HUMAN,28.341,621,367,11,493,2325,841,1393,9.82E-62,234,Q8TEQ6,reviewed,GEMI5_HUMAN,Gem-associated protein 5 (Gemin5),GEMIN5,Homo sapiens (Human),1508,"mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]",GO:0000340; GO:0000387; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016020; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0065003; GO:0097504
g4288,8430.540375,0.966822434,0.29661044,3.259569804,0.001115813,0.005222272,9298,9711,5784,10188,9337,9636,7148,4875,6755,7371,7997,6750,sp,P62861,RS30_HUMAN,59.398,133,54,0,1,399,1,133,9.18E-47,150,P62861,reviewed,RS30_HUMAN,Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein (FAU ubiquitin like and ribosomal protein S30 fusion) [Cleaved into: Ubiquitin-like protein FUBI; Small ribosomal subunit protein eS30 (40S ribosomal protein S30)],FAU,Homo sapiens (Human),133,antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; translation [GO:0006412],GO:0002181; GO:0002227; GO:0003723; GO:0003735; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0015935; GO:0019731; GO:0022626; GO:0022627; GO:0050830; GO:0061844
g4123,10805.53159,1.059171921,0.247637307,4.27710968,1.89E-05,0.000158192,12889,13308,8617,12299,11695,12635,10741,7829,8385,8468,5972,9771,sp,P79781,RS27A_CHICK,96.032,126,5,0,1,378,1,126,5.72E-58,179,P79781,reviewed,RS27A_CHICK,Ubiquitin-ribosomal protein eS31 fusion protein (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; Small ribosomal subunit protein eS31 (40S ribosomal protein S27a)],RPS27A UBA80,Gallus gallus (Chicken),156,modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0016567; GO:0019941; GO:0022627; GO:0031386; GO:0031625; GO:0032040; GO:0042274; GO:0046872
g22484,450.1030864,1.378304025,0.309608834,4.451759364,8.52E-06,7.96E-05,876,1024,606,253,356,372,581,199,293,362,208,258,sp,Q13310,PABP4_HUMAN,42.667,375,158,13,157,1167,100,455,2.67E-76,252,Q13310,reviewed,PABP4_HUMAN,Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP),PABPC4 APP1 PABP4,Homo sapiens (Human),644,blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412],GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0006412; GO:0007596; GO:0008143; GO:0008266; GO:0010494; GO:0043488; GO:0061515; GO:1990904
g4651,103.1045994,-2.115825779,0.439774511,-4.811160555,1.50E-06,1.72E-05,52,52,25,16,27,28,100,220,241,167,313,112,sp,Q8N5C6,SRBD1_HUMAN,45.879,813,401,9,25,2400,199,993,0,693,Q8N5C6,reviewed,SRBD1_HUMAN,S1 RNA-binding domain-containing protein 1,SRBD1,Homo sapiens (Human),995,nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412],GO:0003729; GO:0003735; GO:0006139; GO:0006412
g8184,8285.680597,1.289497785,0.314624953,4.098523573,4.16E-05,0.00031201,10723,9821,5108,10740,10347,9812,5790,5080,7009,6047,4937,5640,sp,P47772,RS13_ICTPU,80.124,161,22,1,1,483,1,151,5.16E-89,259,P47772,reviewed,RS13_ICTPU,Small ribosomal subunit protein uS15 (40S ribosomal protein S13),rps13,Ictalurus punctatus (Channel catfish) (Silurus punctatus),151,translation [GO:0006412],GO:0003735; GO:0005730; GO:0006412; GO:0022627; GO:0070181
g9336,10861.06428,0.817615737,0.213122719,3.836361225,0.000124871,0.000818279,13499,15708,9264,10289,9268,11994,10357,7545,8077,10249,10184,10244,sp,P31674,RS15_ORYSJ,82.677,127,22,0,64,444,28,154,1.75E-74,222,P31674,reviewed,RS15_ORYSJ,Small ribosomal subunit protein uS19 (40S ribosomal protein S15),RPS15 Os07g0184300 LOC_Os07g08660 OJ1046_F10.119,Oryza sativa subsp. japonica (Rice),154,ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627
g8522,10718.82258,0.82498213,0.288402383,2.86052466,0.004229407,0.015832421,11514,11664,7696,10693,11948,12527,9451,8732,7890,12175,7085,10650,sp,G1TU13,RS17_RABIT,90.517,116,11,0,1,348,1,116,1.00E-73,218,G1TU13,reviewed,RS17_RABIT,Small ribosomal subunit protein eS17 (40S ribosomal protein S17),RPS17,Oryctolagus cuniculus (Rabbit),135,translation [GO:0006412],GO:0003735; GO:0005730; GO:0006412; GO:0022626; GO:1990904
g11006,967.3006128,1.273667338,0.323033734,3.942830745,8.05E-05,0.000559112,1374,1038,863,934,1430,877,1186,599,659,741,367,706,sp,Q8BWW4,LARP4_MOUSE,47.771,314,125,8,64,975,10,294,9.88E-74,260,Q8BWW4,reviewed,LARP4_MOUSE,La-related protein 4 (La ribonucleoprotein domain family member 4),Larp4,Mus musculus (Mouse),719,cytoskeleton organization [GO:0007010]; positive regulation of translation [GO:0045727]; regulation of cell morphogenesis [GO:0022604]; translation [GO:0006412],GO:0003730; GO:0005829; GO:0006412; GO:0007010; GO:0010494; GO:0022604; GO:0045727
g15800,10333.23026,0.845776243,0.249686122,3.387357839,0.000705693,0.003527877,10774,11183,7991,12281,10289,12249,10094,8460,9464,9788,6871,8904,sp,P17074,RS19_RAT,69.63,135,40,1,1,405,1,134,1.32E-66,202,P17074,reviewed,RS19_RAT,Small ribosomal subunit protein eS19 (40S ribosomal protein S19),Rps19,Rattus norvegicus (Rat),145,"antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; monocyte chemotaxis [GO:0002548]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; Notch signaling pathway [GO:0007219]; nucleolus organization [GO:0007000]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]",GO:0000028; GO:0000462; GO:0002548; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006364; GO:0006412; GO:0007000; GO:0007219; GO:0014069; GO:0015935; GO:0017134; GO:0019901; GO:0022626; GO:0022627; GO:0030218; GO:0030490; GO:0031369; GO:0032040; GO:0042274; GO:0042802; GO:0045202; GO:0060265; GO:0060266; GO:0061844
g23830,11112.26495,0.977313747,0.251882639,3.880036162,0.000104441,0.000702875,11493,16400,10064,10362,10793,14011,9401,6669,7894,10707,9877,9311,sp,G1TFM5,RS5_RABIT,90.547,201,19,0,16,618,4,204,1.04E-136,384,G1TFM5,reviewed,RS5_RABIT,Small ribosomal subunit protein uS7 (40S ribosomal protein S5),RPS5,Oryctolagus cuniculus (Rabbit),204,ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],GO:0000028; GO:0003729; GO:0003735; GO:0005730; GO:0006412; GO:0019843; GO:0022626; GO:0022627
g8633,183.6909178,-1.189550375,0.255038154,-4.66420556,3.10E-06,3.29E-05,90,157,158,92,34,75,374,311,282,349,214,339,sp,Q6DH02,RM24_DANRE,50.442,226,100,3,4,675,1,216,1.14E-74,228,Q6DH02,reviewed,RM24_DANRE,"Large ribosomal subunit protein uL24m (39S ribosomal protein L24, mitochondrial) (L24mt) (MRP-L24)",mrpl24 si:ch211-210h11.6 zgc:92702,Danio rerio (Zebrafish) (Brachydanio rerio),216,ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; translation [GO:0006412],GO:0003723; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0006754; GO:0045333
g22950,17935.18184,0.85391637,0.234629804,3.639419866,0.000273253,0.001589747,17847,24741,16807,21795,15895,18239,16601,10932,16385,15100,16389,16253,sp,P05388,RLA0_HUMAN,73.091,275,74,0,1,825,1,275,2.37E-141,404,P05388,reviewed,RLA0_HUMAN,Large ribosomal subunit protein uL10 (60S acidic ribosomal protein P0) (60S ribosomal protein L10E),RPLP0,Homo sapiens (Human),317,cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0036464; GO:0070062; GO:0070180; GO:0098794; GO:1990904
g17251,2117.554634,1.57437225,0.333700465,4.717920456,2.38E-06,2.60E-05,2700,2626,2083,3247,2579,2238,1255,925,1833,973,1666,877,sp,Q8R050,ERF3A_MOUSE,74.824,425,106,1,493,1767,209,632,0,688,Q8R050,reviewed,ERF3A_MOUSE,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (EC 3.6.5.-) (G1 to S phase transition protein 1 homolog),Gspt1 Erf3a,Mus musculus (Mouse),636,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]",GO:0000184; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006415; GO:0006449; GO:0018444; GO:0022626
g18210,13485.69093,1.033389249,0.280883665,3.679064954,0.000234091,0.001393809,16170,19478,11623,13658,13283,15955,14561,9848,10453,13995,4502,12247,sp,P51410,RL9_MOUSE,67.188,192,61,1,1,570,1,192,2.53E-96,280,P51410,reviewed,RL9_MOUSE,Large ribosomal subunit protein uL6 (60S ribosomal protein L9),Rpl9,Mus musculus (Mouse),192,cytoplasmic translation [GO:0002181]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236],GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0019843; GO:0022625; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242
g23759,11367.7429,0.756051084,0.262759802,2.877346838,0.004010345,0.015153832,12393,15158,9363,10217,10580,13174,9882,7180,8812,11839,11995,10761,sp,Q8ISP0,RS18_BRABE,86.26,131,18,0,1,393,1,131,1.14E-83,245,Q8ISP0,reviewed,RS18_BRABE,Small ribosomal subunit protein uS13 (40S ribosomal protein S18),RPS18,Branchiostoma belcheri (Amphioxus),152,translation [GO:0006412],GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843; GO:1990904
g14573,21281.47584,0.744190784,0.217372113,3.423579846,0.000618021,0.003162298,22203,23641,18290,23029,19429,24930,20764,17872,19049,21526,17365,18382,sp,P49165,RL4_URECA,68.802,359,111,1,13,1089,2,359,0,522,P49165,reviewed,RL4_URECA,Large ribosomal subunit protein uL4 (60S ribosomal protein L4) (L1),RPL4 RPL1,Urechis caupo (Innkeeper worm) (Spoonworm),386,translation [GO:0006412],GO:0003723; GO:0003735; GO:0006412; GO:0022625
g15019,8702.448958,0.719627349,0.294253592,2.445602599,0.01446103,0.043272791,10196,12567,7140,7157,7422,10044,7724,5745,5931,7445,12223,7595,sp,Q9GNE2,RL23_AEDAE,88.976,127,14,0,40,420,14,140,3.71E-79,233,Q9GNE2,reviewed,RL23_AEDAE,Large ribosomal subunit protein uL14 (60S ribosomal protein L23) (AeRpL17A) (L17A),RpL23-A RpL17A AAEL013097; RpL23-B AAEL013583; RpL23-C AAEL015006,Aedes aegypti (Yellowfever mosquito) (Culex aegypti),140,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412; GO:1990904
g3214,7045.763729,0.938589692,0.250789054,3.742546488,0.000182165,0.001126848,7735,8104,6007,8170,7250,8069,6410,4868,6051,7032,4130,6551,sp,G1SZ12,RL14_RABIT,61.538,130,50,0,1,390,1,130,2.65E-46,152,G1SZ12,reviewed,RL14_RABIT,Large ribosomal subunit protein eL14 (60S ribosomal protein L14),RPL14,Oryctolagus cuniculus (Rabbit),218,ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412],GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0042273
g14704,10175.79973,1.099321377,0.300945132,3.652896358,0.000259299,0.001519834,11242,11078,8075,11648,12044,12635,9026,5649,7269,9966,5300,9972,sp,Q3T0B7,RS27L_BOVIN,92.857,84,6,0,1,252,1,84,2.79E-49,153,Q3T0B7,reviewed,RS27L_BOVIN,Small ribosomal subunit protein eS27-like (40S ribosomal protein S27-like),RPS27L,Bos taurus (Bovine),84,ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627; GO:0046872
g2420,22317.48488,0.761256614,0.265359774,2.86877172,0.004120691,0.015518804,25466,25292,19206,23962,20272,25072,17881,14605,20249,21652,25834,17335,sp,Q90Z10,RL13_DANRE,71.134,194,56,0,1,582,1,194,6.84E-93,273,Q90Z10,reviewed,RL13_DANRE,Large ribosomal subunit protein eL13 (60S ribosomal protein L13),rpl13,Danio rerio (Zebrafish) (Brachydanio rerio),211,embryonic cranial skeleton morphogenesis [GO:0048701]; regulation of cell cycle [GO:0051726]; translation [GO:0006412],GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0048701; GO:0051726
g18317,79.84153995,-1.33010275,0.419762908,-3.168700053,0.001531223,0.006793015,40,66,26,68,7,37,200,70,129,203,100,148,sp,Q0VFH6,RM22_XENTR,56.742,178,75,2,280,810,28,204,1.11E-67,211,Q0VFH6,reviewed,RM22_XENTR,"Large ribosomal subunit protein uL22m (39S ribosomal protein L22, mitochondrial) (L22mt) (MRP-L22)",mrpl22,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),204,translation [GO:0006412],GO:0003735; GO:0005739; GO:0005762; GO:0006412
g16424,7200.551812,0.929171008,0.257045715,3.614808395,0.00030057,0.001719298,8329,9611,6255,7589,6944,8164,5479,4938,4840,6089,7211,6710,sp,P33095,RS15A_STRPU,91.538,130,11,0,1,390,1,130,9.74E-88,254,P33095,reviewed,RS15A_STRPU,Small ribosomal subunit protein uS8 (40S ribosomal protein S15a) (Ribosomal protein S24),RPS15A,Strongylocentrotus purpuratus (Purple sea urchin),130,translation [GO:0006412],GO:0003735; GO:0006412; GO:0022627
g16116,4512.928363,1.019573035,0.253247886,4.025988338,5.67E-05,0.000411545,5130,6295,4521,5347,4089,4941,4890,3484,3461,4153,1599,4433,sp,P18101,RL40_DROME,97.656,128,3,0,1,384,1,128,1.06E-89,258,P18101,reviewed,RL40_DROME,Ubiquitin-ribosomal protein eL40 fusion protein (CEP52) [Cleaved into: Ubiquitin; Large ribosomal subunit protein eL40 (60S ribosomal protein L40)],RpL40 Ubi-f UBI-F52 CG2960,Drosophila melanogaster (Fruit fly),128,cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; translation [GO:0006412]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0006412; GO:0006511; GO:0016567; GO:0019941; GO:0022625; GO:0022627; GO:0031386; GO:0031625; GO:0036211
g9254,18348.9864,0.819490903,0.217768937,3.763121198,0.000167806,0.001052987,20093,19254,15666,20936,17005,22440,18606,15372,15444,16462,14688,15610,sp,O01727,RS6_BRAFL,81.967,244,43,1,1,732,1,243,2.05E-146,411,O01727,reviewed,RS6_BRAFL,Small ribosomal subunit protein eS6 (40S ribosomal protein S6),RPS6,Branchiostoma floridae (Florida lancelet) (Amphioxus),244,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412; GO:1990904
g17568,7661.615053,1.080860375,0.303965515,3.555865127,0.000376737,0.002086103,8570,11168,6944,9093,7733,8119,5682,4196,5329,4970,9341,5240,sp,P29314,RS9_RAT,90.588,170,16,0,13,522,8,177,5.91E-100,290,P29314,reviewed,RS9_RAT,Small ribosomal subunit protein uS4 (40S ribosomal protein S9),Rps9,Rattus norvegicus (Rat),194,positive regulation of cell population proliferation [GO:0008284]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],GO:0003735; GO:0005730; GO:0005737; GO:0006412; GO:0008284; GO:0019843; GO:0022626; GO:0022627; GO:0032040; GO:0042274; GO:0045182; GO:0045202; GO:1990904; GO:1990932
g22178,13102.7054,1.015003552,0.287643737,3.528682952,0.000417633,0.00226596,15657,20288,9135,12612,12881,16486,10280,7798,8182,11558,11747,12513,sp,O42387,RS24_TAKRU,77.863,131,28,1,1,393,1,130,3.14E-59,182,O42387,reviewed,RS24_TAKRU,Small ribosomal subunit protein eS24 (40S ribosomal protein S24),rps24,Takifugu rubripes (Japanese pufferfish) (Fugu rubripes),132,translation [GO:0006412],GO:0003735; GO:0005737; GO:0006412; GO:0044391
g10949,13044.80766,0.837495616,0.239214113,3.501029289,0.000463465,0.002476066,13758,18621,10491,13576,12624,13784,12535,9115,9956,12450,12444,11040,sp,P62907,RL10A_RAT,79.07,215,45,0,4,648,3,217,4.18E-111,320,P62907,reviewed,RL10A_RAT,Large ribosomal subunit protein uL1 (60S ribosomal protein L10a),Rpl10a,Rattus norvegicus (Rat),217,cytoplasmic translation [GO:0002181]; response to ethanol [GO:0045471]; translation [GO:0006412],GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0014069; GO:0022625; GO:0022626; GO:0045202; GO:0045471
g22835,73.23213815,-1.197408412,0.426695277,-2.806237792,0.005012369,0.018267007,24,26,77,68,20,16,133,144,149,138,96,79,sp,Q6B860,RT14_BOVIN,51.37,146,51,2,1,432,1,128,4.03E-43,141,Q6B860,reviewed,RT14_BOVIN,"Small ribosomal subunit protein uS14m (28S ribosomal protein S14, mitochondrial) (MRP-S14) (S14mt)",MRPS14,Bos taurus (Bovine),128,mitochondrial translation [GO:0032543]; translation [GO:0006412],GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0032543
g2446,236.9445478,-1.422026641,0.397911575,-3.57372525,0.000351938,0.001967605,110,117,146,164,83,38,382,270,308,510,698,283,sp,S4R2K0,DEFM_MOUSE,49.724,181,91,0,10,552,50,230,1.15E-57,184,S4R2K0,reviewed,DEFM_MOUSE,"Peptide deformylase, mitochondrial (EC 3.5.1.88) (Polypeptide deformylase)",Pdf,Mus musculus (Mouse),231,co-translational protein modification [GO:0043686]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412],GO:0005739; GO:0006412; GO:0008284; GO:0042586; GO:0043686; GO:0046872
g18280,228.8111438,-0.755383593,0.226774806,-3.330985513,0.000865391,0.004199439,184,176,180,132,62,169,382,407,345,383,361,204,sp,O54873,AIMP1_CRIGR,42.953,298,148,4,664,1521,72,359,1.85E-67,224,O54873,reviewed,AIMP1_CRIGR,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-II) (Small inducible cytokine subfamily E member 1)],AIMP1 SCYE1,Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),359,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412],GO:0000049; GO:0001525; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006412; GO:0006915; GO:0006954; GO:0017101; GO:0070094
g9910,6452.160958,0.815956711,0.32421106,2.516745452,0.011844437,0.036784639,7015,9449,4371,5993,6623,7014,4874,3655,5176,5707,7816,5789,sp,O61462,RL37A_CRYST,85.87,92,13,0,1,276,1,92,2.92E-41,133,O61462,reviewed,RL37A_CRYST,Large ribosomal subunit protein eL43 (60S ribosomal protein L37a),RPL37A,Cryptochiton stelleri (Giant gumboot chiton),92,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412; GO:0046872; GO:1990904
g23480,19.87067832,-3.019619249,1.18876043,-2.540141121,0.011080775,0.034875261,6,0,7,11,0,0,44,49,40,86,0,44,sp,Q0VCQ4,RRFM_BOVIN,55.618,178,79,0,208,741,69,246,1.61E-65,207,Q0VCQ4,reviewed,RRFM_BOVIN,"Ribosome-recycling factor, mitochondrial (RRF) (Ribosome-releasing factor, mitochondrial)",MRRF,Bos taurus (Bovine),262,ribosome disassembly [GO:0032790]; translation [GO:0006412],GO:0005739; GO:0006412; GO:0032790; GO:0043023
g19369,18751.12667,0.623582392,0.225130555,2.769870102,0.005607865,0.0200208,20494,22399,14592,17333,17510,19990,19820,16030,15714,19684,16104,19458,sp,P62752,RL23A_RAT,80.87,115,22,0,190,534,42,156,9.57E-61,188,P62752,reviewed,RL23A_RAT,Large ribosomal subunit protein uL23 (60S ribosomal protein L23a),Rpl23a,Rattus norvegicus (Rat),156,ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],GO:0000027; GO:0003735; GO:0005634; GO:0005737; GO:0006412; GO:0022625; GO:0022626; GO:0045202; GO:0070180; GO:1904841
g18429,24299.01843,0.74584029,0.238285553,3.130027312,0.001747901,0.007597389,24931,31766,20292,20680,23660,28683,23956,18939,20942,26299,19156,22175,sp,P62909,RS3_RAT,90.476,231,22,0,1,693,1,231,1.54E-152,428,P62909,reviewed,RS3_RAT,Small ribosomal subunit protein uS3 (EC 4.2.99.18) (40S ribosomal protein S3),Rps3,Rattus norvegicus (Rat),243,apoptotic process [GO:0006915]; base-excision repair [GO:0006284]; cell division [GO:0051301]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412],GO:0003677; GO:0003684; GO:0003723; GO:0003729; GO:0003735; GO:0003906; GO:0004520; GO:0005634; GO:0005730; GO:0005737; GO:0005743; GO:0005759; GO:0005829; GO:0005840; GO:0005886; GO:0006281; GO:0006284; GO:0006412; GO:0006915; GO:0006974; GO:0007059; GO:0008017; GO:0010628; GO:0014069; GO:0015631; GO:0017148; GO:0019899; GO:0019900; GO:0019901; GO:0022626; GO:0022627; GO:0030425; GO:0030544; GO:0031116; GO:0031334; GO:0031397; GO:0032357; GO:0032358; GO:0032587; GO:0032743; GO:0034614; GO:0042104; GO:0042981; GO:0044390; GO:0044877; GO:0045202; GO:0045738; GO:0045739; GO:0050862; GO:0051018; GO:0051225; GO:0051301; GO:0051879; GO:0061481; GO:0070181; GO:0070301; GO:0071159; GO:0071356; GO:0072686; GO:0097100; GO:0140078; GO:0140297; GO:1901224; GO:1902231; GO:1905053; GO:1990090; GO:1990904; GO:2001235
g655,15424.24033,1.156253949,0.26705996,4.32956685,1.49E-05,0.000129008,17220,18484,12204,19386,16800,19566,12847,9855,12407,12942,8350,12825,sp,P62083,RS7_RAT,78.866,194,41,0,7,588,1,194,2.02E-110,316,P62083,reviewed,RS7_RAT,Small ribosomal subunit protein eS7 (40S ribosomal protein S7) (S8),Rps7,Rattus norvegicus (Rat),194,negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural crest cell differentiation [GO:0014033]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412],GO:0001843; GO:0003730; GO:0003735; GO:0005634; GO:0005730; GO:0005813; GO:0006364; GO:0006412; GO:0008266; GO:0010628; GO:0014033; GO:0019901; GO:0022626; GO:0022627; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1990904; GO:1990948; GO:2000059
g24032,29899.91829,0.934071249,0.284040519,3.288514085,0.001007177,0.004787077,34735,48007,25077,19522,29258,39266,25033,20262,21517,33770,20729,27286,sp,Q26481,RL5_STYCL,75.338,296,71,1,1,888,1,294,1.25E-160,452,Q26481,reviewed,RL5_STYCL,Large ribosomal subunit protein uL18 (60S ribosomal protein L5),RPL5,Styela clava (Sea squirt),295,translation [GO:0006412],GO:0003735; GO:0005634; GO:0005737; GO:0005840; GO:0006412; GO:0008097; GO:1990904
g3344,1597.760932,0.808996289,0.261404397,3.094807504,0.001969407,0.008392416,1978,1912,1631,1839,1548,1253,1850,1249,1262,2056,678,1511,sp,P60522,GBRL2_RAT,73.276,116,31,0,1,348,1,116,7.07E-60,182,P60522,reviewed,GBRL2_RAT,Gamma-aminobutyric acid receptor-associated protein-like 2 (GABA(A) receptor-associated protein-like 2) (Ganglioside expression factor 2) (GEF-2) (Golgi-associated ATPase enhancer of 16 kDa) (GATE-16),Gabarapl2 Gef2,Rattus norvegicus (Rat),117,autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein localization to endoplasmic reticulum [GO:0070972]; protein transport [GO:0015031],GO:0000045; GO:0000139; GO:0000421; GO:0000422; GO:0005737; GO:0005776; GO:0005789; GO:0005794; GO:0006995; GO:0008429; GO:0015031; GO:0031410; GO:0031625; GO:0070972; GO:0097352; GO:1901799
g16749,673.9120492,0.617833253,0.244232224,2.529695893,0.011416143,0.035675693,1164,722,589,652,616,410,938,595,494,631,681,574,sp,Q7Z6L1,TCPR1_HUMAN,43.831,616,325,7,2302,4098,533,1144,3.70E-167,535,Q7Z6L1,reviewed,TCPR1_HUMAN,Tectonin beta-propeller repeat-containing protein 1,TECPR1 KIAA1358,Homo sapiens (Human),1165,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096],GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0043231; GO:0097352; GO:1901096
g17176,150.6575296,-1.32541662,0.418334122,-3.16832061,0.001533223,0.006796876,62,77,116,130,28,42,378,271,216,393,68,291,sp,O94817,ATG12_HUMAN,63.83,94,34,0,94,375,47,140,6.37E-45,145,O94817,reviewed,ATG12_HUMAN,Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like),ATG12 APG12 APG12L,Homo sapiens (Human),140,autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; glycophagy [GO:0061723]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of viral translation [GO:1904973]; regulation of autophagosome maturation [GO:1901096],GO:0000045; GO:0000421; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0016236; GO:0030670; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0034727; GO:0043231; GO:0045824; GO:0050687; GO:0061723; GO:0097352; GO:1901096; GO:1904973; GO:1990234
g1872,430.9500762,-1.023777763,0.315902865,-3.240799236,0.001191951,0.005518009,150,321,453,303,94,193,1130,794,598,749,365,695,sp,Q99570,PI3R4_HUMAN,53.89,1414,578,21,1,4188,1,1358,0,1424,Q99570,reviewed,PI3R4_HUMAN,Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein),PIK3R4 VPS15,Homo sapiens (Human),1358,autophagosome maturation [GO:0097352]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241],GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005930; GO:0006468; GO:0006622; GO:0006623; GO:0010506; GO:0015630; GO:0016020; GO:0016236; GO:0016241; GO:0030242; GO:0030670; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0036092; GO:0042149; GO:0043231; GO:0043491; GO:0045022; GO:0045324; GO:0071561; GO:0097352; GO:0106310
g2075,794.6119887,1.029178979,0.202804721,5.074728907,3.88E-07,5.19E-06,1562,1012,881,806,654,644,860,538,544,758,432,721,sp,Q5R605,CHM1A_PONAB,59.296,199,77,1,10,606,1,195,5.83E-68,209,Q5R605,reviewed,CHM1A_PONAB,Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a),CHMP1A PCOLN3,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),196,autophagosome maturation [GO:0097352]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; nuclear membrane reassembly [GO:0031468]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005828; GO:0007080; GO:0015031; GO:0016363; GO:0030496; GO:0031468; GO:0032509; GO:0032585; GO:0039702; GO:0043162; GO:0045324; GO:0046761; GO:0061952; GO:0097352; GO:1901673; GO:1902774; GO:1904930
g12900,555.0512908,1.364437665,0.239277469,5.702324051,1.18E-08,2.37E-07,1071,659,696,411,609,607,453,299,355,477,341,340,sp,Q8CGS4,CHMP3_RAT,61.435,223,81,2,1,654,1,223,2.95E-66,206,Q8CGS4,reviewed,CHMP3_RAT,Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein sorting-associated protein 24) (rVps24p),Chmp3 Vps24,Rattus norvegicus (Rat),223,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of cytokinesis [GO:0032467]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of endosome size [GO:0051036]; regulation of mitotic spindle assembly [GO:1901673]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005546; GO:0005643; GO:0005765; GO:0005769; GO:0005770; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006997; GO:0007080; GO:0008333; GO:0010824; GO:0015031; GO:0030496; GO:0031210; GO:0031410; GO:0031468; GO:0032467; GO:0032509; GO:0032585; GO:0039702; GO:0043162; GO:0044790; GO:0045324; GO:0046761; GO:0051036; GO:0051258; GO:0061763; GO:0061952; GO:0071985; GO:0097352; GO:0140678; GO:1901673; GO:1902774; GO:1904930; GO:1990381; GO:2000641
g14682,1533.555792,1.602748672,0.247443228,6.477237979,9.34E-11,2.91E-09,2695,1766,2168,1388,1690,1929,1147,685,677,978,1226,797,sp,Q4QQV8,CHMP5_RAT,71.689,219,62,0,1,657,1,219,4.84E-98,287,Q4QQV8,reviewed,CHMP5_RAT,Charged multivesicular body protein 5 (Chromatin-modifying protein 5),Chmp5,Rattus norvegicus (Rat),219,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; endosome to lysosome transport [GO:0008333]; erythrocyte differentiation [GO:0030218]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; lysosome organization [GO:0007040]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],GO:0000421; GO:0000776; GO:0001778; GO:0001919; GO:0005634; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007040; GO:0007080; GO:0008333; GO:0010824; GO:0015031; GO:0030218; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0039702; GO:0043162; GO:0046761; GO:0061952; GO:0071222; GO:0071225; GO:0071985; GO:0097352; GO:1901673; GO:1902774; GO:1904930
g19769,451.5904072,-1.107626659,0.299962669,-3.692548355,0.000222018,0.001331592,202,429,438,139,86,262,1083,656,772,770,581,692,sp,Q63615,VP33A_RAT,62.007,608,209,7,1,1800,1,594,0,782,Q63615,reviewed,VP33A_RAT,Vacuolar protein sorting-associated protein 33A (r-vps33a),Vps33a,Rattus norvegicus (Rat),597,autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle-mediated transport [GO:0016192],GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0016192; GO:0030123; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0035751; GO:0043473; GO:0044877; GO:0048070; GO:0048471; GO:0071439; GO:0097352
g19020,173.4340301,2.122647802,0.394522164,5.380300509,7.44E-08,1.21E-06,245,180,216,95,287,311,103,81,86,56,54,91,sp,Q9Z2P6,SNP29_RAT,41.176,68,40,0,55,258,190,257,3.99E-11,60.1,Q9Z2P6,reviewed,SNP29_RAT,Synaptosomal-associated protein 29 (SNAP-29) (Golgi SNARE of 32 kDa) (Gs32) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29),Snap29,Rattus norvegicus (Rat),257,autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082],GO:0000139; GO:0000421; GO:0005484; GO:0005737; GO:0005776; GO:0005886; GO:0006887; GO:0008021; GO:0015031; GO:0016082; GO:0016240; GO:0019905; GO:0020018; GO:0031201; GO:0031629; GO:0043195; GO:0060271; GO:0097352; GO:0098693; GO:0098850; GO:2000300
g2401,1695.33763,1.03936002,0.173404416,5.993849768,2.05E-09,4.82E-08,3171,1911,1934,1617,1470,1650,2077,1231,1358,1221,1095,1229,sp,O75351,VPS4B_HUMAN,69.321,427,122,2,13,1281,7,428,0,567,O75351,reviewed,VPS4B_HUMAN,Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1),VPS4B SKD1 VPS42 MIG1,Homo sapiens (Human),444,angiogenesis [GO:0001525]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; canonical Wnt signaling pathway [GO:0060070]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; establishment of blood-brain barrier [GO:0060856]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],GO:0000922; GO:0001525; GO:0001778; GO:0005524; GO:0005634; GO:0005643; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006813; GO:0006914; GO:0006997; GO:0007033; GO:0007080; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016236; GO:0016887; GO:0030301; GO:0030496; GO:0031468; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0046761; GO:0051261; GO:0060070; GO:0060856; GO:0061738; GO:0061764; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:1901673; GO:1903542; GO:1903543; GO:1903724; GO:1904903; GO:1904949
g1447,15111.59746,1.640544969,0.324675797,5.052871148,4.35E-07,5.78E-06,23115,14364,14613,18800,20762,18543,9586,6852,9186,7080,12576,7029,sp,P23787,TERA_XENLA,87.223,767,96,2,2155,4455,10,774,0,1330,P23787,reviewed,TERA_XENLA,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (p97) (Valosin-containing protein) (VCP),vcp,Xenopus laevis (African clawed frog),805,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985],GO:0000785; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0042802; GO:0043161; GO:0044877; GO:0061857; GO:0097352; GO:1903843; GO:1905634
g19019,308.7521553,1.989230387,0.354662062,5.608805107,2.04E-08,3.82E-07,411,417,393,189,529,401,217,135,167,190,91,121,sp,Q0II86,SNP29_BOVIN,41.489,94,52,1,145,417,35,128,2.82E-16,76.6,Q0II86,reviewed,SNP29_BOVIN,Synaptosomal-associated protein 29 (SNAP-29) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29),SNAP29,Bos taurus (Bovine),258,autophagosome maturation [GO:0097352]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082],GO:0000139; GO:0000421; GO:0005484; GO:0005776; GO:0005886; GO:0006887; GO:0015031; GO:0016082; GO:0019905; GO:0020018; GO:0031201; GO:0031410; GO:0031629; GO:0060271; GO:0097352; GO:0098793
g15024,973.4485068,0.954725692,0.388569843,2.457024676,0.014009306,0.042193917,1154,490,653,1658,1181,919,1320,799,542,943,511,860,sp,Q9HCE0,EPG5_HUMAN,30.813,886,539,15,1,2592,1746,2579,1.79E-94,330,Q9HCE0,reviewed,EPG5_HUMAN,Ectopic P granules protein 5 homolog,EPG5 KIAA1632,Homo sapiens (Human),2579,autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162],GO:0005737; GO:0005764; GO:0006862; GO:0008333; GO:0032456; GO:0034162; GO:0048471; GO:0097352; GO:1990786
g15023,1241.93982,1.190409882,0.410285024,2.901421723,0.003714736,0.014208388,1658,630,895,1962,1612,1388,1955,870,448,1198,621,766,sp,Q9HCE0,EPG5_HUMAN,34.458,1541,863,27,1447,5892,254,1706,0,734,Q9HCE0,reviewed,EPG5_HUMAN,Ectopic P granules protein 5 homolog,EPG5 KIAA1632,Homo sapiens (Human),2579,autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162],GO:0005737; GO:0005764; GO:0006862; GO:0008333; GO:0032456; GO:0034162; GO:0048471; GO:0097352; GO:1990786
g12129,6611.832074,1.10614453,0.247272839,4.473376595,7.70E-06,7.28E-05,8931,9095,6756,6110,7549,6268,5178,3952,4604,5595,5751,5006,sp,P60517,GBRAP_RAT,93.966,116,7,0,7,354,1,116,1.15E-76,225,P60517,reviewed,GBRAP_RAT,Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein),Gabarap,Rattus norvegicus (Rat),117,autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein transport [GO:0015031]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rac protein signal transduction [GO:0035020],GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000422; GO:0005764; GO:0005776; GO:0005790; GO:0005794; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008429; GO:0008625; GO:0015031; GO:0015629; GO:0031410; GO:0031625; GO:0032436; GO:0035020; GO:0044297; GO:0048471; GO:0048487; GO:0050811; GO:0097225; GO:0097352; GO:0098696; GO:0098982; GO:0099091; GO:1902524
g4218,2704.023843,4.558149407,0.553261137,8.238694363,1.74E-16,1.44E-14,2043,1389,1815,5358,7604,3605,341,209,317,247,165,326,sp,Q9BXW4,MLP3C_HUMAN,76.271,118,28,0,19,372,9,126,2.03E-62,190,Q9BXW4,reviewed,MLP3C_HUMAN,Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C) (MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma),MAP1LC3C,Homo sapiens (Human),147,aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; protein exit from endoplasmic reticulum [GO:0032527],GO:0000045; GO:0000421; GO:0000422; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008429; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0032527; GO:0035973; GO:0036464; GO:0097352
g14647,317.479228,-1.115178772,0.330365548,-3.375590396,0.000736575,0.003658951,222,117,182,317,87,114,618,361,438,653,678,401,sp,Q9H269,VPS16_HUMAN,54.034,533,240,3,1,1584,303,835,0,558,Q9H269,reviewed,VPS16_HUMAN,Vacuolar protein sorting-associated protein 16 homolog (hVPS16),VPS16,Homo sapiens (Human),839,"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]",GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0010008; GO:0016197; GO:0030136; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0042144; GO:0055037; GO:0097352
g9303,2581.872791,1.153947796,0.208790703,5.526815979,3.26E-08,5.82E-07,4054,2700,2690,3377,2527,2534,2663,1976,2131,1928,1271,1805,sp,Q9UMX0,UBQL1_HUMAN,58.609,302,111,2,481,1344,179,480,6.68E-102,323,Q9UMX0,reviewed,UBQL1_HUMAN,Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1),UBQLN1 DA41 PLIC1,Homo sapiens (Human),589,aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0036503; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1904294
g21630,328.4367915,1.242444462,0.48239645,2.575567175,0.010007583,0.032147891,299,143,205,809,446,226,255,239,222,202,252,230,sp,O70404,VAMP8_MOUSE,47.692,65,34,0,28,222,9,73,1.44E-15,69.3,O70404,reviewed,VAMP8_MOUSE,Vesicle-associated membrane protein 8 (VAMP-8) (Endobrevin) (Edb),Vamp8,Mus musculus (Mouse),101,autophagosome maturation [GO:0097352]; cellular response to type II interferon [GO:0071346]; defense response to virus [GO:0051607]; establishment of localization in cell [GO:0051649]; membrane fusion [GO:0061025]; mucus secretion [GO:0070254]; positive regulation of pancreatic amylase secretion [GO:1902278]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of endocytosis [GO:0030100]; SNARE complex assembly [GO:0035493]; symbiont entry into host cell [GO:0046718]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]; zymogen granule exocytosis [GO:0070625],GO:0005484; GO:0005739; GO:0005764; GO:0005765; GO:0005769; GO:0005829; GO:0005886; GO:0006906; GO:0009986; GO:0015031; GO:0016192; GO:0016323; GO:0019905; GO:0030100; GO:0030141; GO:0030496; GO:0031201; GO:0031901; GO:0031902; GO:0035493; GO:0042588; GO:0042589; GO:0045178; GO:0045335; GO:0046718; GO:0051607; GO:0051649; GO:0055037; GO:0061025; GO:0065003; GO:0070254; GO:0070625; GO:0071346; GO:0097352; GO:0098594; GO:1902278; GO:1990794